WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals...

162
1 DISCLOSURE SUMMARY ACCME Definition OF A Commercial Interest: A commercial interest is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. This IASLC CME educational activity was planned and developed to: uphold academic standards to ensure balance, independence, objectivity and scientific rigor; adhere to requirements to protect health information under the Health Insurance Portability and Accountability Act of 1996 (HIPAA); and include a mechanism to inform learners when unapproved or unlabeled uses of therapeutic products or agents are discussed or referenced. IASLC CME Department assures that the planners/reviewers/authors/faculty/peer reviewers et al. conflicts of interest were identified, reviewed and resolved from all individuals involved in the development or able to influence and control the content of this CME activity. The IASLC CME Department assures that disclosure is given prior to an educational activity being delivered to learners. Any individual who failed or refused to disclose relevant financial relationships was disqualified from this CME activity and removed from all IASLC CME activity presentations. All commercial relationships and conflicts of interest that are identified are thoroughly vetted by IASLC Ethics Committee, CME Subcommittee and an independent reviewer. COI will be evaluated by the IASLC Board of Directors for fair balance, scientific objectivity of studies utilized in this activity and patient care recommendations. The IASLC CME Department is committed to providing its learners with high- quality CME activities and related materials that promote improvements or quality in health care and not a specific proprietary business interest of a commercial entity. A conflict of interest (COI) is created and exists when individuals in a position to control the content of CME (or their spouses/partners) have a relevant personal financial relationship within the past 12 months with a commercial interest that produces, markets, re-sells or distributes health care goods or services consumed by, or used on, patients that benefits the individual in any financial amount and therefore may bias their opinions and teachings. This may include receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds) or any other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research and clinical trials), consulting, speaking and teaching, membership on advisory committees or review panels, board membership and other activities for which remuneration is received or expected. The intent of this disclosure is not to prevent a speaker with a relevant financial or other relationship from making the presentation, but rather to identify and resolve any conflicts of interest that may control the content of the activity. It is also intended that any potential conflict be identified openly so that the listeners have a full disclosure of the facts and may form their own judgments about the presentation. It remains for the audience to determine whether the speaker’s interests or relationships may influence the presentation with regard to exposition or conclusion.

Transcript of WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals...

Page 1: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

1

DISCLOSURESUMMARY

ACCME Definition OF A Commercial Interest: A commercial interest is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

This IASLC CME educational activity was planned and developed to: uphold academic standards to ensure balance, independence, objectivity and scientific rigor; adhere to requirements to protect health information under the Health Insurance Portability and Accountability Act of 1996 (HIPAA); and include a mechanism to inform learners when unapproved or unlabeled uses of therapeutic products or agents are discussed or referenced.

IASLC CME Department assures that the planners/reviewers/authors/faculty/peer reviewers et al. conflicts of interest were identified, reviewed and resolved from all individuals involved in the development or able to influence and control the content of this CME activity. The IASLC CME Department assures that disclosure is given prior to an educational activity being delivered to learners. Any individual who failed or refused to disclose relevant financial relationships was disqualified from this CME activity and removed from all IASLC CME activity presentations.

All commercial relationships and conflicts of interest that are identified are thoroughly vetted by IASLC Ethics Committee, CME Subcommittee and an independent reviewer. COI will be evaluated by the IASLC Board of Directors for fair balance, scientific objectivity of studies utilized in this activity and patient care recommendations. The IASLC CME Department is committed to providing its learners with high-quality CME activities and related materials that promote improvements or quality in health care and not a specific proprietary business interest of a commercial entity.

A conflict of interest (COI) is created and exists when individuals in a position to control the content of CME (or their spouses/partners) have a relevant personal financial relationship within the past 12 months with a commercial interest that produces, markets, re-sells or distributes health care goods or services consumed by, or used on, patients that benefits the individual in any financial amount and therefore may bias their opinions and teachings. This may include receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds) or any other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research and clinical trials), consulting, speaking and teaching, membership on advisory committees or review panels, board membership and other activities for which remuneration is received or expected.

The intent of this disclosure is not to prevent a speaker with a relevant financial or other relationship from making the presentation, but rather to identify and resolve any conflicts of interest that may control the content of the activity. It is also intended that any potential conflict be identified openly so that the listeners have a full disclosure of the facts and may form their own judgments about the presentation. It remains for the audience to determine whether the speaker’s interests or relationships may influence the presentation with regard to exposition or conclusion.

Page 2: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

2

All other faculty/contributors have reported no commercial affiliation associated with this conference or intent to reference off-label/unapproved uses of products or devices in their presentations.

All planning committee members, faculty’s, reviewers, authors et al. identified conflicts of interest pertaining to this activity were resolved prior to the activity.

NO commercial Support was provided to fund this activity.

Page 3: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

3

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

   

First Name Last Name Nature of Relevant Financial Relationship

Name of Company(s)

Taher Abbasi Employee (full time or part time) Cellworks Group

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Cellworks Group

Other Cellworks Group

Antonello Abbattista Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Pfizer

Employee (full time or part time) Pfizer

Ahmed Abdulla Employee (full time or part time) Roche

Amy Abernethy Employee (full time or part time) Flatiron Health

Pranav Abraham Employee (full time or part time) Bristol-Meyers Squibb

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Bristol-Meyers Squibb

Salary Bristol-Meyers Squibb

Bonne Adams Employee (full time or part time) Tracon Pharmas

Bambang Adiwijaya Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Merrimack Pharmas

Salary Sage Therapeutics

Brittany Admire Employee (full time or part time) Roche

Page 4: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

4

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Joachim Aerts Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Amphera

Speakers or Advisory Board Bristol-Meyers Squibb, Merck Oncology, Boehringer Ingelheim, Eli-Lilly, Roche, Ampera

Speakers Bureau AstraZeneca, Verastem

Supported/Contracted Research/Grant

Genentech, AstraZeneca

Royalty, Intellectual Property/Patent Holder

Tumor cell lysate for dendritic cell loading

Charu Aggarwal Speakers or Advisory Board Celgene, Bristol-Meyers Squibb

Zuleima Aguilar Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Janssen

Salary Janssen

Employee (full time or part time) Janssen

Jason Agulnik Honoraria Merck, Pfizer, Bristol-Meyers Squibb, AstraZeneca

Samreen Ahmed Other Bristol-Meyers Squibb, Merck, Takeda

Myung-Ju Ahn Other AstraZeneca, Bristol-Meyers Squibb, Boehringer Ingelheim, Merck, Novartis, Alpha BioPharmas

Speakers or Advisory Board AstraZeneca, Eli Lilly, Bristol-Meyers Squibb, Merck, Ono Pharma, Roche

Dara Aisner Other AbbVie, Genentech, Bristol-Meyers Squibb

Honoraria AbbVie, Bristol Meyers Squibb, Inivata

Aparna Aiyer Employee (full time or part time) Thermo Fisher Scientific

Page 5: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

5

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Hiroaki Akamatsu Honoraria AstraZeneca, Ono Pharma, Boehringer Ingelheim, Taiho Pharma, Chugai Pharma, Bristol-Meyers Squibb, Eli Lilly Japan, Merck, Novartis, Pfizer

Supported/Contracted Research/Grant

Merck, Eli Lilly

Speakers or Advisory Board Eli Lilly

Lee Albacker Employee (full time or part time) Foundation Medicine

Siraj Ali Employee (full time or part time) Foundation Medicine

Nava Almog Employee (full time or part time) Foundation Medicine

Nasser Altorki Supported/Contracted Research/Grant

AstraZeneca

Nelusha Amaladas Employee (full time or part time) Eli Lilly

Helen Ambrose Other AstraZeneca

Karen Andreas Salary Boston Pharmas

Samuel Angiouli Employee (full time or part time) Personal Genome Diagnostics

Scott Antonia Speakers or Advisory Board Bristol-Meyers Squibb, Novartis, Merck, Cellular Biomedicine Group, Boehringer Ingelheim, AstraZeneca, MedImmune, Memgen, FLX Bio

Supported/Contracted Research/Grant

Novartis

Keisuke Aoe Supported/Contracted Research/Grant

Ono Pharmas, Eli Lilly, AstraZeneca, Merck, Bristol-Meyers Squibb

Honoraria Ono Pharmas AstraZeneca, Bristol-Meyers Squibb, Novartis, Merck, Eli Lilly

Speakers or Advisory Board Ono Pharmas, Boehringer Ingelheim, Bristol-Meyers Squibb

Page 6: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

6

Maria Arcila Speakers or Advisory Board RainDance Technologies

Other Raindance Technologies

Andrea Ardizzoni Supported/Contracted Research/Grant

Bristol-Meyers Squibb, Celgene

Speakers or Advisory Board Bristol-Meyers Squibb, Merck, Boehringer Ingelheim

Honoraria Eli Lilly, Bristol-Meyers Squibb, Merck, Boehringer Ingleheim, Pfizer

Brandon Arnieri Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Roche

Salary Genentech

Employee (full time or part time) Genentech

Other Roche

Carlos Arteta Employee (full time or part time) Optellum

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Optellum

Hisao Asamura Honoraria Lecturer of seminar - Johnson & Johnson, Covidien, Eli Lilly, Taiho, Boehringer Ingelheim, Ono Pharmaceuticals

Thomas Asfeldt Honoraria Association of Community Cancer Centers

Vasileios Askoxylakis Employee (full time or part time) Merrimack Pharmas

Marie-Liesse Asselin-Labat Supported/Contracted Research/Grant

Servier

Stephanie Astrow Employee (full time or part time) Kite Pharma

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Kite Pharma

Royalty, Intellectual Property/Patent Holder

Kite Pharma

Page 7: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

7

Shinji Atagi Honoraria Merck, Chugai Pharma, Ono Pharma, AstraZeneca, Nippon Boehringer Ingelheim, Pfizer, Bristol-Meyers Squibb, Hisamitsu Pharma, Eli Lilly, Taiho

Supported/Contracted Research/Grant

Merck, Chugai Pharma, Ono Pharma, AstraZeneca, Taiho Pharma, Nippon Boehringer Ingelheim, Pfizer, Bristol-Meyers Squibb, Eli Lilly

Speakers Bureau Ono Pharma, Bristol-Meyers Squibb, Taiho Pharma, Chugai Pharma, AstraZeneca, Eli Lilly, Boehringer Ingelheim

Jean-Sebastien Aucoin Other AstraZeneca, Bristol-Meyers Squibb, Merck, Roche

 

Page 8: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

8

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Clarisse Audigier-Valette

Other Bristol-Meyers Squibb, Foundation Medicine Roche, AbbVie, Pfizer, Merck, AstraZeneca, Boerhinger Ingelheim, Eli Lilly, Novartis, Amgen

Speakers or Advisory Board Roche, Pfizer, Boeringer Ingelheim, Novartis, AstraZeneca, Eli Lilly, Amgen, Bristol-Meyers Squibb, Sysmex, Merck, Clovis Oncology, AbbVie

Supported/Contracted Research/Grant

Roche, Bristol-Meyers Squibb

Jean Bernard Auliac Speakers or Advisory Board AstraZeneca, Roche, Bristol-Meyers Squibb

Supported/Contracted Research/Grant

Pfizer

Mark Awad Other Genentech, Merck, Pfizer, Boehringer Ingelheim, AbbVie, AstraZeneca, MedImmune, Clovis Oncology, Nektar, Bristol-Meyers Squibb, Ariad, Foundation Medicine, Syndax, Novartis

Koichi Azuma Supported/Contracted Research/Grant

Boehringer Ingelheim

Houda Bahig Contracted/Support Research Grant

Varian Medical System Reserach Grant

Bismark Baidoo Employee (full time or part time) McKesson

Christina Baik Speakers or Advisory Board Novartis

Supported/Contracted Research/Grant

Novartis, Loxo, Pfizer, AstraZeneca, Celgene, Roche, Genetech, Merck, MedImmune, Mirati, GlaxoSmithKline

Marcis Bajars Employee (full time or part time) Merck

Page 9: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

9

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Katherine Baker-Neblett Employee (full time or part time) Inivata, GlaxoSmithKline

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

GlaxoSmithKline

Dhananjay Bakhle Employee (full time or part time) Lupin Limited

David Baldwin Honoraria AstraZeneca

Karla Ballman Supported/Contracted Research/Grant

Natoinal Cancer Institute

Ani Balmanoukian Speakers Bureau Bristol-Meyers Squibb, Genentech, Merck, AstraZeneca

Sandeep Bansal Other Medtronic, Pinnacle Biologics, Sunovion Pharmas

Honoraria Pinnacle Biologics, Sunovion Pharmas

Speakers or Advisory Board Sunovion Pharmas

Ilze Bara Employee (full time or part time) Genentech

David Barbie Honoraria Johnson &Johnson, Covidien, Eli Lilly, Taiho, Boehringer Ingelheim, Ono Pharmas

Craig Barker Employee (full time or part time) AstraZeneca

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

AstraZeneca

Page 10: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

10

 

 

 

 

 

 

 

 

 

 

 

 

 

Fabrice Barlesi Speakers or Advisory Board AstraZeneca, Bristol-Meyers Squibb, Boehringer Ingelheim, Clovis Oncology, Eli Lilly, Roche, Novartis, Merck, Pierre Fabre, Pfizer, Takeda

Other Roche, Genentech., AstraZeneca, Bristol-Meyers Squibb, Boehringer Ingelheim, Clovis, Eli Lilly, Roche, Novartis, Merck, Pierre Fabre, Pfizer, Takeda

Supported/Contracted Research/Grant

AstraZeneca, Bristol-Meyers Squibb, Boehringer Ingelheim, Eli Lilly, Roche, Novartis, Merck, Pierre Fabre, Pfizer, Takeda

Honoraria AstraZeneca, Bristol-Meyers Squibb, Boehringer Ingelheim, Clovis Oncology, Eli Lilly, Roche, Novartis, Merck, Pierre Fabre, Pfizer, Takeda, Serono

Giulia Barletta Employee (full time or part time) AstraZeneca

Page 11: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

11

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Carlos Barrios Honoraria Novartis, Roche, Genentech, Pfizer, GlaxoSmithKline, Sanofi, Boehringer Ingelheim, Eisai

Other Boehringer Ingelheim, Roche, Genentech, Novartis, GlaxoSmithKline, Eisai, Pfizer

Supported/Contracted Research/Grant

Pfizer, Novartis, Amgen Inc., AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Roche, Genentech, Eli Lilly, Sanofi, Taiho Pharma, Mylan, Merrimack, Merck, AbbVie, Astellas Pharma, Biomarin, Bristol-Meyers Squibb, Daiichi Sankyo, Abraxis BioScience, AB Science, Asana Biosciences, Medivation, Exelixis, ImClone Systems, Leo Pharma, Millennium

José Barrueco Employee (full time or part time) Boehringer Ingelheim

Kabya Basu Employee (full time or part time) Cellworks Research

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Cellworks Research

Page 12: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

12

Todd Bauer Speakers or Advisory Board Ignyta, Guardant Health, Loxo, Pfizer, Moderna Therapeutics

Employee (full time or part time) Tennessee Oncology, Sarah Cannon Research Institute

Supported/Contracted Research/Grant

Daiichi Sankyo, Medpacto, Incyte, Mirati Therapeutics, MedImmune, AbbVie, AstraZeneca, Leap Therapeutics, MabVax, Stemline Therapeutics, Merck, Eli Lilly, GlaxoSmithKline, Novartis, Pfizer, Principa Biopharma, Genentech, Roche, Deciphera, Merrimack, Immunogen, Millennium, Ignyta, Calithera Biosciences, Kolltan Pharmas, Principa Biopharma, Peleton, Immunocore, Aileron Therapeutics, Bristol-Meyers Squibb, Amgen, Moderna Therapeutics, Sanofi, Boehringer Ingelheim, Astellas Pharma

Jason Baum Employee (full time or part time) Novartis, Abbott Diabetes

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Novartis

Joshua Bauml Supported/Contracted Research/Grant

Merck, Novartis, Carevive Systems, Janssen, Bayer

Other Merck, Bristol-Meyers Squibb, Celgene, Boehringer-Ingelheim, AstraZeneca, Genentech, Guardant Health

Honoraria Clovis, Bristol-Meyers Squibb, Celgene, Boehringer Ingleheim, AstraZeneca, Genentech, Guardant Health

Alessandra Bearz Speakers or Advisory Board AstraZeneca, Pfizer, Eli Lilly, Bristol-Meyers Squibb, Novartis, Roche, Merck, Boehringer Ingelheim, Takeda

Page 13: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

13

Mary Beth Beasley Honoraria Genentech, Merck, Bristol-Meyers Squibb

Hubert Beaumont Employee (full time or part time) Median Technologies

John Beeler Employee (full time or part time) Inivata

Mike Beggs Employee (full time or part time) MagArray

Jill Bell Other Millennium Pharmas, Takeda

Tim Bell Employee (full time or part time) VisionGate

R. Joseph Bender Employee (full time or part time) Perthera

Jaafar Bennouna Speakers or Advisory Board Roche, Boehringer Ingelheim, AstraZeneca, Bristol-Meyers Squibb

Honoraria Roche, Boehringer Ingelheim, AstraZeneca, Bristol-Meyers Squibb

Sadia Benzaquen Other Medtronic

Christine Berg Honoraria Medial Early Sign LLC, GRAIL

Emily Bergsland Supported/Contracted Research/Grant

Novartis, Merck

Royalty, Intellectual Property/Patent Holder

UpToDate

Peter Berzinec Speakers or Advisory Board Boehringer Ingelheim, Roche, Merck

Benjamin Besse Supported/Contracted Research/Grant

Roche, AstraZeneca

Akihiro Bessho Honoraria Chugai Pharma, Eli Lily

Speakers Bureau Chugai Pharma

Christine Bestvina Speakers or Advisory Board AbbVie

Page 14: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

14

Prabhu Bhagavatheeswaran

Employee (full time or part time) Bristol-Meyers Squibb

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Bristol-Meyers Squibb

Mandar Bhonde Employee (full time or part time) Lupin

Rafia Bhore Employee (full time or part time) Celgene Corporation

Paolo Bidoli Other Eli Lilly, Bristol-Meyers Squibb, Boehringer Ingelheim

Paolo Bironzo Speakers or Advisory Board Bristol-Meyers Squibb, Boehringer Ingelheim

Honoraria Bristol-Meyers Squibb

Normand Blais Speakers or Advisory Board AstraZeneca, Merck, Sanofi Canada, Bristol-Meyers Squibb, Roche Canada, Boehringer Ingelheim, Bayer, Pfizer

Collin Blakely Other Jazz Pharmas

Supported/Contracted Research/Grant

Mirati, Ignyta, MedImmune, Novartis, Clovis, AstraZeneca

Ken Bloom Employee (full time or part time) Human Longevity

Other Human Longevity

Honoraria Genentech, Roche, Ventana Medical Systems, Merck, Bristol-Meyers Squibb

Speakers or Advisory Board Ventana Medical Systems, Roche, Bristol-Meyers Squibb

Speakers Bureau Genentech

George Blumenschein Supported/Contracted Research/Grant

Xcovery Holding Company

Speakers or Advisory Board Bristol-Meyers Squibb, Bayer, Clovis, Merck, Celgene, AbbVie, Ariad

Page 15: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

15

Paolo Boffetta Honoraria Nucleix

Contracted/Support Research Grant

National Institute for Occupational Safety and Health

Zeev Bomzon Employee (full time or part time) Novocure

Steven Boniol Honoraria Janssen

Speakers or Advisory Board Janssen

Speakers Bureau Janssen, Bristol Meyers-Squibb

Other Johnson & Johnson

Philip Bonomi Honoraria AstraZeneca, Bristol-Meyers Squibb, Biodesix, Merck, Pfizer, Roche Genentech, Trovagene, Eli Lilly, Clovis, Imedex

Speakers or Advisory Board AstraZeneca, Bristol-Meyers Squibb, Biodesix, Merck, Pfizer, Roche Genentech, Trovagene, Eli Lilly, Clovis, Imedex

Supported/Contracted Research/Grant

AstraZeneca, Bristol-Meyers Squibb, Corvus Pharmas, Five Prime Therapeutics, Biodesix, Roche Genentech, Eli Lilly, Merck, Pfizer

Other Data Monitoring Committee: Genentech, Pfizer

Anne-Marie Boothman Employee (full time or part time) AstraZeneca

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

AstraZeneca

Page 16: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

16

Hossein Borghaei Supported/Contracted Research/Grant

Bristol-Meyers Squibb, Eli Lilly, Genentech, Celgene, Merck, Pfizer, Millennium

Speakers or Advisory Board Bristol-Meyers Squibb, Eli Lilly, Genentech, Celgene, Merck, Pfizer, Boerhinger Ingelheim, AstraZeneca, Genmab, Trovagene, Novartis, Regeneron, Cantargia AB, BioNTech

Other University of Pennsylvania MIllennium

Employee (full time or part time) Fox Chase Cancer Center

Diana Borthwick Speakers or Advisory Board Boerhinger Ingelheim, Novartis, Merck, Bristol-Meyers Squibb

Joaquim Bosch Barrera Speakers or Advisory Board Boheringer Ingelheim

Nandita Bose Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Biothera

Johan Botling Honoraria AstraZeneca, Merck, Roche, Pfizer, Bristol-Meyers Squibb, Boehringer Ingelheim, Novartis

Dean Bottino Employee (full time or part time) Millennium Pharma

Souheil Boubia Speakers Bureau Medtronic

Honoraria Medtronic

Nicole Bouchard Supported/Contracted Research/Grant

Pfizer, Bristol-Meyers Squibb, Merck

Speakers or Advisory Board Bristol-Meyers Squibb, Merck, Roche

J. Philip Boudreaux Speakers Bureau Ipsen BioPharmas, Novartis, Lexicon Pharma

Jill Bowman Employee (full time or part time) Incyte

Page 17: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

17

Michael Boyer Honoraria Roche, Bristol-Meyers Squibb, Merck, AstraZeneca, Novartis

Speakers or Advisory Board Merck, Amgen, Roche, Bristol-Meyers Squibb, Pfizer, AstraZeneca

Contracted/Support Research Grant

Merck, Amgen, Genentech, Roche, Bristol-Meyers Squibb, AstraZeneca, Novartis, Pfizer

Penelope Bradbury Honoraria AbbVie, Merck, Pfizer

Anthony Brade Speakers or Advisory Board AstraZeneca

Other Eli Lilly

Jeffrey Bradley Speakers or Advisory Board AstraZeneca, ViewRay, Varoian

Supported/Contracted Research/Grant

Mevion Medical Systems, Viewray

Manisha Brahmachary Employee (full time or part time) Eli Lilly

Julie Brahmer Speakers or Advisory Board Merck, Genetech, Bristol-Meyers Squibb, Syndax, AstraZeneca, Celgene, Amgen Oncology

Other Celgene, Eli Lilly, MedImmune, AstraZeneca, Bristol-Meyers Squibb

Supported/Contracted Research/Grant

Medimmune, AstraZeneca, Bristol-Meyers Squibb

Rachael Brake Employee (full time or part time) Millennium Pharmas, Cambridge, MA, Takeda

Rolf Brekken Honoraria BerGenBio ASA

Page 18: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

18

Emilio Bria Honoraria Merck, AstraZeneca, Celgene, Pfizer, Helsinn, Eli Lilly, Bristol-Meyers Squibb, Novartis, Roche

Supported/Contracted Research/Grant

Associazione Italiana Ricerca sul Cancro, IASCL, Lega Italiana per la Lotta contro i Tumori, Fondazione Cariverona, Astra-Zeneca, Roche, Open Innovation

Speakers Bureau Merck, Pfizer, Helsinn, Bristol-Meyers Squibb, Novartis

Speakers or Advisory Board Celgene, AstraZeneca, Roche

John Bridges Other ICON

Supported/Contracted Research/Grant

Lungevity

Honoraria Bayer, Boehringer Ingelheim

J. Michelle Brockman Employee (full time or part time) Genentech

Stephen Broderick Other Bristol-Meyers Squibb

Susan Brouwer Employee (full time or part time) Syndax

Anthony Brown Employee (full time or part time) BerGenBio ASA

Helen Brown Employee (full time or part time) AstraZeneca

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

AstraZeneca

Wolfram Brugger Other AstraZeneca

Rolf Bruns Employee (full time or part time) Merck

Page 19: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

19

 Odd Terje Brustugun Speakers or Advisory Board Novartis, Merck, Boehringer

Ingelheim, Ariad

Honoraria AstraZeneca, Bristol-Meyers Squibb, Roche, PierreFabre, Novartis, Pfizer, Boehringer Ingelheim, Merck, Eli Lilly

Supported/Contracted Research/Grant

Roche, AstraZeneca, GlaxoSmithKline, Novartis

Lukas Bubendorf Speakers or Advisory Board Roche, Bristol-Meyers Squibb, AbbVie, AstraZeneca, Novartis, Pfizer, Takeda, Merck

Honoraria Roche, Pfizer, Bristol-Meyers Squibb, Merck

Supported/Contracted Research/Grant

Roche, Merck

Other Roche, Roche, Pfizer, Bristol-Meyers Squibb

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Roche, Novartis

Employee Roche, Pfizer, Bristol-Meyers Squibb, Merck

Financial Support from Tobacco Company(ies)

Merck, Roche, Novartis

Raphael Bueno Supported/Contracted Research/Grant

NIH U01 SPECS II

Paul Bunn, Jr. Other AstraZeneca, Bristol-Meyers Squibb, Genentech, Eli Lilly, Pfizer, Merck, Novartis, Merrimack, Daiichi

Supported/Contracted Research/Grant

Genentech, Roche

Honoraria AstraZeneca, Guardant Health

Speakers or Advisory Board AstraZeneca, Bristol-Meyers Squibb, Eli Lilly, Genentech, Merck, MerckSerono, Takeda

Page 20: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

20

Mark Burkard Speakers or Advisory Board Strata Oncology

Thomas Burke Employee (full time or part time) Merck

Ronald Burkes Speakers or Advisory Board AstraZeneca, Roche, Boehringer Ingelheim, Merck, Eli Lilly, Amgen

Page 21: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

21

Charles Butts Honoraria Pfizer, Boehringer Ingelheim, AstaZeneca, Bristol-Meyers Squibb, Merck, Takeda

Speakers or Advisory Board Pfizer, AstraZeneca, Boehringer Ingelheim, Bristol-Meyers Squibb, Merck, Takeda

Jacques Cadranel Speakers or Advisory Board Boerhinger Ingelheim, AstraZeneca, Roche

Junliang Cai Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Bristol-Meyers Squibb

Employee (full time or part time) Bristol-Meyers Squibb

Wilson Caldwell Employee (full time or part time) Regeneron Pharmas

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Regeneron Pharmas, Bristol-Meyers Squibb, Merck

Raffaele Califano Other AstraZeneca, Bristol-Meyers Squibb, Roche, Merck, Boehringer Ingelheim, Takeda, Novartis, Pfizer, Eli Lilly

Speakers Bureau Bristol-Meyers Squibb, AstraZeneca, Medimmune, Roche, Novartis, Merck, Eli Lilly

Speakers or Advisory Board Bristol-Meyers Squibb, AstraZeneca, Medimmune, Roche, Takeda, Novartis, Merck, Eli Lilly

Honoraria Bristol-Meyers Squibb, AstraZeneca, Medimmune, Roche, Takeda, Novartis, Merck, Eli Lilly

Kim Caliri Employee (full time or part time) Merrimack Pharma

Page 22: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

22

Emiliano Calvo Supported/Contracted Research/Grant

Boehringer Ingelheim, Roche, Genentech, Bristol-Meyers Squibb, Novartis, PsiOxus, Nanobiotix, Janssen, AbbVie, PharmaMar, PUMA, Sanofi, Eli Lilly, Pfizer, Merck, Nektar, Amcure, Amgen, AstraZeneca, Principia, Bayer, CytomX, H3, Incyte, Kura, Loxo, Macrogenics, Menarini, Serono, Merus, Millenium, Rigontec, Tahio, TesaroReceipt

Honoraria Novartis, Nanobiotix, Janssen-Cilag, PsiOxus Therapeutics, Seattle Genetics, Pierre Fabre, Boehringer Ingelheim, Cerulean Pharma, EUSA, AbbVie, Celgene

Speakers Bureau Novartis, Nanobiotix, Janssen-Cliag, PsiOxus, Genetics, Pierre Fabre, Boehringer Ingelheim

Ross Camidge Honoraria Takeda, G1 Therapeutics, Mersana Therapeutics, Roche, Genentech, AstraZeneca, Arrys/Kyn, Genoptix, Ignyta, Daichii Sankyo, Hansoh SRC, Bio-Thera, Lycera, Revolution Med, Orion, Clovis, Celegene, Novartis

Supported/Contracted Research/Grant

Ariad, Takeda, Pfizer

Speakers or Advisory Board AstraZeneca, Takeda, Arrys/Kyn, Genoptix, G1 Therapeutics, Mersana Therapeutics, Roche, Genentech, Takeda, Ignyta, Daichii Sankyo, Hansoh SRC, Bio-Thera DSMB, Lycera, Revolution Med

Jeroen Cant Employee (full time or part time) Agfa HealthCare

Andrew Capen Employee (full time or part time) Eli Lilly

Page 23: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

23

Federico Cappuzzo Speakers or Advisory Board Bristol-Meyers Squibb, Merck, AstraZeneca, Pfizer, Roche

William Capra Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Roche

Salary Genentech

Employee (full time or part time) Genentech

Other Roche

David Carbone Other Genentech

Supported/Contracted Research/Grant

Merck, Bristol-Meyers Squibb

Speakers or Advisory Board AbbVie, Adaptimmune, Agenus, Amgen, Ariad, AstraZeneca, Biocept, Boehringer Ingelheim, Bristol-Meyers Squibb, Celgene, EMD Serono, Inc, Foundation Medicine, Genentech, Roche, Gritstone, Guardant Health, Inovio, Merck, Novartis, Palobiofarma, Pfizer, prIME Oncology, Stemcentrx, Takeda

Honoraria AbbVie, Adaptimmune, Agenus, Amgen, Ariad, AstraZeneca, Biocept, Boehringer Ingelheim, Bristol-Meyers Squibb, Celgene, Foundation Medicine, Genentech, Roche, Gritstone, Guardant Health, Inovio, Merck, Novartis, Palobiofarma, Pfizer, prIME Oncology, Stemcentrx, Takeda

Luis Carbonell Employee (full time or part time) MagArray

Cynthia Card Speakers or Advisory Board Boehringer Ingelheim

Carmine Carpenito Employee (full time or part time) Eli Lilly

Page 24: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

24

Marina Carpentieri Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Pfizer

Employee (full time or part time) Pfizer

Philippe Carriere Employee (full time or part time) Boehringer Ingelheim

Marion Carrigan Employee (full time or part time) Merck

Ken Carson Employee (full time or part time) Flatiron Health

Francesca Cavallo Employee (full time or part time) Personal Genome Diagnostics

Pilar Cazorla Arratia Employee (full time or part time) Novartis

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Novartis

Fabiola Cecchi Employee (full time or part time) NantOmics

Anne Marie Cerato Honoraria AstraZeneca, Roche, Takeda

Other Bristol-Meyers Squibb

Giovanni Ceresoli Supported/Contracted Research/Grant

Bayer

Andres Cervantes Speakers or Advisory Board Roche

Honoraria Roche

Supported/Contracted Research/Grant

Genentech, Roche

Jamie Chaft Other Genentech, Roche, AstraZeneca, MedImmune, Merck, Bristol-Meyers Squibb

Supported/Contracted Research/Grant

Genentech, Roche, Bristol-Meyers Squibb, AstraZeneca, MedImmune

Speakers or Advisory Board Genentech, Bristol-Meyers Squibb, Merck, AstraZeneca

Carlos Chaib Employee (full time or part time) Bristol-Myers Squibb

Yajnaseni Chakraborti Employee (full time or part time) Novartis

Page 25: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

25

Oscar S.H. Chan Speakers or Advisory Board AstraZeneca, Merck

Honoraria Bristol-Meyers Squibb, AstraZeneca

Sheenu Chandwani Employee (full time or part time) Merck

Gee-Chen Chang Honoraria Roche, Eli Lilly and Company Oncology, AstraZeneca, Pfizer, Boehringer Ingelheim, Bristol-Meyers Squibb, Merck

Joe Chang Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Global Oncoloe One

Supported/Contracted Research/Grant

Bristol-Meyers Squibb

Bo Chao Employee (full time or part time) Eli Lilly

Sandra Chaplan Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Janssen

Salary Janssen

Employee (full time or part time) Janssen

Haris Charalambous Supported/Contracted Research/Grant

Merck

Aafia Chaudhry Employee (full time or part time) Eli Lilly

Parneet Cheema Speakers or Advisory Board Pfizer, AstraZeneca, Roche, Merck, Novartis, Takeda, Boehringer Ingelheim, Bristol-Meyers Squibb

Nabil Chehab Employee (full time or part time) AstraZeneca

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

AstraZeneca

Hui Chen Employee (full time or part time) OrigiMed

Page 26: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

26

Shuquan Chen Employee (full time or part time) Daiichi Sankyo

Paul Ning-Man Cheng Royalty, Intellectual Property/Patent Holder

Bio-cancer Treatment

Salary Bio-cancer Treatment

Carol Cheung Honoraria Merck, Bristol-Meyers Squibb

Page 27: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

27

 Anne Chiang Speakers or Advisory Board AstraZeneca, AbbVie

Other AstraZeneca

Supported/Contracted Research/Grant

AstraZeneca, AbbVie

Speakers Bureau Bristol-Meyers Squibb

Alberto Chiappori Speakers or Advisory Board Genentech, Merck, Takeda, AstraZeneca, Bristol-Meyers Squibb, Novartis

Supported/Contracted Research/Grant

Novartis, Bristol-Meyers Squibb, AstraZeneca

Speakers Bureau Genentech, Takeda, Merck, Boehringer Ingelheim, Celgene, Pfizer

James Chih-Hsin Yang Honoraria Boehringer Ingelheim, Eli Lilly, Roche, Genentech, Chugai, Merck, Pfizer, Novartis, Celgene, Bristol-Meyers Squibb, Ono Pharma, AstraZeneca, Takeda, Hansoh Pharmas

Darin Chin Employee (full time or part time) Eli Lilly

Marc Chioda Employee (full time or part time) Pfizer

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Pfizer

Michael Chisamore Employee (full time or part time) Merck

Juliann Chmielecki Employee (full time or part time) AstraZeneca

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

AstraZeneca

Page 28: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

28

Byoung Chul Cho Honoraria AstraZeneca, Boehringer Ingelheim, Novartis, Ono Pharmas

Other AstraZeneca, Janssen, MedImmune, Merck, Novartis, Ono Pharma, Pfizer, Roche, Yuhan

Speakers Bureau Novartis

Krishna Chodavarapu Employee (full time or part time) Eli Lilly

Soongyu Choi Employee (full time or part time) Yuhan Corporation

Quentin Chometon Employee (full time or part time) Optellum

Teh-Ying Chou Speakers or Advisory Board Merck, Foundation Medicine, Roche, Novartis

Christos Chouaid Speakers or Advisory Board Roche, Boehringer Ingelheim, AstraZeneca, Eli Lilly, Novartis, Merck, Bristol-Meyers Squibb, GlaxoSmithKline, Amgen

Jouhara Chouitar Employee (full time or part time) Millennium Pharmas, Cambridge, MA, Takeda

Laura Chow Speakers or Advisory Board Bristol-Meyers Squibb, Merck, Genentech, Astra-Zeneca, Seattle Genetics, Pfizer, Novartis, Dynavax

Other Bristol-Meyers Squibb

Honoraria Amgen, Sanofi-Genzyme, Takeda

Supported/Contracted Research/Grant

Bristol Meyers Squibb, Merck, Genentech, Astra-Zeneca, Pfizer, Seattle Genetics, Novartis, Dynavax, VentiRx, Eli Lilly, Imclone, Incyte

Edna Chow-Maneval Employee (full time or part time) Ignyta

Hak Choy Speakers Bureau AstraZeneca

Honoraria AstraZeneca, Merck

Page 29: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

29

Paula Chu Employee (full time or part time) Roche

Shannon Chuai Employee (full time or part time) Burning Rock Biotech

Mattia Cinelli Supported/Contracted Research/Grant

Inivata

Employee (full time or part time) Inivata

Andrew Ciupek Speakers or Advisory Board Takeda Pharmas, AbbVie, Grail, Genentech

Jill Clancy Employee (full time or part time) Pfizer

Jeffrey Clark Supported/Contracted Research/Grant

Pfizer

C Clifford Employee (full time or part time) Blueprint Medicines

Roger Cohen Supported/Contracted Research/Grant

Merck

Esther Conde Speakers or Advisory Board Pfizer, Roche

Henry Conter Other Roche, Eli Lilly, Janssen

Keegan Cooke Employee (full time or part time) Amgen

Wendy Cooper Speakers or Advisory Board Bristol-Meyers Squibb, Merck, AstraZeneca

Other Travel support

Romain Corre Speakers or Advisory Board Bristol-Meyers Squibb

Stefani Corsi-Travali Employee (full time or part time) Loxo

Alexis Cortot Speakers or Advisory Board AstraZeneca, Roche, Pfizer, Takeda, Novartis

Daniel Costa Speakers or Advisory Board Tadeka, AstraZeneca

Honoraria Pfizer, Tadeka

Supported/Contracted Research/Grant

Pfizer

Other Ariad

Page 30: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

30

Christian Couture Speakers or Advisory Board AstraZeneca, Merck, Bristol-Meyers Squibb, Pfizer

Honoraria AstraZeneca, Merck, Bristol-Meyers Squibb, Pfizer

Supported/Contracted Research/Grant

AstraZeneca, Merck, Bristol-Meyers Squibb, Pfizer

Honoraria AstraZeneca, Merck, Bristol-Meyers Squibb, Pfizer

Michael Cox Employee (full time or part time) Loxo

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Loxo

Angela Coxon Employee (full time or part time) Amgen

Jeffrey Crawford Speakers or Advisory Board Amgen

Diana Cripps Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

AstraZeneca

Employee (full time or part time) AstraZeneca

Marka Crittenden Supported/Contracted Research/Grant

Jounce, Nanobiotix

Victoria Crossland Employee (full time or part time) Takeda

Scott Cruickshank Employee (full time or part time) Loxo

Agnieszka Cseh Employee (full time or part time) Boehringer Ingelheim

J. Jean Cui Employee (full time or part time) TP Therapeutics

Na Cui Employee (full time or part time) Roche, Genentech

Zhanglin Cui Employee (full time or part time) Eli Lilly

Page 31: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

31

 Alessandra Curioni

Fontecedro Other Bristol-Meyers Squibb, Merck,

Roche, AstraZeneca, Pfizer, Takeda, Novartis, Boehringer Ingelheim

Speakers or Advisory Board Roche, Merck, Bristol-Meyers Squibb, Boehringer-Ingelheim, Pfizer, AstraZeneca, Takeda

Supported/Contracted Research/Grant

Novartis

Martin Curtis Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Janssen

Employee (full time or part time) Janssen

Salary Janssen

Paul Curtis Employee (full time or part time) Regeneron Pharma

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Regeneron Pharma

Sanja Dacic Speakers or Advisory Board Bristol-Meyers Squibb, Astra-Zeneca

Honoraria Bristol-Meyers Squibb, AstraZeneca

Ibiayi Dagogo-Jack Honoraria Foundation Medicine

Other Boehringer Ingelheim

Suzanne Dahlberg Other AstraZeneca

Page 32: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

32

Samir Dalia Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

32nd Street Surgery Center

Speakers or Advisory Board New Century Health

Supported/Contracted Research/Grant

Novartis Bristol-Meyers Squibb, Calithera, Helsinn, Genentech, Celgene

Deepa Dalvi Employee (full time or part time) Roche

Bita Damadzadeh Employee (full time or part time) Roche

Gina D'Amato Speakers or Advisory Board Novartis, Bayer, Eisai, Eli Lilly, Janssen

Speakers Bureau Novartis, Eisai, Eli Lilly, Janssen

Thomas D'Amico Other Consultant for Scanlan Instruments

Speakers or Advisory Board Scanlon

Kathleen Danenberg Employee (full time or part time) Nant Health, Liquid Genomics

Peter Danenberg Employee (full time or part time) Liquid Genomics

Thao Dang Employee (full time or part time) Merck

Jeannie Daniel Employee (full time or part time) Incyte

Marianne Davies Speakers Buerau AstraZeneca, Genentech, Bristol-Meyers Squibb, Merck

Gilberto De Castro Speakers or Advisory Board AstraZeneca

Floris De Jong Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Amgen, Shire

Employee (full time or part time) Shire

Filippo De Marinis Honoraria Bristol-Meyers Squibb, AstraZeneca, Roche, Merck

Cisio De Oliveira Brandao

Employee (full time or part time) Amgen

Ownership Interest (stocks or stock options, or other

Amgen

Page 33: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

33

 ownership interest Excluding diversified mutual funds)

Page 34: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

34

Peter De Porre Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Johnson & Johnson

Employee (full time or part time) Johnson & Johnson

Michael De Rosa Employee (full time or part time) Adelphi Values

Other Bristol-Meyers Squibb

Maike De Wit Supported/Contracted Research/Grant

AstraZeneca

Speakers or Advisory Board AstraZeneca

Jerome Declerck Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Optellum

Employee (full time or part time) Optellum

Chantal Decroisette Speakers or Advisory Board Roche, Bristol-Meyers Squibb, Boehringer Ingelheim, AstraZeneca, Pierre Fabre, Novartis

Justine Degrandpre Employee (full time or part time) Thermo Fisher Scientific

Angelo Delmonte Other AstraZeneca, Boehringer Ingelheim

Todd Demmy Other Medtronic

Phillip Dennis Employee (full time or part time) AstraZeneca

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

AstraZeneca

Other AstraZeneca

Charuhas Deshpande Speakers Bureau Merck

Frank Detterbeck Speakers or Advisory Board Spiration

Supported/Contracted Research/Grant

Medela

Geeta Devgan Ownership Interest (stocks or stock options, or other

Pfizer

Page 35: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

35

ownership interest Excluding diversified mutual funds)

Employee (full time or part time) Pfizer

Rasvan Diaconescu Honoraria Merck, Bristol-Meyers Squibb

Sven Diederichs Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Biotech, Martinsried

Maximilian Diehn Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

CiberMed

Honoraria Roche

Supported/Contracted Research/Grant

Varian Medical Systems

Royalty, Intellectual Property/Patent Holder

Patents on Cancer Biomarkers

Martin Dietrich Speakers Bureau AstraZeneca, Novartis

Speakers or Advisory Board AstraZeneca, Novartis, Takeda

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Pfizer

Beiying Ding Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Roche

Salary Roche/Genentech

Employee (full time or part time) Roche, Genentech

Other Roche

Lieming Ding Employee (full time or part time) Bettapharma Pharmas

Yan Ding Employee (full time or part time) Geneseeq Technology

Winand Dinjens Supported/Contracted Research/Grant

AstraZeneca

Page 36: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

36

Honoraria Thermo Fisher, Life, Roche, Bristol-Meyers Squibb

Speakers or Advisory Board Amgen

Page 37: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

37

Robert Doebele Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Rain Therapeutics

Speakers or Advisory Board Ignyta, AstraZeneca, Bayer, Takeda, Bristol-Meyers Squibb, Ariad

Supported/Contracted Research/Grant

Ignyta

Other Pfizer, OncoMed, Trovagene, Ignyta, GreenPeptide, AstraZeneca, Ignyta, Ariad, Guardant Health

Honoraria Pfizer, AstraZeneca, Ariad, Guardant Health, Takeda, Spectrum Pharmas, Trovagene

Royalty, Intellectual Property/Patent Holder

Abbott Molecular, Rain Therapeutics, Igynta

Toshihiko Doi Supported/Contracted Research/Grant

Daiichi Sankyo

Thompson Doman Employee (full time or part time) Eli Lilly

Yu-An Dong Employee (full time or part time) OrigiMed

Jessica Donington Honoraria AstraZeneca

Gregory Donoho Employee (full time or part time) Eli Lilly

Frank Dorsey Employee (full time or part time) Eli Lilly

Helene Doubre Speakers or Advisory Board Novartis

Supported/Contracted Research/Grant

Merck, Bristol-Meyers Squibb, Boehringer Ingelheim, AstraZeneca

Afshin Dowlati Other AbbVie, Stemcentrx, Ariad, Amgen, Bristol-Meyers Squibb, Mercl, Eli Lilly, MedImmune, OncoMed

Page 38: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

38

Nick Dowson Employee (full time or part time) Optellum

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Optellum

Alexander Drilon Speakers or Advisory Board Ignyta, Loxo, TP Therapeutics, AstraZeneca, Pfizer, Blueprint Medicines, Genentech, Roche, Takeda, Helsinn Therapeutics, BeiGene

Honoraria TP Therapeutics, Loxo, Ignyta, Roche, Genentech, Pfizer

Supported/Contracted Research/Grant

Foundation Medicine

Other Ignyta, Loxo, TP Therapeutics, AstraZeneca, Pfizer, Blueprint Medicines, Genentech, Roche, Takeda, Helsinn Therapeutics, BeiGene

Erik Jan Dubbink Supported/Contracted Research/Grant

AstraZeneca

Speakers or Advisory Board Pfizer, Personal Genome Diagnostics

Steven Dubinett Speakers or Advisory Board T-Cure, EarlyDiagnostics, AstraZeneca

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

EarlyDiagnostics

Royalty, Intellectual Property/Patent Holder

Patent holder DC-CCL21

Elizabeth Dudnik Other Boehringer Ingelheim, Merck, Roche, AstraZeneca, Pfizer, Bristol-Meyers Squibb, Novartis

Mei Sheng Duh Supported/Contracted Research/Grant

AstraZeneca

Other AstraZeneca

Page 39: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

39

Gary Dukart Speakers or Advisory Board Xcovery Holding Company

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Xcovery Holding Company

Addie Dvir Employee (full time or part time) Oncotest Teva Pharmas

Rafal Dziadziuszko Speakers or Advisory Board Roche, AstraZeneca, Pfizer, Bristol Meyers-Squibb, Ignyta

Honoraria Roche, Pfizer, Novartis, Ignyta, AstraZeneca, Bristol-Meyers Squibb

Speakers Bureau Roche, Bristol-Meyers Squibb, AstraZeneca

Beth Eaby-Sandy Speakers Bureau Helsinn, Merck, AstraZeneca, Takeda

Other Consultant- AbbVie

Kevin Ebata Employee (full time or part time) Loxo

Wilfried Ernst Erich

Eberhardt Speakers or Advisory Board Bristol-Meyers Squibb, Roche, AstraZeneca, Merck, Boehringer Ingelheim, Celgene, Eli Lilly, Pfizer, Novartis, Takeda, AbbVie

Honoraria Bristol-Meyers Squibb, Roche, AstraZeneca, Merck, Boehringer Ingelheim, Celgene, Eli Lilly, Pfizer, Novartis, Takeda, AbbVie

Supported/Contracted Research/Grant

Eli Lilly, Bristol-Meyers Squibb, AstraZeneca

Other Bristol-Meyers Squibb, Roche, AstraZeneca, Boehringer Ingelheim

François Eisinger Honoraria Roche

Martin Edelman Speakers or Advisory Board Bristol-Meyers Squibb, Eli Lilly

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Andarix, Biomarker

Page 40: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

40

Supported/Contracted Research/Grant

Bristol-Meyers Squibb

Other Eli Lilly, Boehringer Ingelheim, AstraZeneca

David Eiznhamer Salary Kadmon Corporation, LLC

Ehab Elgabry Employee (full time or part time) Roche

Ivy Elkins Speakers or Advisory Board Astrazeneca

Honoraria Boehringer Ingelheim, AstraZeneca, AbbVie

Barbara Ellers-Lenz Employee (full time or part time) Merck KGaA

Peter Ellis Honoraria AbbVie, AstraZeneca

Other Celegene, Mylan

Sotaro Enatsu Employee (full time or part time) Eli Lilly

Masahiro Endo Honoraria AstraZeneca

Judson Englert Employee (full time or part time) MedImmune, LLC

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

MedImmune, LLC

Rachel Erlich Employee (full time or part time) Foundation Medicine

Carin Espenschied Employee (full time or part time) Guardant Health

Janet Espirito Employee (full time or part time) McKesson

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

McKesson

E Evans Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Blueprint Medicines

Employee (full time or part time) Blueprint Medicines

Page 41: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

41

Supported/Contracted Research/Grant

AstraZeneca, Celgene, Roche, Boehringer Ingelheim, Eli Lilly

Tracey Evans Speakers Bureau Genentech

Honoraria Genentech

William Evans Speakers or Advisory Board AbbVie, Astellas, Bristol-Meyers Squibb, Eisai, Eli Lilly, Janseen, Gilead, Takeda, AstraZeneca, Janssen, Boehringer Ingelheim, Roche, Celgene

Other AstraZeneca, Janssen, Boehringer Ingelheim, Roche, Celgene

Corinne Faivre-Finn Supported/Contracted Research/Grant

Merck, AstraZeneca, Elekta

Other Merck, AstraZeneca, Elekta, Pfizer, Respective Meeting-Related Travel Support

Speakers or Advisory Board Pfizer, Merck

Honoraria AstraZeneca, Merck

Speakers Bureau AstraZeneca, Merck

lionel Falchero Speakers or Advisory Board Roche, Boehringer Ingelheim, Bristol-Meyers Squibb, Novartis, AstraZeneca, AbbVie

Markus Falk Speakers or Advisory Board Boehringer Ingelheim, Pfizer, Roche

Minhao Fan Employee (full time or part time) AstraZeneca

Anna Farago Supported/Contracted Research/Grant

AbbVie, Stemcentrx, PharmaMar, Ignyta, Bristol-Meyers Squibb, Merck, AstraZeneca, Novartis, Bayer, Loxo

Honoraria Foundation Medicine

Other AbbVie, PharmaMar, Takeda, Stemcentrx, Loxo, Bayer

Page 42: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

42

Speakers or Advisory Board AbbVie, Loxo, Pharmamar

Ori Farber Employee (full time or part time) Novocure

Claire Faure Employee (full time or part time) Roche Diagnostics

Emily Fay Employee (full time or part time) Optellum

Nathalie Faye Employee (full time or part time) Median Technologies

Bruce Feinberg Employee (full time or part time) Cardinal Health

Enriqueta Felip Other AstraZeneca, Boehringer Ingelheim, Bristol-Meyers Squibb Celgene, Eli Lilly, Guardant Health, Novartis, Pfizer, Roche, Takeda, Merck

Speakers or Advisory Board Boehringer Ingelheim, Eli Lilly, Pfizer, Roche, AstraZeneca, Bristol-Meyers Squibb, Novartis, AbbVie, Takeda, Celegene, Guardant Health, Merck

Speakers Bureau AstraZeneca, Boehringer Ingelheim, Bristol-Meyers Squibb, MSD, Novartis, Pfizer, Roche, Takeda, AbbVie, Merck, Celegne, Eli Lilly, Guardant Health

Federico Felizzi Employee (full time or part time) Roche

Minjie Feng Employee (full time or part time) Regeneron

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Regeneron, Bayer

Dean Fennell Speakers or Advisory Board AbbVie, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Meyers Squibb, Clovis, Eli Lilly, Lab21, Oncos, Polaris, Bristol-Meyers Squibb, Epizyme, Roche

Supported/Contracted Research/Grant

Boehringer Ingelheim, Bergen Bio, Bayer, Bristol-Meyers

Page 43: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

43

Squibb, Pierre Fabre, Eli Lilly, Roche-Genentech, Astex

Speakers Bureau Boehringer Ingelheim, Roche, Bristol-Meyers Squibb, Merck, AstraZeneca

Honoraria AbbVie, Boehringer Ingelheim, Bayer, Bristol-Meyers Squibb, Epizyme, Roche, AstraZeneca

Ancilla Fernandes Employee (full time or part time) AstraZeneca

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

AstraZeneca

Mary Jo Fidler Honoraria Genentech, Celgene, Merck, AbbVie

Speakers or Advisory Board AstraZeneca, AbbVie, Takeda, Genentech

Supported/Contracted Research/Grant

Biodesix

John Field Speakers Bureau Roche

Speakers or Advisory Board Epigenomics, VisonGate

Joseph Fiore Employee (full time or part time) Bristol-Meyers Squibb

Other Merck

Martin Filipits Speakers or Advisory Board AstraZeneca, Boehringer Ingelheim, Myriad

Homoraria AstraZeneca, Boehringer Ingelheim, Merck, Eli Lilly, Ratiopharm, Novartis

Juergen Fischer Speakers or Advisory Board AstraZeneca, Bristol-Meyers Squibb, Celgene, Roche, Merck, Boehringer Ingelheim,

Speakers Bureau AstraZeneca, Celgene, Roche

Honoraria AstraZeneca, Bristol-Meyers Squibb, Celgene, Roche, Merck, Boehringer Ingelheim

Page 44: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

44

Other Celgene

Amanda Fish Employee (full time or part time) MagArray,

Javier Flandes Other Medtronic, Olympus, BTG-PulmonX

Supported/Contracted Research/Grant

BTG-PulmonX

Emuella Flood Employee (full time or part time) ICON

Marie Florescu Speakers Bureau Roche, Bristol Meyers Squibb, AstraZeneca

Speakers or Advisory Board AstraZeneca, Roche, Bristol-Meyers Squibb, Merck, Boehringer Ingelheim

Erik Folch Other Medtronic

Speakers or Advisory Board Medtronic

Patrick Forde Supported/Contracted Research/Grant

AstraZeneca, Bristol-Meyers Squibb, Novartis, Kyowa, Janssen

Other Merck, Inivata, AbbVie, Boehringer Ingelheim

Speakers or Advisory Board Bristol-Meyers Squibb, AstraZeneca, Novartis, Merck

Tim Forshew Employee (full time or part time) Inivata

Martin Forster Speakers or Advisory Board Eli Lilly, Pfizer, Clovis, Novartis, Merck, AstraZeneca

Stefan Foser Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Roche

Salary Roche

Employee (full time or part time) Roche

Other Roche

Paul Foster Employee (full time or part time) Genentech

Page 45: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

45

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Roche, Exelixis

Garrett Frampton Employee (full time or part time) Foundation Medicine

Fabio Franke Speakers or Advisory Board Bristol-Meyers Squibb

Other Bristol-Meyers Squibb

Supported/Contracted Research/Grant

Bristol-Meyers Squibb

Stuart Fraser Employee (full time or part time) Oncimmune LLC

Elke K. Friedman Speakers Bureau Gilead Pharma

Employee (full time or part time) Virginia Cancer Institute

Matthias Friedrich Employee (full time or part time) Amgen

Osvaldo Frontera Other Bristol-Meyers Squibb, Roche, AstraZeneca, Regeneron

Honoraria Bristol-Meyers Squibb, Roche, Novartis

Nobukazu Fujimoto Honoraria Ono Pharmacuticals, Eli Lilly, Chugai, Taiho, Hisamitsu

Speakers or Advisory Board Boehringer Ingelheim, Bristol-Meyers Squibb, Kyorin

Supported/Contracted Research/Grant

Ono Pharmas, Novartis, GlaxosmithKline, Merck

Yuka Fujita Speakers Bureau Eli Lilly, Chugai Pharma

Supported/Contracted Research/Grant

Eli Lilly, Chugai Pharma, Taiho Pharma, Pfizer

Minoru Fukuda Supported/Contracted Research/Grant

AstraZeneca

Honoraria Taiho Pharma, Merck, Chugai Pharma, Boehringer Ingelheim

Page 46: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

46

Tatsuro Fukuhara Supported/Contracted Research/Grant

AstraZeneca, Merck, Ono Pharma, Bristol-Meyers Squibb, Chugai Pharma, Novartis

Tomoya Fukui Honoraria Chugai Pharma, Novartis Pharma, Ono Pharma, Taiho Pharma

Matthew Fury Employee (full time or part time) Regeneron Pharmas

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Regeneron Pharmas

Royalty, Intellectual Property/Patent Holder

Regeneron Pharmas

Rabab Gaafar Supported/Contracted Research/Grant

Roche, Boehringer Ingelheim, AbbVie, AstraZeneca

Louis Gaboury Supported/Contracted Research/Grant

AstraZeneca

Shirish Gadgeel Speakers or Advisory Board Astra-Zeneca, Genentech, Roche, Ariad, Takeda, AbbVie, Bristol Meyers-Squibb

Justin Gainor Other Bristol-Meyers Squibb, Genentech, Roche, Novartis, Loxo, Theravance, Clovis, Merck, Boehringer Ingelheim, Incyte, Affymetrix, Pfizer, Amgen, Agios

Honoraria Bristol-Meyers Squibb, Merck, Genentech, Roche, Pfizer, Array Biopharm, Loxo, Ariad, Takeda, Agios, Amgen, Novartis

Speakers or Advisory Board Bristol-Meyers Squibb, Array Biopharma, Ariad, Takeda, Theravance

Supported/Contracted Research/Grant

Genentech

Page 47: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

47

Thomas Gajewski Speakers or Advisory Board Merck, Roche, Genentech, Jounce Therapeutics, Bayer, AbbVie, Amgen, Aduro Biotech, Forma Therapeutics

Supported/Contracted Research/Grant

Bristol-Meyers Squibb, Merck, Roche, Genentech, Incyte, Seattle Genetics, Ono Pharma

Aaron Galaznik Employee (full time or part time) Millennium Pharmas, Takeda Pharma

Domenico Galetta Speakers or Advisory Board Bristol-Meyesr Squibb

Hui Gan Speakers or Advisory Board AbbVie

Speakers Bureau Ignyta, Bristol-Meyers Squibb

Supported/Contracted Research/Grant

AbbVie

David Gandara Honoraria AstraZeneca, Celgene, Genentech, Guardant Health, Eli Lilly, Liquid Genomics, Nant Health

Other Genentech, AstraZeneca, Celgene, Guardant Health, Eli Lilly, Liquid Genomics

Supported/Contracted Research/Grant

AstraZeneca, Genentech

Speakers or Advisory Board AstraZeneca, Celgene, Genentech, Gaurdant Health, Eli Lilly, Liquid Genomics, Nant Health

Mayank Gandhi Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Merck, Neurocrine, Acadia Pharmas, Spark Therapeutics

Employee (full time or part time) Roche, Genentech

Gérard Ganem Honoraria Roche

Apar Kishor Ganti Supported/Contracted Research/Grant

Merck, AstraZeneca, Bristol-Meyers Squibb, Amgen, NewLink Genetics, Novartis

Page 48: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

48

Speakers or Advisory Board Takeda, Pfizer

Bo Gao Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Regeneron Pharmas

Employee (full time or part time) Regeneron Pharmas

Yuki Gao Employee (full time or part time) Amoy Diagnostics

Marina Garassino Other Merck, Bristol-Meyers Squibb AstraZeneca, Roche

Honoraria Merck, Bristol-Meyers Squibb, AstraZeneca, Roche, Boehringer Ingelheim

Maria Rosario Garcia Campelo

Honoraria Ariad, AstraZeneca, Roche, Pfizer, Bristol-Meyers Squibb, Boehringer Ingelheim

Speakers or Advisory Board Ariad, AstraZeneca, Roche, Pfizer, Bristol-Meyers Squibb, Boehringer Ingelheim

Chad Garner Employee (full time or part time) Nantomics

Edward Garon Other Bristol-Meyers Squibb, Eli Lilly, AstraZeneca, Genentech, Merck, Novartis, Pfizer, Boehringer Ingelheim, Mirati, Dynavax

Speakers or Advisory Board AstraZeneca, Bristol-Meyers Squibb, Eli Lilly, Genetech, Merck, Novartis, Pfizer, Boehringer Ingelheim, Mirati, Dynavax

Supported/Contracted Research/Grant

Merck, Genentech, AstraZeneca, Novartis, Pfizer, Eli Lilly, Bristol-Meyers Squibb, Boehringer Ingelheim, Mirati Therapeutics, Dyanvax

Pilar Garrido Other Roche, Merck, AstraZeneca, Boehringer Ingelheim, Pfizer, Bristol-Meyers Squibb, Eli Lilly and Company, AbbVie, Novartis

Page 49: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

49

Speakers Bureau Roche, Merck, Bristol-Meyers Squibb, Pfizer

Supported/Contracted Research/Grant

Guardant

Pere Gascón Honoraria Sandoz, Hospira, Amgen

Other Merck, Sandoz, Hospira

Laurie Gay Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Gilead Sciences, Foundation Medicine

Salary Foundation Medicine

Employee (full time or part time) Foundation Medicine

Other Roche

Jun Ge Employee (full time or part time) Merck

Sandaruwan Geeganage Employee (full time or part time) Eli Lilly

William Geese Employee (full time or part time) Bristol-Meyers Squibb

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Bristol-Meyers Squibb

Akihiko Gemma Speakers Bureau AstraZeneca

Carlo Genova Honoraria AstraZeneca, Boehringer Ingelheim, Bristol-Meyers Squibb, Merck, Roche

Ryan Gentzler Speakers or Advisory Board AstraZeneca

Supported/Contracted Research/Grant

Merck, Bristol-Myers-Squibb, Celgene

David Gerber Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Gilead

Speakers or Advisory Board Bristol-Meyers Squibb, Samsung-Bioepis

Speakers Bureau Guardant

Page 50: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

50

Other Karyopharm

Supported/Contracted Research/Grant

Karyopharm, BerGenBio

Kelly Gerding Employee (full time or part time) Personal Genome Diagnostics

Yaron Gesthalter Honoraria Intuitive Surgical

Scott Gettinger Supported/Contracted Research/Grant

Ariad, AstraZeneca, MedImmune, Bristol-Meyers Squibb, Boehringer Ingelheim, Incyte, Pfizer, Roche, Genentech

Other Bristol-Meyers Squibb, Genentech, Ariad, Incyte, Pfizer, Celldex, Alexion Pharmas, Merck, Janssen

Speakers or Advisory Board Bristol-Meyers Squibb

Sara Ghassemifar Employee (full time or part time) Merrimack Pharmas

Sharmistha Ghosh Other Pfizer

Don Gibbons Supported/Contracted Research/Grant

Janssen

Michael Giffin Employee (full time or part time) Amgen

Moshe Giladi Employee (full time or part time) Novocure

Nicolas Girard Other Bristol-Meyers Squibb, Merck Roche, AstraZeneca

Etienne Giroux Leprieur Speakers or Advisory Board AstraZeneca, Novartis, Roche, Merck

Barbara Gitlitz Employee (full time or part time) Genentech

Fergus Gleeson Supported/Contracted Research/Grant

EIT health, National Institute for Health Research

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Optellum

Shobha Gokul Employee (full time or part time) Asuragen

Page 51: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

51

Sarah Goldberg Supported/Contracted Research/Grant

AstraZeneca

Honoraria AstraZeneca, Bristol-Meyers Squibb, Eli Lilly, Boehringer Ingelheim

Speakers or Advisory Board AstraZeneca, Bristol-Meyers Squibb, Eli Lilly, Boehringer Ingelheim Daiichi

Terri Goldberg Employee (full time or part time) Sankyo

Jonathan W. Goldman Speakers or Advisory Board Genentech, Roche, Bristol-Meyers Squibb, Eli Lilly, Pfizer

Other Genentech, Roche, Bristol-Meyers Squibb

Speakers Bureau Merck

Honoraria AstraZeneca

Supported/Contracted Research/Grant

AstraZeneca, MedImmune, Bristol-Meyers Squibb, Genentech, Roche, Eli Lilly, Merck

Jerome Goldschmidt Jr. Other Amgen

Honoraria Amgen

Speakers Bureau Bristol-Meyers Squibb, Celgene, Eli Lilly

Speakers or Advisory Board Amgen

Daniel Gomez Honoraria Merck, Bristol-Meyers Squibb, AstraZeneca, Varian, Reflexion

Speakers or Advisory Board AstraZeneca, Merck

Maciej Goniewicz Speakers or Advisory Board Johnson & Johnson

Jin Mo Goo Supported/Contracted Research/Grant

Lunit

Leonid Gorelik Employee (full time or part time) Checkpoint Therapeutics

Page 52: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

52

John Gosney Speakers or Advisory Board AbbVie, AstraZeneca, Bristol-Meyers Squibb, Merck, Pfizer, Roche

Other AbbVie, AstraZeneca, Bristol-Meyers Squibb, Merck, Pfizer, Roche

Koichi Goto Supported/Contracted Research/Grant

Nippon Boehringer Ingelheim, Chugai Phamaceutical, Eli Lilly

Honoraria Nippon Boehringer Ingelheim, Chugai Phamaceutical, Eli Lilly

Yasushi Goto Other Eli Lilly, Boehringer Ingelheim, Taiho Pharma, GlaxoSmithKline, Pfizer, Novartis, AstraZeneca

Honoraria AstraZeneca, Boehringer Ingelheim, Lilly Japan, Chugai Pharma, Taiho Pharma, Ono Pharma, Merck, Pfizer, Bristol-Myers Squiibb Japan, Shionogi Pharma, Novartis, Kyorin

Supported/Contracted Research/Grant

AbbVie, Eli Lilly, Pfizer

Speakers Bureau AstraZeneca, Eli Lilly, Chugai, Taiho Pharma, Boehringer Ingelheim, Ono Pharma, Bristol-Meyers Squibb, Pfizer, Merck, Shionogi Pharma, Novartis

Ramaswamy Govindan Speakers or Advisory Board Merck, Baxalta, Roche, Boehringer Ingleheim, Novartis, Pfizer, Celgene, AstraZeneca, MSK, AbbVie Inivata, Pfizer, NeoHealth, Bristol-Meyers Squibb, Nektar, GlaxcSmithKline

Other Genentech, Ariad, Astellas, Bristol-Meyers Squibb, INC Research, AbbVie

Honoraria AbbVie, Genentech, Boehringer Ingelheim

Fred Grannis Supported/Contracted Research/Grant

International Early Lung Cancer Action Program

Page 53: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

53

Other Paolicelli and Phillips Law, International Early Lung Cancer Action Program, Steven Phillip attorney

Jhanelle Gray Supported/Contracted Research/Grant

AstraZeneca, Celgene, Eli Lilly, Janssen, Merck, Genentech, Boehringer Ingelheim, Bristol-Meyers Squibb, Array

Speakers or Advisory Board AstraZeneca

Honoraria Celgene, Eli Lilly, Janssen, AstraZeneca

Laura Greco Speakers or Advisory Board Genentech

Emma Green Employee (full time or part time) Inivata

Other Inivata

Laurie Green Employee (full time or part time) Kadmon Corporation, LLC

Jeffrey Gregg Speakers or Advisory Board Foundation Medicine, AstraZeneca, Bristol-Meyers Squibb, Roche

Speakers Bureau AstraZeneca, Foundation Medicine

Laurent Greillier Speakers or Advisory Board Roche, AstraZeneca, Bristol-Meyers Squibb, Merck, AbbVie, Novartis, Pfizer, Boehringer Ingelheim

Cesare Gridelli Other Pfizer, Roche

Frank Griesinger Speakers or Advisory Board Ariad, AstraZeneca, Boehringer Ingelheim, Bristol-Myer-Squibb, Celegene, Clovis, Eli Lilly, Merck, Novartis, Pfizer, Roche

Other Ariad, AstraZeneca, Boehringer Ingelheim, Bristol-Meyers Squibb, Celgene, Clovis, Eli Lilly, Merck, Novartis, Pfizer, Roche, Siemens

Page 54: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

54

Supported/Contracted Research/Grant

Roche, AstraZeneca, Eli Lilly, Bristol-Meyers Squibb, Merck, Celgene, Boehringer Ingelheim, Pfizer, Novartis

Daniel Grima Employee (full time or part time) Cornerstone Research Group

Harry Groen Other Roche-Genentech, Merck, Novartis, Bristol-Meyers Squibb

Francesco Grossi Speakers Bureau Amgen, Celgene, Eli Lilly

Speakers or Advisory Board Bristol-Meyers Squibb, Merck, AstraZeneca Pierre Fabre, Roche, Boehringer Ingelheim

Supported/Contracted Research/Grant

Bristol-Meyers Squibb

Other Bristol-Meyers Squibb, Merck, AstraZeneca, Pierre Fabre, Roche, Boehringer Ingelheim, Pfizer, Amgen, Eli Lilly, Celgene

Honoraria Bristol-Meyers Squibb, Merck, AstraZeneca, Pierre Fabre, Boehringer Ingelheim, Pfizer, Celgene, Amgen, Roche

Federica Grosso Other PharmaMar, Boehringer Ingelheim

Aaron Gruver Employee (full time or part time) Eli Lilly

Tao Gu Employee (full time or part time) Bristol-Meyers Squibb

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Bristol-Meyers Squibb

Salary Bristol-Meyers Squibb

Maria Guerin Speakers or Advisory Board AstraZeneca

Honoraria AstraZeneca

Ferdinand Morales

Guevara Employee (full time or part time) Daiichi Sankyo

Ownership Interest (stocks or stock options, or other

AstraZeneca

Page 55: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

55

ownership interest Excluding diversified mutual funds)

Florian Guisier Speakers or Advisory Board AstraZeneca, Roche, Boehringer Ingelheim

Honoraria Bristol-Meyers Squibb, Merck, Roche, AstraZeneca, Boehringer Ingelheim

Honglin Guo Employee (full time or part time) OrigiMed

Zaid Haddad Employee (full time or part time) MagArray

Nahor Haddish-Berhane

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Janssen

Salary Janssen

Eric Hailman Employee (full time or part time) Mersana Therapeutics

Richard Hall Speakers or Advisory Board AstraZeneca, Takeda

Honoraria Merck

Supported/Contracted Research/Grant

Merck, AbbVie, Eli Lilly

Gerald Hall Employee (full time or part time) Eli Lilly

Balazs Halmos Speakers or Advisory Board AstraZeneca, Boehringer Ingelheim, Genentech, Pfizer, Eli Lilly, Foundation Medicine, Guardant Health, Takeda, Novartis, Merck, Bristol-Meyers Squibb

Supported/Contracted Research/Grant

Merck, AstraZeneca, Mirati Therapeutics, Boehringer Ingelheim, Pfizer, Takeda, Novartis, Eli Lilly

Other Foundation Medicine, Guardant Health

Honoraria AstraZeneca, Novartis, Takeda, Pfizer, Eli Lilly, Foundation One, Guardant Health, Boehringer Ingelheim, Genentech

Page 56: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

56

Celeste Hamilton Employee (full time or part time) VisionGate

Geoffrey Hamilton-Fairley

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Oncimmune LLC

Ji-Youn Han Other Roche, Bristol-Meyers Squibb, AstraZeneca, Merck, Takeda, Novartis

Honoraria Ono Pharma

Yimei Han Employee (full time or part time) Eli Lilly

Valdimir Hanes Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Amgen

Employee (full time or part time) Amgen

Jeff Haney Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Ariad

Employee (full time or part time) Ariad

Masaki Hanibuchi Honoraria Taiho Pharma, Kyowa Hakko Kirin

Amy Hanlon Newell Employee (full time or part time) Roche

Nasser Hanna Supported/Contracted Research/Grant

Merck, Bristol-Meyers Squibb, Genentech, AstraZeneca

Daijiro Harada Honoraria Ono Pharmaceutica, Bristol-Meyers Squibb, Yakult Honsya, Kyowa Hakko Kirin, AstraZeneca, Eli Lilly

David Harpole Speakers or Advisory Board Medtronic, AstraZeneca

Kimberly Harrow Employee (full time or part time) Xcovery Holding Company

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Xcovery Holding Company

Salary Xcovery Holding Company

Page 57: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

57

Stephen Harrow Honoraria AstraZeneca

Speakers or Advisory Board AstraZeneca

Akito Hata Speakers or Advisory Board Eli Lilly

AN Hata Supported/Contracted Research/Grant

Novartis, Relay Therapeutics, Amgen

Hiroto Hatabu Supported/Contracted Research/Grant

Toshiba Medical Systems, Canon, Konica-Minolta

Matthew Hatton Speakers or Advisory Board AstraZeneca

Eric Haura Other Bristol-Meyers Squibb, Janssen Oncology, Roche

Royalty, Intellectual Property/Patent Holder

Patent

Supported/Contracted Research/Grant

Eli Lilly, Ignyta, Janssen, Boehringer Ingelheim, Forma Therapeutics

Libor Havel Other Roche

Hidetoshi Hayashi Speakers Bureau Eli Lilly

Yong He Speakers or Advisory Board AstraZeneca, Eli Lilly, Pfizer, Roche

Kai He Other Perthera

Honoraria Geneplus

Supported/Contracted Research/Grant

Bristol-Meyers Squibb, Mirati Therapeutics, Adaptimmune, Genentech, Roche

Graham Healey Employee (full time or part time) Oncimmune LLC

Andreas Heilmann Employee (full time or part time) Foundation Medicine

Rebecca Heist Honoraria Boehringer Ingelheim

Supported/Contracted Research/Grant

Genentech, Roche, Millenium, Novartis, Celgene, Peregrine, Mirati, Corvus, Incyte, AbbVie, Agios, Debiopharm

Page 58: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

58

Matthew Hellmann Other Bristol-Meyers Squibb, Merck, Genentech Roche, AstraZeneca, MedImmune, Novartis, Janseen, Shattuck Lab, Syndax

Supported/Contracted Research/Grant

Bristol-Meyers Squibb

Speakers or Advisory Board Bristol-Meyers Squibb, Merck, Genentech, AstraZeneca, MedImmune, Novartis, Janssen Pharmas, Mirati Therapeutics, Shattuck Labs

Royalty, Intellectual Property/Patent Holder

Memorial Sloan Kettering Cancer Center

Todd Hembrough Employee (full time or part time) NantOmics

Roy Herbst Speakers or Advisory Board AstraZeneca, Eli Lilly, Genentech, Roche, Merck, NextCure, Novartis, Pfizer

Supported/Contracted Research/Grant

AstraZeneca, Eli Lilly, Merck, Genentech

Genevive Hernandez Employee (full time or part time) Genentech

James Hernandez Employee (full time or part time) Personal Genome Diagnostics

Nadine Hertel Employee (full time or part time) Bristol-Meyers Squibb Pharmas

John Heymach Royalty, Intellectual Property/Patent Holder

Spectrum Pharmas

Other AstraZeneca, AbbVie, Boehringer Ingelheim, Medivation, Ariad, Synta, Oncomed, Novartis, Genentech, Calithera Biosciences

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Cardinal Spine, Bio-Tree, Spectrum Pharmas

Supported/Contracted Research/Grant

AstraZeneca, Bayer, GlaxoSmithKline, Threshold Pharmas

Honoraria Ariad

Page 59: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

59

Speakers or Advisory Board AstraZeneca

Toyoaki Hida Supported/Contracted Research/Grant

Ono Pharma, Bristol-Meyers Squibb, Chugai Pharma, Nippon Boehringer Ingelheim, Merck, AstraZeneca, Pfizer, Astellas, Taiho Pharma, Clovis Oncology, Novartis

Honoraria Eli Lilly

Prista Hikmawati Supported/Contracted Research/Grant

International Office UNS

Katsuya Hirano Speakers Bureau Taiho Pharma

Fred Hirsch Other AstraZeneca, Genentech, HTG Molecular Diagnostics, Eli Lilly, Merck, Clovis Oncology, Ventana Medical Systems, Bristol-Meyers Squibb, Pfizer, Roche

Royalty, Intellectual Property/Patent Holder

University of Colorado Cancer Center

Supported/Contracted Research/Grant

Eli Lilly, Genentech, Amgen, Bristol-Meyers Squibb, Celgene

Speakers or Advisory Board AbbVie, AstraZeneca, Biocept, Bristol-Meyers Squibb, HTG, Eli Lilly, Loxo, Merck, Novartis, Pfizer, Roche, Genentech, Ventana, Bayer

Cheryl Ho Supported/Contracted Research/Grant

BC Cancer Foundation

Honoraria AstraZeneca

Other Roche

James Chung-man

Ho Honoraria AstraZeneca, Roche, Boehringer Ingelheim, Merck, Bristol-Meyers Squibb, Pfizer, Novartis

Speakers Bureau AstraZeneca, Roche, Boehringer Ingelheim, Merck, Bristol-Meyers Squibb, Pfizer, Novartis

Page 60: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

60

Speakers or Advisory Board AstraZeneca, Roche, Boehringer Ingelheim, Merck, Bristol-Meyers Squibb, Pfizer, Novartis

Supported/Contracted Research/Grant

AstraZeneca, Roche, Bristol-Meyers Squibb, Pfizer, Merck, Novartis

Tien Hoang Employee (full time or part time) Genentech, Roche

Maximilian Hochmair Speakers Bureau AstraZeneca, Roche, Novartis, Takeda

Speakers or Advisory Board Boehringer Ingelheim, AstraZeneca, Merck, Bristol-Meyers Squibb

Other Roche

Cyrla Hoffert Royalty, Intellectual Property/Patent Holder

Replicor

Kyle Hogarth Other Medtronic

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Auris Surgical Robotics

Honoraria Medtronic, Boston Scientific

Speakers or Advisory Board Medtronic, Auris Surgical Robotics, Boston Scientific, Grifols, Shire, CSL

Burton Holmes Employee (full time or part time) Roche

Robert Holt Employee (full time or part time) BerGenBio

Allison Holzhausen Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Xcovery Holding Company

Salary Xcovery Holding Company

Employee (full time or part time) Xcovery Holding Company

Florian Honeyball Honoraria AstraZeneca

Thomas Hope Supported/Contracted Research/Grant

GE Healthcare

Page 61: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

61

Leora Horn Other AbbVie, AstraZeneca, Genentech, Merck, Incyte, Xcovery, Roche

Supported/Contracted Research/Grant

Xcovery Holding Company, Bristol-Meyers Squibb, Boehringer Ingelheim, AbbVie, Genentech, Merck

Yukio Hosomi Speakers Bureau AstraZeneca, Taiho Pharma, Eli Lilly Japan, Chugai Pharma, Ono Pharma, Bristol-Meyers Squibb, Merck

Katsuyuki Hotta Honoraria AstraZeneca, Ono Pharma, Boehringer Ingelheim, Nihon Kayaku, Taiho Pharma, Chugai Pharma, Novartis, Bristol-Meyers Squibb, Eli Lilly Japan, Merck, AstraZeneca, Astellas

Supported/Contracted Research/Grant

Astellas, AstraZeneca, Ono Pharma, Boehringer-Ingelheim, Chugai Pharma, Novartis, Bristol-Meyers Squibb, Eli Lilly Japan, Merck

Karen Howarth Supported/Contracted Research/Grant

Inivata

Employee (full time or part time) Inivata

Royalty, Intellectual Property/Patent Holder

Inivata

Salary Inviata

Hsin-ju Hsieh Employee (full time or part time) MedImmune, LLC

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

MedImmune, LLC

Tun-Ying Hsu Employee (full time or part time) Merck

Jinwei Hu Employee (full time or part time) OrigiMed

Wenhua Hu Employee (full time or part time) Bristol-Meyers Squibb

Page 62: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

62

Dennis Chin-Lun

Huang Employee (full time or part time) Boehringer Ingelheim

Hui Huang Employee (full time or part time) Takeda Pharmas

Min Huang Employee (full time or part time) Merck

Richard Huang Employee (full time or part time) Roche

Xiaodong Huang Employee (full time or part time) Eli Lilly

Xin Huang Employee (full time or part time) Loxo

Yifan Huang Employee (full time or part time) AstraZeneca

Florian Huemer Speakers or Advisory Board Roche, Bristol-Myers-Squibb

Other Roche

Rina Hui Honoraria Bristol-Meyers Squibb, Boehringer Ingelheim, Merck, AstraZeneca, Novartis, Roche

Speakers or Advisory Board AstraZeneca, Merck, Novartis, Pfizer, Roche, Bristol-Meyers Squibb

Other Merck, AstraZeneca, Novartis, Roche, Bristol-Meyers Squibb, Boehringer Ingelheim, Pfizer

Olivier Huillard Speakers or Advisory Board Bristol-Meyers Squibb, Novartis, Sanofi

Martin Hüllner Other GE Healthcare

Annie Hung Employee (full time or part time) Armo BioSciences

Manjusha Hurry Employee (full time or part time) AstraZeneca Canada

Felipe Hurtado Employee (full time or part time) Novartis

Hatim Husain Speakers Bureau AstraZeneca, Bristol-Meyers Squibb, Merck

Speakers or Advisory Board AstraZeneca, Foundation Medicine

Supported/Contracted Research/Grant

Pfizer

Page 63: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

63

David Hwang Honoraria Merck, Pfizer, Takeda

Speakers or Advisory Board Merck

Harry Hwang Speakers Bureau Roche, AstraZeneca

Speakers or Advisory Board Roche, AstraZeneca

Honoraria Roche, AstraZeneca

Supported/Contracted Research/Grant

Abbott Molecular

David Hyman Speakers or Advisory Board Atara Biotherapeutics, Chugai Pharma, CytomX Therapeutics, Boehringer Ingelheim, AstraZeneca, Pfizer, Bayer, Debiopharm Group, ArQule, Genentech

A. John Iafrate Speakers or Advisory Board Roche, Chugai

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

ArcherDX

Royalty, Intellectual Property/Patent Holder

ArcherDX

Shannon Ibabekci Employee (full time or part time) Loxo

Norihiko Ikeda Honoraria AstraZeneca, Chugai, Merck, Ono Pharma, Taiho, Eli Lilly, Pfizer, Johnson & Johnson

Fumio Imamura Speakers Bureau Ono Pharma

Supported/Contracted Research/Grant

Ono Pharma

Martina Imbimbo Honoraria Bristol-Meyers Squibb

Maurizio Infante Honoraria Merck

Akira Inoue Speakers Bureau AstraZeneca, Eli Lilly, Chugai Pharma., Boehringer Ingelheim

Honoraria Chugai, Eli Lilly, Bristol-Meyers Squibb, Nihonkayaku, AstraZeneca, Pfizer, Boehringer Ingelheim

Page 64: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

64

Diana Ionescu Honoraria Merck, Bristol-Meyers Squibb, AstraZeneca

Hidenobu Ishii Supported/Contracted Research/Grant

Boehringer Ingelheim

Kumiko Isse Employee (full time or part time) AbbVie

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

AbbVie

Kentaro Ito Speakers Bureau AstraZeneca, Boehringer Ingelheim, Chugai Pharma, Ono Pharma, Pfyzer, Merck, Eli Lily

Eiji Iwama Honoraria AstraZeneca, Eli Lilly, Pfizer., Chugai Pharma

Tae Iwasawa Honoraria Ono Pharmas, Astellas, Boehringer Ingelheim, Shionogi, Canon Medical

Salma Jabbour Supported/Contracted Research/Grant

Merck, Nestle

David Jablons Other Razor Genomics

Philippe Jacques Other AstraZeneca

Thierry Jahan Supported/Contracted Research/Grant

Atomic, Acerta Acerta, Aduro, Bristol-Meyers Squibb, Boehringer Ingelheim, AstraZeneca, Eli Lilly, Epizyme, Merck, Polaris

Mohammad Jahanzeb Supported/Contracted Research/Grant

Eli Lilly, Boehringer Ingelheim, Callisto

Other Novartis, Ipsen, Roche, Genentech

Yolanda Jaimes Employee (full time or part time) Liquid Genomics

Ariel Jaimovich Employee (full time or part time) Guardant Health

Page 65: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

65

Marko Jakopovic Other Boehringer Ingelheim, AstraZeneca, Roche, Novartis, Merck, Bristol-Meyers Squibb, Pfizer

Speakers or Advisory Board Boehringer Ingelheim, AstraZeneca, Roche, Novartis, Merck, Bristol-Meyers Squibb, Pfizer

Seong Bok Jang Employee (full time or part time) Yuhan Corporation

Pasi Jänne Other Araxes Pharmas, Ariad, AstraZeneca, Boehringer Ingelheim, Chugai, Ignyta, Eli Lilly, Loxo, Merrimack, Mirati Therapeutics, Pfizer, Roche, Dana-Farber Cancer Institute

Speakers or Advisory Board AstraZeneca, Boehringer Ingelheim, Pfizer, Merrimack Pharmas, Roche, Genentech, Chugai Pharmas, Acea Biosciences, Ignyta, Loxo, Ariad, Eli Lilly, Araxes Pharmas

Speakers Bureau Loxo

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Gatekeeper Pharmas

Supported/Contracted Research/Grant

Astellas Pharmas, AstraZenenca, Daiichi Sankyo, PUMA, Eli Lilly, Boehringer Ingelheim

Royalty, Intellectual Property/Patent Holder

LabCorp

Ellen Janssen Employee (full time or part time) ICON

Milenka Jean-Baptiste Employee (full time or part time) Evidera

Min-Hua Jen Employee (full time or part time) Eli Lilly and Company

James Jett Employee (full time or part time) Oncimmune LLC

Other Oncimmune LLC

Philip Jewsbury Other AstraZeneca

Page 66: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

66

Fengge Jiang Employee (full time or part time) Amoy Diagnostics

Takahiro Jikoh Employee (full time or part time) Daiichi Sankyo

Thomas John Speakers or Advisory Board Bristol-Meyers Squibb, AstraZeneca, Boehringher Ingelheim, Takeda, Pfizer, Novartis, Merck, Ignyta

Other Bristol-Meyers Squibb, AstraZeneca, Boehringer Ingelheim, Takeda, Pfizer, Novartis, Merck

Bruce Johnson Royalty, Intellectual Property/Patent Holder

Dana-Farber Cancer Institute

Other KEW

Supported/Contracted Research/Grant

Novartis, Toshiba, Genentech, Roche, Medical Systems

Melissa Johnson Supported/Contracted Research/Grant

BerGenBio, Eli Lilly, Merck Serono, Janssen, Mirati Therapeutics, Genmab, Pfizer, AstraZeneca, Genentech, Roche, Stemcentrix, Novartis, Checkpoint Therapeutics, Array BioPharma, Regeneron, Apexigen, AbbVie, Tarveda, Adaptimmune, Syndax, Neovia, Boehringer Ingelheim, Sanofi, Hengrui Therapeutics, Daiichi – Sankyo, Lycera, G1 Therapeutics, Dynavax, OncoMed, Kadmon, BeiGen, Loxo, Mersana

Speakers or Advisory Board Astellas, Otsuka Pharmas, Genentech, Roche, Celgene, Boehringer Ingelheim, Sanofi, Mirati, Loxo, AstraZeneca, Mersana

Other Astellas, Otsuka Pharmas, Roche

Bonita Jones Employee (full time or part time) Eli Lilly

Greg Jones Employee (full time or part time) Inivata

Page 67: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

67

Gregory Jones Speakers or Advisory Board MDxHealth

Sian Jones Employee (full time or part time) Personal Genome Diagnostics

Mirjana Josipovic Other Varian Medical Systems

Alice Juang Employee (full time or part time) MagArray

Rosalyn Juergens Speakers or Advisory Board Bristol-Meyers Squibb, Merck, Roche, Boehringer Ingelheim, Eli Lilly, Pfizer, Amgen, Novartis, AstraZeneca, Takeda

Honoraria Bristol-Meyers Squibb, Merck, Roche, Boehringer Ingelheim, AstraZeneca, MedImmune, Eli Lilly, Takeda, Novartis, Amgen Pfizer

Speakers Bureau Amgen

Other Boehringer Ingelheim, Bristol-Meyers Squibb, Eli Lilly, Merck, Novartis, Pfizer, Amgen, Roche, AstraZeneca, MedImmune,

Supported/Contracted Research/Grant

AstraZeneca, MedImmune, Merck, Bristol-Meyers Squibb

Daniela Juri Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Guardant Health

Employee (full time or part time) Guardant Health

Fairooz Kabbinavar Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Genentech

Salary Genentech

Employee (full time or part time) Genentech

Other Roche

Timor Kadir Employee (full time or part time) Optellum

Ownership Interest (stocks or stock options, or other

Optellum

Page 68: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

68

ownership interest Excluding diversified mutual funds)

Carmen Kahatt Employee (full time or part time) PharmaMar S.A.

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

PharmaMar S.A.

Michael Kalos Employee (full time or part time) Eli Lilly

Rajender Kamboj Employee (full time or part time) Lupin

Sandy Kamer Employee (full time or part time) MagArray

Walid Kamoun Employee (full time or part time) Merrimack Pharmas

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Merrimack Pharmas

Salary Takeda

Kuninobu Kanai Supported/Contracted Research/Grant

Ono Pharma

Seonmi Kang Employee (full time or part time) Seonmi Kang

Steven Kao Honoraria Roche, Bristol-Meyers Squibb, Merck, AstraZeneca

Speakers or Advisory Board AstraZeneca, Pfizer, Boehringer Ingelheim

Supported/Contracted Research/Grant

Pfizer

Chris Karapetis Speakers or Advisory Board AstraZeneca

Peter Kasan Speakers or Advisory Board Boehringer Ingelheim, Roche, Merck

Elie Kassouf Speakers or Advisory Board Sanofi, Amgen, Celgene, Bristol-Meyers Squibb, Pfizer, Lundbeck, Boehringer Ingelheim, Janssen, AstraZeneca, Novartis

Rahul Katdare Employee (full time or part time) VisionGate

Page 69: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

69

Tatsuya Kato Supported/Contracted Research/Grant

Ono Pharmas, Bristol-Meyers Squibb, AstraZeneca, Boehringer Ingerheim, Chugai, Eli Lilly, Kirin Kyowa, Merck, Pfixer, Quintiles, Taiho, Parexel, AbbVie, Astellas

Honoraria Ono Pharma, Bristol-Meyers Squibb, AstraZeneca, Boehringer Ingerheim, Chugai, Eli Lilly, Merck, Novartis, Pfizer, Quintiles, Roche, Taiho, Parexel, AbbVie

Speakers or Advisory Board Chugai, Eli Lilly, Merck

Terufumi Kato Honoraria AbbVie, AstraZeneca, Boehringer Ingelheim, Bristol-Meyers Squibb, Chugai, Eli Lilly, Merck, Novartis, Ono Pharma, Pfizer, Quintiles, Taiho

Supported/Contracted Research/Grant

AbbVie, Astellas, AstraZeneca, Bristol-Meyers Squibb, Chugai, Eli Lilly, Kirin Kyowa, Merck, Ono Pharma, Pfizer, Quintiles, Novartis

Speakers or Advisory Board AstraZeneca, Eli Lilly, Merck

Employee (full time or part time) Eli Lilly

Other Merck

Tomoya Kawaguchi Honoraria Chugai Pharma, AstraZeneca, Boehringer Ingelheim

Supported/Contracted Research/Grant

AstraZeneca, Chugai Pharma, Boehringer Ingelheim

Laurel Keefer Employee (full time or part time) Personal Genome Diagnostics

Robert Keith Speakers Bureau Boehringer Ingelheim

Speakers or Advisory Board Lungevity, American Lung Association - Lung Cancer Medical Advisory Panel

Royalty, Intellectual Property/Patent Holder

Patent - Use of Prostacyclin Agonists to Prevent Cancer

Page 70: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

70

Laimonas Kelbauskas Employee (full time or part time) VisionGate

Karen Kelly Speakers or Advisory Board AbbVie, AstraZeneca, Genentech, Janssen, Eli Lilly, Merck

Supported/Contracted Research/Grant

AbbVie, Celgene, Merck, Five Prime, Genentech, Eli Lilly, Lycera, Novartis, Regeneron, Transgene

Royalty, Intellectual Property/Patent Holder

UpToDate

Honoraria Merck

Other AbbVie, Genentech, Eli Lilly, Merck, UpToDate

Hirotsugu Kenmotsu Honoraria Boehringer Ingelheim, Chugai Pharma, AstraZeneca

Supported/Contracted Research/Grant

Boehringer Ingelheim, Chugai Pharma, AstraZeneca

Drew Kennedy Employee (full time or part time) Guardant Health

Keith Kerr Other Bristol-Meyers Squibb

Speakers or Advisory Board AstraZeneca, Bristol Meyers Squibb, Merck, Roche, Pfizer

David Kerstein Employee (full time or part time) Ariad

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Ariad

Sandeep Khandhar Other Medtronic

Supported/Contracted Research/Grant

Medtronic

Speakers or Advisory Board Medtronic

Behzad Kharabi Masouleh

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Johnson & Johnson

Page 71: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

71

Employee (full time or part time) Johnson & Johnson

Leila Khoja Employee (full time or part time) AstraZeneca

Mohsen Khorshid Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Roche, Foundation Medicine

Salary Roche

Other Roche

Employee (full time or part time) Roche

Lesli Kiedrowski Employee (full time or part time) Guardant Health

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Guardant Health

Takashi Kijima Speakers Bureau Boehringer Ingelheim, Shionogi, Ono Pharma, Taiho Pharma, Meiji Seika Pharma, Novartis Pharma, Chugai Pharma, Daiichi Sankyo, AstreZeneca, Merck, Pfizer, Eli Lilly

Supported/Contracted Research/Grant

Ono Pharma

Hironori Kikkawa Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Pfizer

Employee (full time or part time) Pfizer

Anthony Kim Speakers or Advisory Board Medtronic, Genentech

Edward Kim Honoraria Eli Lilly, AstraZeneca, Celgene, Boehringer Ingelheim

Speakers or Advisory Board Eli Lilly, AstraZeneca, Celgene, Boehringer Ingelheim

Other Eli Lilly, AstraZeneca, Celgene, Boehringer Ingelheim

Page 72: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

72

Hye Ryun Kim Other AstraZeneca, Roche, Boehringer Ingelheim

Min Kim Honoraria Intuitive Surgical, Medtronics, Boston Scientific, Olympus

Miyoung Kim Employee (full time or part time) Boehringer Ingelheim

Sohee Kim Employee (full time or part time) Yuhan Corporation

Young-Chul Kim Supported/Contracted Research/Grant

AstraZeneca, Roche

Speakers or Advisory Board Caris Life Sciences

Speakers Bureau AstraZeneca, Roche

Hedy Lee Kindler Speakers or Advisory Board Merck

Jennifer King Speakers or Advisory Board Grail, AstraZeneca, Genentech, Tesaro, AbbVie

Supported/Contracted Research/Grant

AstraZeneca

Speakers Bureau AstraZeneca

Eilon Kirson Employee (full time or part time) Novocure

Takumi Kishimoto Speakers or Advisory Board Ono Pharma

Roland Knoblauch Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Janssen

Salary Janssen

Employee (full time or part time) Janssen

Elizabeth Knowles Salary Elekta

Kunihiko Kobayashi Speakers or Advisory Board AstraZeneca

Speakers Bureau Chugai Pharma., AstraZeneca, Ono Pharma., Eli Lilly

Yoshihisa Kobayashi Speakers Bureau Boehringer Ingelheim

Supported/Contracted Research/Grant

The Japan Society for the Promotion of Science, Osaka Cancer Society, Novartis

Page 73: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

73

Mark Kockx Employee (full time or part time) Histogenex

Barbara Koetz Other AstraZeneca

Yasuhiro Koh Honoraria Boehringer Ingelheim, AstraZeneca, Kyowa Hakko Kirin, Chugai Pharma, Ono Pharma, Bristol-Meyers Squibb, Thermo Fisher Scientific, Tosoh Corporation

Supported/Contracted Research/Grant

Boehringer Ingelheim, AstraZeneca, Daiichi Sankyo, Novartis

Alexander Kohlmann Employee (full time or part time) AstraZeneca

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

AstraZeneca

Jill Kolesar Honoraria AbbVie

Feng-Ming (Spring)

Kong Speakers Bureau Varian Medical

Honoraria Varian Medical

Beata Korytowsky Employee (full time or part time) Bristol-Meyers Squibb

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Bristol-Meyers Squibb

Salary Bristol-Meyers Squibb

Marcin Kowanetz Employee (full time or part time) Roche, Genentech

Royalty, Intellectual Property/Patent Holder

Roche, Genentech

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Roche

Mark Kozloff Speakers Bureau Genentech, Roche, AbbVie, Amgen, Merck, Eli Lilly

Other Genentech, Roche, AbbVie, Merck

Page 74: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

74

Toshiyuki Kozuki Honoraria Kyowa, AstraZeneca, Pfizer, Eli Lilly, Ono, Chugai, Boehringer Ingelheim, Bristol-Meyers Squibb, Taiho, Nippon Kayaku, Merck

Supported/Contracted Research/Grant

Chugai Pharma, Eli Lily

Johannes Kratz Speakers or Advisory Board Razor

Other Razor

Matthew Krebs Speakers or Advisory Board Roche

William Krimsky Other Medtronic, Innovital Systems

Employee (full time or part time) Medtronic

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

CSA Medical, Innovital Systems, Peytant Solutions, Gala Therapeutics

Speakers or Advisory Board Gala Therapeutics, SOC, Peytant

Royalty, Intellectual Property/Patent Holder

Medtronic, Merit

Honoraria CSA Medical, Merit Medical

Mark Kris Honoraria AstraZeneca

Other Genetech Roche, AstraZeneca, Ariad

Vimal Krishnan Supported/Contracted Research/Grant

AstraZeneca

Ian Krop Speakers or Advisory Board Daiichi Sankyo, Genentech

Maciej Krzakowski Speakers or Advisory Board Boehringer Ingelheim, AstraZeneca

Other Roche

Nora Ku Employee (full time or part time) Loxo

Ownership Interest (stocks or stock options, or other

Loxo

Page 75: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

75

ownership interest Excluding diversified mutual funds)

Akihito Kubo Honoraria Chugai Pharma, Boehringer Ingelheim, Taiho Pharma, AstraZeneca, Novartis, Lilly Japan

Supported/Contracted Research/Grant

Lilly Japan, Chugai Pharma, Boehringer Ingelheim

Kaoru Kubota Honoraria Chugai, Merck, Taiho, Boehringer Ingerheim, AstraZeneca, Eli Lilly, Ono, KyowaKirin, Novaltis, DaiichSankyo, Eisai, Roche

Geoffrey Kuesters Employee (full time or part time) Merrimack Pharmas

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Merrimack Pharmas

Swati Kulkarni Honoraria AstraZeneca

Rakesh Kumar Employee (full time or part time) MedImmune, LLC

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

MedImmune, LLC

Ansu Kumar Employee (full time or part time) Cellworks Research, Bangalore

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Cellworks Research, Bangalore

Rajesh Kumawat Employee (full time or part time) Lupin Limited

Hiromi Kumon Speakers or Advisory Board Kyorin

Other Momotaro Gene

Royalty, Intellectual Property/Patent Holder

Patent

Page 76: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

76

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Momotaro Gene

Honoraria Momotaro Gene

Supported/Contracted Research/Grant

Kyorin

Pamela Kunz Speakers or Advisory Board Ipsen, Lexicon Pharmas

Supported/Contracted Research/Grant

Dicerna, Esanex, Oxigene, Advanced Accelerator Applications, Genentech, Incyte, Ipsen, Lexicon Pharmas, Merck

Takayasu Kurata Honoraria Ono Pharma, Eli Lilly, Bristol-Meyers Squibb, AstraZeneca, Chugai, Nippon Boehringer Ingelheim, Merck

Supported/Contracted Research/Grant

AstraZeneca

Masahiko Kusumoto Honoraria Ono Pharmas, AstraZeneca, Merck

David Kwiatkowski Other AstraZeneca, Genentech, Roche

Supported/Contracted Research/Grant

AADi

Catherine Labbe Honoraria Bristol-Meyers Squibb, Merck

Laure Lacoin Supported/Contracted Research/Grant

Bristol-Myers-Squibb

Marc Ladanyi Other Boehringer-Ingelheim, Afatinib Targeted Therapy

Speakers or Advisory Board Foundation Medicine

Supported/Contracted Research/Grant

Loxo

Rahul Ladwa Other Novartis, Bristol-Meyers Squibb

David Laidley Speakers or Advisory Board Ipsen

Honoraria Novartis, Ipsen

Page 77: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

77

Supported/Contracted Research/Grant

Ipsen, Novartis

Francois Laliberté Supported/Contracted Research/Grant

AstraZeneca

Other AstraZeneca

Sivuonthanh Lam Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Roche, Genentech

Salary Roche, Genentech

Employee (full time or part time) Roche, Genentech

Other Roche.

Peter Lambert Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Genentech, Roche

Salary Genentech

Employee (full time or part time) Genentech

Supported/Contracted Research/Grant

Roche, Genentech

Other Roche

Lorenza Landi Speakers or Advisory Board Bristol-Meyers Squibb AstraZeneca, Pfizer, Boehringer Ingelheim

Joshua Lang Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Salus Discovery LLC

Corey Langer Supported/Contracted Research/Grant

Pfizer, Eli Lilly, Genentech, OSI Pharmas, GlaxoSmithKline, Clovis, Merck, Advantagene, Inovio, Takeda, AbbVie, Celgene, Incyte, Macrogenics

Page 78: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

78

Honoraria Bristol-Meyers Squibb, Imclone Systems, Pfizer, Eli Lilly, AstraZeneca, Merck, Novartis, Genentech, Bayer, Celgene, Abbott Labs, Biodesix, Clariant, CarisDx, Ariad, Boehringer Ingelheim, Synta, Clovis

Other Amgen, Synta, Peregrine, SWOG, Incyte, VA, Eli Lilly, PIK, PER, NOCR, CCO, RTP

Richard Lanman Employee (full time or part time) Guardant Health

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Guardant Health

Other Guardant Health

Si-Houy Lao-Sirieix Royalty, Intellectual Property/Patent Holder

AstraZeneca

Sylvie Laquerre Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Janssen

Salary Janssen

Employee (full time or part time) Janssen

Janessa Laskin Honoraria Roche, Boehringer Ingelheim, AstraZeneca

Supported/Contracted Research/Grant

AstraZeneca, Roche, Pfizer

Gary Latham Employee (full time or part time) Asuragen

Christopher Lathan Honoraria Association of Community Cancer Centers

Speakers or Advisory Board Eli Lilly, Bristol-Meyers Squibb

Supported/Contracted Research/Grant

CVS Health

Kelvin Lau Honoraria Medtronic

Page 79: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

79

Supported/Contracted Research/Grant

Philips

Yvonne Lau Employee (full time or part time) Novartis

Scott Laurie Other Bristol-Meyers Squibb, Novartis, Pfizer, Boehringer Ingelheim, AstraZeneca, BBI

Honoraria Novartis, Pfizer, Boehringer Ingelheim, AstraZeneca

Rachael Lawrance Employee (full time or part time) Adelphi Values

Other Bristol-Meyers Squibb

Ben Lawrence Honoraria Novartis

Other Merck

Anh Le Royalty, Intellectual Property/Patent Holder

Abbott Molecular

Catherine Le Employee (full time or part time) Roche

Trong Le Employee (full time or part time) Bristol-Meyers Squibb

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Bristol-Meyers Squibb

Salary Bristol-Meyers Squibb

Cecile Le Pechoux Speakers or Advisory Board AstraZeneca

Ticiana Leal Speakers or Advisory Board Takeda, AstraZeneca, Novartis, AbbVie, Bristol-Meyers Squibb

Alexandra Leary Honoraria AstraZeneca

Speakers or Advisory Board AstraZeneca, Clovis, Gristone, Gamamabs

Supported/Contracted Research/Grant

Gamamabs, Merus, Clovis, AstraZeneca, Roche, Merck, Pfizer

Other AstraZeneca

Shiang Leaw Employee (full time or part time) BeiGene

Page 80: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

80

Anthony Lee Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Genentech

Employee (full time or part time) Genentech

Caleb Lee Employee (full time or part time) Daiichi Sankyo

Dae Ho Lee Honoraria AstraZeneca, Boehringer Ingelheim, CJ Healthcare, Eli Lilly, Merck, Mundipharma, Novartis, Ono Pharma, Pfizer, Roche, Samyang, STCube Pharmas, Ministry of Food and Drug Safety, National Evidence-based Collaborating Agency, Korea, National Cancer Control Planning Board, Takeda, Bristol-Meyers Squibb

Other AstraZeneca, Boehringer Ingelheim, Bristol-Meyers Squibb, CJ Healthcare, Eli Lilly, Merck, Mundipharma, Novartis, Ono Pharma, Pfizer, Roche, Samyang, STCube Pharmas, Ministry of Food and Drug Safety, National Evidence-based Collaborating Agency, National Cancer Control Planning Board, Takeda

Jay Lee Other Genentech, Roche

Jong-Seok Lee Other Ono Pharma, AstraZeneca

John Lee Employee (full time or part time) Nantkwest

Ki Lee Other AstraZeneca, Eli Lilly, Boehringer Ingelheim, Bristol-Meyers Squibb, Merck, Pfizer

Sue Lee Employee (full time or part time) Regeneron Pharma

Ownership Interest (stocks or stock options, or other

Regeneron Pharma

Page 81: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

81

ownership interest Excluding diversified mutual funds)

Martina Lefterova Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Guardant Health

Employee (full time or part time) Guardant Health

Natasha Leighl Supported/Contracted Research/Grant

Novartis

Honoraria Merck, Bristol-Meyers Squibb

Other Novartis, AstraZeneca, Bristol-Meyers Squibb, Merck, Pfizer, Canadian Agency for Drugs and Technologies in Health

Hervé Lena Other AstraZeneca, Roche, Merck, Bristol-Meyers Squibb, Pfizer, Novartis, Eli Lilly, Amgen

Guillaume Lessene Supported/Contracted Research/Grant

Servier

Joseph Leveque Employee (full time or part time) Armo BioSciences

Benjamin Levy Speakers or Advisory Board AstraZeneca, Celgene, Merck, Eli Lilly, Genetech, Roche, Takeda

Supported/Contracted Research/Grant

Celgene, Boehringer Ingleheim

Conrad Lewanski Speakers or Advisory Board Eli Lilly

Honoraria Eli Lilly

Christine Lhomel Employee (full time or part time) Roche

Ang Li Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Bristol-Meyers Squibb

Employee (full time or part time) Bristol-Meyers Squibb

Bob Li Other Genentech, Roche, Thermo Fischer Scientific, Guardant Health

Page 82: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

82

Speakers or Advisory Board Genentech, Guardant Health, Mersana Therapeutics

Chunjie Li Employee (full time or part time) OrigiMed

Gerald Li Employee (full time or part time) Foundation Medicine

Haocheng Li Employee (full time or part time) Roche

Jack Li Employee (full time or part time) Daiichi Sankyo

Jacky Yu-Chung

Li Speakers Bureau AstraZeneca, Roche, Genentech

Supported/Contracted Research/Grant

Roche, Genentech

Jian Li Employee (full time or part time) BeiGene

Jingjin Li Employee (full time or part time) Regeneron Pharma

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Regeneron Pharma

Kitty Li Employee (full time or part time) Guardant Health

Sherry Li Employee (full time or part time) Pfizer

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Pfizer

Shuanglian Li Employee (full time or part time) Millennium Pharmas, Takeda, Ariad

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Ariad

Xiaodong Li Employee (full time or part time) Merck

Xin Li Employee (full time or part time) BeiGene

Xuemei Li Employee (full time or part time) Bristol-Meyers Squibb

Page 83: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

83

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Bristol-Meyers Squibb

Yanxia Li Employee (full time or part time) Eli Lilly

Yuping Li Other Amoy Diagnostics

Chris Liang Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Xcovery Holding Company

Salary Xcovery Holding Company

Employee (full time or part time) Xcovery Holding Company

Wei Liao Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

EZLife Bio

Eric Lim Speakers Bureau Abbott Molecular, Pfizer, Roche, Eli Lily, Boehringer Ingelheim, Ethicon

Supported/Contracted Research/Grant

Medela, ScreenCell, Clearbridge Biomedics, Illumina, Guardant Health

John Lim Employee (full time or part time) TP Therapeutics

Huamao Lin Other Takeda

Jessica Lin Honoraria Chugai, Boehringer Ingelheim

Wei Lin Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Roche, Genentech

Salary Roche, Genentech

Employee (full time or part time) Roche, Genentech

Other Roche

Helena Linardou Other Bristol-Meyers Squibb, Roche, Merck

Page 84: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

84

Philip Linden Other Medtronic

Rolf Linke Employee (full time or part time) SFJ Pharmas Group

Geoffrey Liu Honoraria AstraZeneca, Novartis, Takeda, Bristol-Meyers Squibb, AbbVie, Pfizer, Merck

Speakers Bureau AstraZeneca

Speakers or Advisory Board AstraZeneca, Roche, Merck, Novartis, Takeda, Bristol-Meyers Squibb, AbbVie

Juan Liu Salary Roche

Employee (full time or part time) Roche

Other Roche

Stephen Liu Speakers or Advisory Board Genentech, Pfizer, Takeda, Celgene, Eli Lilly, Taiho, Bristol-Meyers Squibb, AstraZeneca, Ignyta

Supported/Contracted Research/Grant

Genentech, Pfizer, Threshold, Clovis, Corvus, Esanex, Bayer, OncoMed, Ignyta, Merck, Lycera, AstraZeneca, Molecular Partners

Other Roche

Qi Liu Employee (full time or part time) Zai Laboratory

Wen-Wei Liu Employee (full time or part time) Roche

Giuseppe Lo Russo Honoraria Ely Lilly, Bristol-Meyers Squibb, AstraZeneca

Edward Lobenhofer Employee (full time or part time) Amgen

John Longshore Speakers Bureau Roche, AstraZeneca, Bristol-Meyers Squibb, Merck, Genentech

Speakers or Advisory Board Roche, AbbVie, AstraZeneca, Bristol-Meyers Squibb, Merck, Pfizer

Supported/Contracted Research/Grant

Roche, AstraZeneca

Page 85: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

85

Billy Loo Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

TibaRay

Supported/Contracted Research/Grant

Varian Medical Systems, RaySearch Laboratories

Maria Pilar Lopez-Criado Other Bristol

Fernando Lopez-Rios Supported/Contracted Research/Grant

Roche

Speakers or Advisory Board Roche, Life Technologies,

Bristol-Meyers Squibb, AbbVie,

AstraZeneca, Merck, Pfizer

Speakers Bureau AbbVie, AstraZeneca, Bristol-Meyers Squibb, Life Technologies, Merck, Pfizer, Roche

Honoraria AbbVie, AstraZeneca, Bristol-Meyers Squibb, Life Technologies, Merck, Pfizer, Roche

Jose Lopez-Vilariño Employee (full time or part time) PharmaMar S.A.

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

PharmaMar S.A.

Robert Lorence Employee (full time or part time) Boehringer Ingelheim

James Lorens Employee (full time or part time) BerGenBio

Matthew Lorenzi Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Janssen

Salary Janssen

Employee (full time or part time) Janssen

Gyorgy Losonczy Other Roche

Alexander Louie Honoraria Varian Medical Systems, AstraZeneca

Page 86: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

86

Christine Lovly Other Pfizer, Novartis, AstraZeneca, Genoptix, Sequenom, Ariad, Takeda, Foundation Medicine

Speakers or Advisory Board Cepheid, Pfizer, Takeda, Novartis, AstraZeneca

Honoraria Foundation Medicine, Roche

Israel Lowy Employee (full time or part time) Regeneron Pharma

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Regeneron Pharma

Other Regeneron Pharma

Gerard Lozanski Supported/Contracted Research/Grant

Genentech, Stemline Therapeutics

Shun Lu Supported/Contracted Research/Grant

AstraZeneca

Speakers or Advisory Board Eli Lilly, Hutchison MediPharma, Simcere, Bristol-Meyers Squibb, Roche, Pfizer, AstraZeneca

Zhao Hai Lu Employee (full time or part time) Eli Lilly

Gregory Lubiniecki Employee (full time or part time) Merck

Shuang Luo Employee (full time or part time) Eli Lilly

Xueting Lv Employee (full time or part time) Novartis

Gustavo Lyons Speakers Bureau Johnson & Johnson

Brigette Ma Speakers or Advisory Board Roche, Merck, Boerhinger Ingelheim, Novartis, Bristol-Meyers Squibb

Honoraria Roche, Merck, Boerhinger ingelheim, Novartis, Bristol-Meyers Squibb

Supported/Contracted Research/Grant

Novartis

Mitchell Machtay Supported/Contracted Research/Grant

Eli Lilly, ImClone

Page 87: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

87

Philip Mack Supported/Contracted Research/Grant

Boehringer Ingelheim

Other Guardant Health, Apton Biosystems

Speakers or Advisory Board AstraZeneca, Eli Lilly, Pfizer

Hebert MacMahon Speakers or Advisory Board Riverain Technologies, GE Healthcare

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Hologic

Honoraria Konica Minolta

Supported/Contracted Research/Grant

Philips Healthcare

Contracted/Support Research Grant

University of Chicago

Anant Madabhushi Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Elucid Bioimaging, Inspirata

Supported/Contracted Research/Grant

Philips, Inspirata, PathCore

Speakers or Advisory Board Inspirata, AstraZeneca, Merck

Other Elucid Bioimaging, Inspirata, PathCore

Subha Madhavan Employee (full time or part time) Perthera

Anne Madroszyk Speakers or Advisory Board AstraZeneca, Boehringer Ingelheim

Supported/Contracted Research/Grant

Bristol-Meyers Squibb, Novartis

Other Roche, AstraZeneca, Boehringer Ingelheim

Narendra Maharaj Employee (full time or part time) Lupin

Kathleen Maignon Employee (full time or part time) Flatiron Health

Page 88: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

88

Jyoti Malhotra Speakers or Advisory Board AstraZeneca, Pfizer

Luigi Manenti Employee (full time or part time) Novartis

Helen Mann Employee (full time or part time) AstraZeneca

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

AstraZeneca

Michael Mann Other Razor Genomics

Jason Manro Employee (full time or part time) Eli Lilly

Aaron Mansfield Speakers or Advisory Board Genentech, Bristol-Meyers Squibb, AbbVie

Supported/Contracted Research/Grant

Novartis, NIH

Other Roche

Huzhang Mao Employee (full time or part time) Eli Lilly

Raji Marati Employee (full time or part time) Roche

Robert Marchesani Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Eli Lilly, Bristol-Meyers Squibb

Employee (full time or part time) Eli Lilly

Other AstraZeneca

Jack Mardekian Salary Pfizer

Employee (full time or part time) Pfizer

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Pfizer

Aleksandra Markovets Employee (full time or part time) AstraZeneca

Melina Marmarelis Supported/Contracted Research/Grant

Novartis, Eli Lilly

Ivonne Marondel Employee (full time or part time) Pfizer

Page 89: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

89

Kristen Marrone Speakers or Advisory Board Compugen, Takeda

Angela Märten Employee (full time or part time) Boehringer Ingelheim

Jean-François Martini Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Pfizer

Employee (full time or part time) Pfizer

Céline Mascaux Honoraria Boehringer Ingelheim, Eli Lilly, Bristol-Meyers Squibb, Roche, AstraZeneca

Other Roche, Kephren, AstraZeneca, Merck

Speakers or Advisory Board AstraZeneca, Roche, Kephren

Kimberly Mason Employee (full time or part time) Perthera

Ashiq Masood Speakers Bureau Bristol-Meyers Squibb

Other Boston Biomedical

Clare Massey Employee (full time or part time) BerGenBio

Elizabeth Masters Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Pfizer

Employee (full time or part time) Pfizer

Noriyuki Masuda Honoraria Ono Pharma, Merck

Christina Matheny Employee (full time or part time) Genentech, Roche

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Roche

Royalty, Intellectual Property/Patent Holder

Stanford

Julien Mazieres Other Roche, Bristol-Meyers Squibb, Merck, AstraZeneca, Pfizer, Novartis

Page 90: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

90

Supported/Contracted Research/Grant

Roche, Genentech, AstraZeneca, Bristol-Meyers Squibb

Speakers or Advisory Board Novartis, Roche, Pfizer, Bristol-Meyers Squibb, Eli Lilly, Merck, AstraZeneca

Peter Mazzone Speakers or Advisory Board Exact Sciences, Grail, Oncimmune

Supported/Contracted Research/Grant

Oncocyte, Veracyte

Caroline McCoach Honoraria Takeda, Guardant

Sherrol McDonough Employee (full time or part time) Thermo Fisher Scientific

Joseph McGill Employee (full time or part time) Daiichi Sankyo

Jessica McLean Employee (full time or part time) Merck

Minesh Mehta Supported/Contracted Research/Grant

Novcoure, Bristol-Meyers Squibb, Pharmacyclics

Tarek Mekhail Speakers Bureau AstraZeneca

Diana Mendus Employee (full time or part time) Genentech

Juscilene Menezes Employee (full time or part time) Thermo Fisher Scientific

Alexander Menzies Speakers or Advisory Board Merck, Bristol-Meyers Squibb, Novartis, Roche, Pierre Fabre

Ina Menzl Employee (full time or part time) Roche

Catalina Meyer Employee (full time or part time) Eli Lilly

Michael Meyer Employee (full time or part time) VisionGate, Syndax

Matthew Meyerson Speakers or Advisory Board OrigiMed

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

OrigiMed

Supported/Contracted Research/Grant

Bayer

Royalty, Intellectual Property/Patent Holder

LabCorp

Page 91: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

91

Michael Michael Speakers or Advisory Board Ipsen, Novartis

Honoraria Ipsen, Novartis

Supported/Contracted Research/Grant

Ipsen

David Micklem Employee (full time or part time) BerGenBio ASA

Maria Rita Migliorino Speakers or Advisory Board AstraZeneca, Boehringer Ingelheim, Bristol-Meyers Squibb

Katherine Mileham Speakers Bureau AstraZeneca

Speakers or Advisory Board Merck

Supported/Contracted Research/Grant

Celgene

Kenneth Miles Employee (full time or part time) Miles Medical Centre

Supported/Contracted Research/Grant

University of Queensland

Vincent Miller Employee (full time or part time) Foundation Medicine

Dawn Millington Employee (full time or part time) Janssen

Salary Janssen

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Janssen

Alvin Milner Employee (full time or part time) AstraZeneca

Erene Mina Employee (full time or part time) Thermo Fisher Scientific

Koichi Minato Supported/Contracted Research/Grant

Taiho Pharma, Bristol-Meyers Squibb, Quintiles

Mari Mino-Kenudson Other Merrimack Pharmas, H3 Biomedicine

Honoraria Merrimac Pharmas, H3 Biomedicine

Miguel Miranda Ownership Interest (stocks or stock options, or other

AstraZeneca

Page 92: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

92

ownership interest Excluding diversified mutual funds)

Employee (full time or part time) AstraZeneca

Tara Mitchell Speakers or Advisory Board Incyte, Bristol-Meyers Squibb

Other Merck

Upasana Mitra Employee (full time or part time) Cellworks Research India Pvt

Tetsuya Mitsudomi Speakers or Advisory Board Eli LIlly

Supported/Contracted Research/Grant

Eli Lilly, Boehringer Ingelheim, AstraZeneca, Chugai, The Japan Society for the Promotion of Science

Other Bristol-Meyers Squibb, Ono Pharma

Speakers Bureau AstraZeneca, Chug, Pfizer, Boehringer Ingelheim

Drew Moghanaki Honoraria Varian Medical Systems

Kosalai Mohan Employee (full time or part time) Regeneron Pharma

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Regeneron Pharma

Tony Mok Speakers or Advisory Board AstraZeneca, Roche, Genentech, Pfizer, Eli Lilly, Boehringer Ingelheim, Merck, Novartis, Bristol-Meyers Squibb, Taiho, Takeda Oncology Serono, SFJ Pharma, ACEA Biosciences, Vertex Pharma, geneDecode, OncoGenex Technologies, Celgene, Ignyta, Cirina, Fishawack Facilitate, Janssen, ChiMed

Page 93: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

93

Honoraria AstraZeneca, Roche, Genentech, Pfizer, Eli Lilly, Boehringer Ingelheim, Merck, Novartis, SFJ Pharma, ACEA Biosciences, Vertex Pharma, Bristol-Meyers Squibb, OncoGenex Pharma, Celgene, Ignyta, Fishawack Facilitate, Takeda Oncology, Janssen, Cirina, Chimed

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Sanomics, Cirina

Other Roche., IASLC, ASCO, ChiMed, Chinese Lung Cancer Research Foundation, Chinese Society of Clinical Oncology, Hong Kong Cancer Therapy Society

Supported/Contracted Research/Grant

AstraZeneca, Boehringer Ingelheim, Pfizer, Novartis, SFJ Pharmas Group, Roche, Merck, Clovis Oncology, Bristol-Meyers Squibb, Taiho Pharma, Eisai

Employee (full time or part time The Chinese University of Hong Kong

Daniel Moldaver Employee (full time or part time) Cornerstone Research Group

Cliff Molife Employee (full time or part time) Eli Lilly

Arta Monjazeb Speakers or Advisory Board AstraZeneca, Incyte, Dynavax

Supported/Contracted Research/Grant

Merck, Genentech, Transgene

Isabelle Monnet Supported/Contracted Research/Grant

AstraZeneca

Rebecca Moor Other Bristol-Meyers Squibb

Alessandro Morabito Honoraria AstraZeneca, Roche, Boehringer Ingelheim, Pfizer, Merck, Bristol-Meyers Squibb

Jean-François Morere Honoraria Roche

Page 94: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

94

Daniel Morgensztern Other Celgene Corporation, AbbVie, Bristol-Meyers Squibb

Satoshi Morita Honoraria AstraZeneca, Eli Lilly

Denis Moro-Sibilot Speakers or Advisory Board Roche, Eli Lilly, Sanofi, Novartis, Amgen, Pfizer, AstraZeneca, Clovis Oncology, Merck, Ariad, AbbVie, Bristol-Meyers Squibb, Boehringer Ingelheim, Takeda

Clive Morris Supported/Contracted Research/Grant

Inivata

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Inivata

Employee (full time or part time) Inviata

Don Morris Honoraria Roche, AstraZeneca, Bristol-Meyers Squibb, Cellgene, Takada, Boehringer Ingelheim, Pfizer, Novartis

Speakers or Advisory Board Roche, AstraZeneca, Bristol-Meyers Squibb, Cellgene, Takada, Boehringer Ingelheim, Pfizer, Novartis

Eric Morris Employee (full time or part time) Novartis

Stefanie Mortimer Employee (full time or part time) Guardant Health

Peter Mortimer Other AstraZeneca

Rebecca Mosher Employee (full time or part time) Mersana Therapeutics

Other Novartis Pharmas, Mersana Therapeutics

Noriko Motoi Speakers Bureau Bristol-Meyers Squibb

Speakers or Advisory Board Bristol-Meyers Squibb, Ono Pharmas, Miraca, AstraZeneca, Merck

Honoraria Bristol-Meyers Squibb, Ono Pharmas, AstraZeneca, Merck, Novartis, Roche, Agilent, Chugai

Page 95: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

95

Supported/Contracted Research/Grant

Roche

Nancy Mueller Employee (full time or part time) MedImmune, LLC

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

MedImmune, LLC

Tariq Mughal Speakers Bureau Sanofi

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Foundation Medicine.

Honoraria Sanofi

Royalty, Intellectual Property/Patent Holder

Oxford University Press

Other Roche

Hiroshi Mukae Supported/Contracted Research/Grant

Merck, Astellas, Kyorin Pharma, Shionogi, Daiichi Sankyo, Taisho Toyama Pharma, Sumitomo Dainippon Pharma, Pfizer, Boehringer Ingelheim

Other Taiho Pharma, Chugai Pharma, Eli Lilly, Fujifilm Pharma, Takeda Pharma, Meiji Seika Pharma, Novartis

Pratik Multani Employee (full time or part time) Ignyta

Haruyasu Murakami Speakers Bureau AstraZeneca

Honoraria AstraZeneca, Chugai Pharma, Boehringer Ingelheim

Supported/Contracted Research/Grant

AstraZenec

Page 96: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

96

Septimiu Murgu Other Educational Consultant Medtronic

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Concordia, Boston Scientific, Merck

Honoraria Pinnacle Biologics, Olympus, Boston Scientific, Cook, Auris Robotics

Speakers or Advisory Board Auris Robotics, Medtronic

Royalty, Intellectual Property/Patent Holder

Elsevier

Danielle Murphy Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Pfizer

Employee (full time or part time) Pfizer

Andrea Murray Employee (full time or part time) Oncimmune LLC

Faith Mutale Speakers Bureau Merck, Helsinn

Andrea Myers Employee (full time or part time) Novartis

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Novartis

Sten Myrehaug Speakers or Advisory Board Novartis, Ipsen

Honoraria Novartis

Supported/Contracted Research/Grant

Novartis

Other Novartis, Ipsen

Page 97: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

97

Eric Nadler Speakers Bureau AstraZeneca, Merck, Genentech

Other AstraZeneca, Merck

Adnan Nagrial Speakers or Advisory Board

Merck

Supported/Contracted Research/Grant

Merck, Bristol-Meyers Squibb

Other Bristol-Meyers Squibb

Rebecca Nagy Employee (full time or part time)

Guardant Health

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Guardant Health

Jarushka Naidoo Supported/Contracted Research/Grant

Merck, AstraZeneca

Other Bristol-Meyers Squibb, Takeda, AstraZeneca

Hideyuki Nakagawa Speakers Bureau Eli Lilly

Kazuhiko Nakagawa Supported/Contracted Research/Grant

Ono Pharma, Merck, A2 Healthcare, inVentiv Health, Astellas Pharma, Daiichi Sankyo, Novartis Pharma, AbbVie, Quintiles, ICON Japan, Chugai Pharma, Takeda Pharma, EP-CRSU, Gritstone, Linical, Eli Lilly, Eisai, Bristol-Meyers Squibb, Nippon Boehringer Ingelheim, Taiho Pharma, Parexel, GlaxoSmithKline

Page 98: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

98

Honoraria Ono Pharma, AstraZeneca, Nichi-Iko Pharma, Astellas Pharma, Clinical Trial, Taiho Pharma, Bristol-Meyers Squibb, Boehringer Ingelheim, Eli Lilly, Novartis, SymBio Pharma, Pfizer, Chugai Pharma, Nikkei Business Publications, Reno. Medical, Merck, Company, Kissei Pharma, Daiichi Sankyo, AYUMI Pharma Corporation

Other EPS Holdings, Showa Yakuhin Kako, Symbio, Kissei, Ayumi

Speakers or Advisory Board

Astellas Pharma, Ono Pharma, Eli Lilly

Takahiro Nakajima Honoraria AstraZeneca

Yukiko Nakamura Honoraria Chugai Pharma

Supported/Contracted Research/Grant

Chugai Pharma, Astellas

Yoichi Nakanishi Honoraria Ono Pharma, Bristol-Meyers Squibb, Pfizer, Boehringer Ingelheim, Eli Lilly, Merck, AstraZeneca

Supported/Contracted Research/Grant

Chugai Pharma, Ono Pharma, Boehringer Ingelheim, Daiichi Sankyo, Pfizer, Astellas Pharma, Taiho Pharma, Eli Lilly, AsahiKasei

Takashi Nakano Honoraria Merck, Olympus, Ishihara Sangyo, Kyorin, Pharma, Boehringer Ingelheim, Ono Pharma

Kazuhisa Nakashima Honoraria Chugai Pharma, Boehringer Ingelheim

Yuko Nakayama Speakers or Advisory Board

AstraZeneca

Julian Nam Employee (full time or part time)

Roche

Hervé Naman Honoraria Roche

Page 99: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

99

Tony Nash Employee (full time or part time)

AstraZeneca

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

AstraZeneca

Ronald Natale Speakers or Advisory Board

AstraZeneca

Employee (full time or part time)

AstraZeneca

Supported/Contracted Research/Grant

AbbVie, Bristol-Meyers Squibb, AstraZeneca, Merck, SynDeRx

Faith Nathan Employee (full time or part time)

Bristol-Meyers Squibb

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Bristol-Meyers Squibb

Natalya Nazarenko Employee (full time or part time)

Ipsen BioPharmas

Joel Neal Other Ariad, Takeda, AstraZeneca, Genentech, Roche, Eli Lilly

Speakers or Advisory Board

Ariad, Takeda, AstraZeneca, Genentech, Roche, Eli Lily, Clovis

Supported/Contracted Research/Grant

Boehringer Ingelheim, Exelixis, Genentech, Roche, Merck, Nektar Therapeutics, Novartis, Ariad, Takeda

Alan Nelson Employee (full time or part time)

VisionGate

Michele Nguyen Employee (full time or part time)

Loxo

Alan Nicholas Employee (full time or part time)

Genentech

Page 100: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

100

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Genentech

Andrew Nicholson Other Merck, Boehringer Ingelheim, Novartis, AstraZeneca, Bristol-Meyers Squibb, Roche, AbbVie

Supported/Contracted Research/Grant

Pfizer, Roche

Speakers or Advisory Board

Pfizer, Abbvie

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Merck

Monique Nilsson Royalty, Intellectual Property/Patent Holder

Spectrum Pharma

Mizuki Nishino Supported/Contracted Research/Grant

Merck, Toshiba Medical Systems, AstraZeneca

Other Daiichi Sankyo

Honoraria Roche

Kazuto Nishio Honoraria Boehringer Ingelheim

Supported/Contracted Research/Grant

Boehringer Ingelheim

Speakers or Advisory Board

Eli Lilly

Makoto Nishio Honoraria Ono Pharma, Bristol-Meyers Squibb, Pfizer, Chugai Pharma, Eli Lilly, Taiho Pharma, AstraZeneca, Boehringer Ingelheim, Merck, Novartis, Daiichi Sankyo Healthcare

Page 101: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

101

Speakers or Advisory Board

Ono Pharma, Bristol-Meyers Squibb, Pfizer, Chugai Pharma, Eli Lilly, Taiho Pharma, AstraZeneca, Boehringer Ingelheim, Merck, Novartis, Sankyo Healthcare

Supported/Contracted Research/Grant

Merck, Novartis, Ono Pharma, Chugai Pharma, Bristol-Meyers Squibb, Taiho Pharma, Eli Lilly, AstraZeneca, Pfizer, Astellas

Other Novartis, Daiichi Sankyo Healthcare, Taiho Pharma, Bristol-Meyers Squibb, Boehringer Ingelheim, Ono Pharma, Eli Lilly, Chugai Pharma, AstraZeneca, Merck, Pfizer, Roche

Speakers Bureau Ono Pharma, Bristol Myers Squibb, Pfizer, Chugai Pharma, Eli Lilly, Taiho Pharma, AstraZeneca, Boehringer Ingelheim, Merck, Novartis

Yasuhiko Nishioka Honoraria Taiho Pharma

Supported/Contracted Research/Grant

Taiho Pharma

Naoyuki Nogami Speakers or Advisory Board

Eli Lilly

Hiroshi Nokihara Honoraria Taiho Pharma, Chugai Pharma, Eli Lilly, AstraZeneca, Boehringer Ingelheim, Ono Pharma, Bristol-Meyers Squibb, Novartis Pharma, Merck

Supported/Contracted Research/Grant

Novartis, Daiichi Sankyo, IQVIA Services, Astellas Pharma, AstraZeneca, Ono Pharma, Pfizer, Taiho Pharma, Chugai Pharma, Eli Lilly

Helene Nordahl Christensen

Employee (full time or part time)

AstraZeneca

Kim Norris Speakers or Advisory Board

Takeda

Page 102: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

102

Other Takeda

Kaname Nosaki Honoraria AstraZeneca, Chugai Pharma, Eli Lilly, MSD, Nippon Boehringer

Ingelheim, Ono Pharma, Pfizer Japan, Taiho Pharma

Supported/Contracted Research/Grant

Merck, Novartis

Page 103: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

103

Silvia Novello Speakers or Advisory Board

Takeda

Speakers Bureau Boehringer Ingelheim, AstraZeneca, Roche, Merck, Bristol-Meyers Squibb, Eli Lilly, Takeda, Pfizer

Ruslan Novosiadly Employee (full time or part time)

Eli Lilly

Petr Novotny Employee (full time or part time)

Optellum

Anna Nowak Speakers or Advisory Board

Bayer, AstraZeneca, Sellas Life Sciences, Trizell, Boehringer Ingelheim, Epizyme, Roche, Merck

Other AstraZeneca, Boehringer Ingelheim, Epizyme

Supported/Contracted Research/Grant

AstraZeneca, Douglas Pharma

Toshihiro Nukiwa Speakers or Advisory Board

Asahi Kasei, Boehringer Ingelheim

Rafael Nuñez Employee (full time or part time)

PharmaMar

Esmond Nwokeji Employee (full time or part time)

Bristol-Meyers Squibb

Kenneth O'Byrne Honoraria Pfizer, Roche, AstraZeneca, Boehringer-Ingelheim, Bristol-Meyers Squibb, Merck, Eli Lilly, Novartis, Teva

Speakers Bureau Pfizer, Roche, AstraZeneca, Boehringer-Ingelheim, Bristol-Meyers Squibb, Merck

Royalty, Intellectual Property/Patent Holder

Queensland University of Technology

Page 104: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

104

Supported/Contracted Research/Grant

Tesaro

Speakers or Advisory Board

Pfizer, Roche, AstraZeneca, Boehringer-Ingelheim, Bristol-Meyers Squibb, Merck, Lilly Oncology, Novartis, Teva

Justin Odegaard Employee (full time or part time)

Guardant Health

Luc Odier Speakers or Advisory Board

Eli Lilly

Supported/Contracted Research/Grant

Pfizer, Amgen, AstraZeneca

John O'Donnell Employee (full time or part time)

Bristol-Meyers-Squibb

Vance Oertel Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Xcovery Holding Company

Salary Xcovery Holding Company

Employee (full time or part time)

Xcovery Holding Company

Filiz Oezkan Other Epigenomics, Genentech, Roche

Honoraria Novartis

Supported/Contracted Research/Grant

Genentech, Roche

Martin Oft Employee (full time or part time)

Armo BioSciences

Yuichiro Ohe Other AstraZeneca, Chugai Pharma, Eli Lilly, Ono Pharma, Novartis

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Ono Pharma

Page 105: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

105

Honoraria AstraZeneca, Chugai Pharma, Lilly Japan, Ono Pharma, Bristol-Meyers Squibb Japan, Daiichi Sankyo, Nippon Kayaku, Boehringer Ingelheim, Bayer, Pfizer, Merck, Taiho Pharma, Novartis, Kyowa Hakko Kirin, Sanofi, Kyorin, Kissei

Supported/Contracted Research/Grant

AstraZeneca, Lilly, Chugai, Taiho, Pfizer, Merck, Novartis, Kyorin, Dainippon-Sumitomo, Ignyta, Bristol-Meyers Squibb, Nipponkayaku, Japan Agency for Medical Research and Development, Ono Pharma, Kissei

Speakers or Advisory Board

AstraZeneca, Chugai, Ono Pharma, Kissei, Kyorin

Carol O'Hear Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Roche

Salary Genentech

Employee (full time or part time)

Genentech

Satoshi Oizumi Honoraria AstraZeneca, Eli Lilly, Ono Pharma

Supported/Contracted Research/Grant

Bristol-Meyers Squibb, Pfizer

Morihito Okada Speakers Bureau Taiho Pharma, Johnson & Johnson, Covidien, Eli Lilly, Chugai Pharma

Supported/Contracted Research/Grant

Taiho Pharma, Nippon Kayaku, Chugai Pharma, Covidien, Johnson & Johnson, Daiichi Sankyo, Yakult Honsha, Eli Lilly, Nihon Medi-Physics, Pfizer, Mochida Pharma, Shionogi Pharma, Ono Pharma

Honoraria Ono Pharma

Page 106: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

106

Hiroaki Okamoto Supported/Contracted Research/Grant

Takeda, Ono Pharma, Astrazeneca, Merck, Chugai Pharma, Taiho Pharma, Bristol-Meyers Squibb, Eli Lilly, Daiich Sankyo

Isamu Okamoto Speakers Bureau Taiho Pharma

Honoraria Nippon Boehringer Ingelheim

Supported/Contracted Research/Grant

Nippon Boehringer Ingelheim, AstraZeneca, Ono Pharma, Chugai Pharma, Bristol-Meyers Squibb, Merck, Eli Lilly, Taiho Pharma, Pfizer

Speakers or Advisory Board

Eli Lilly

Kyoichi Okishio Speakers Bureau Ono Pharma, Bristol-Meyers Squibb

Carlos Oliveira Employee (full time or part time)

Biodesix

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Biodesix

James Oliviero Employee (full time or part time)

Checkpoint Therapeutics

Steven Olsen Employee (full time or part time)

Guardant Health

Anthony Olszanski Speakers or Advisory Board

Bristol-Meyers Squibb, Merck

Other Takeda

Yukie Omori Employee (full time or part time)

Eli Lilly

Umang Ondhia Employee (full time or part time)

Roche

Teng Jin Ong Employee (full time or part time)

Celgene Corporation

Akira Ono Honoraria Chugai Pharma

Page 107: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

107

Supported/Contracted Research/Grant

Chugai Pharma

Erik Orava Employee (full time or part time)

AstraZeneca

Peter Ordentlich Employee (full time or part time)

Syndax

Francisco Orlandi Other AstraZeneca, Roche, Genentech, Bristol-Meyers Squibb, Merck, Eli Lilly, Pfizer

Speakers Bureau AstraZeneca, MedImmune

Supported/Contracted Research/Grant

AstraZeneca, MedImmune, Amgen, Genentech, Roche, Astellas Medivation, Merck, Bristol-Meyers Squibb, Celltrion, Boehringer Ingelheim

Raymond Osarogiagbon Supported/Contracted Research/Grant

Association of Community Cancer Centers

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Foundation Medicine, Pfizer, Eli Lilly

Royalty, Intellectual Property/Patent Holder

Patent

Other Association of Community Cancer Centers

Kenji Otsuka Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Otsuka Holdings

Gregory Otterson Speakers or Advisory Board

Novartis, Takeda, Genentech, Pfizer, Amgen

Supported/Contracted Research/Grant

Pfizer, Bristol-Meyers Squibb, Merck, Novartis, Genentech, AstraZeneca, Ignyta, Clovis

Sai-Hong Ou Speakers Bureau Roche, Genentech, AstraZeneca, Takeda

Page 108: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

108

Speakers or Advisory Board

Pfizer, Roche, Genentech, Novartis, AstraZeneca, Takeda, Foundation Medicine

Honoraria Pfizer, Genentech, Roche, Ariad, Takeda, Novartis, AstraZeneca, Foundation Medicine

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

TP Therapeutics

Supported/Contracted Research/Grant

Pfizer, Roche, MedImmune, AstraZeneca, Clovis Oncology, Ariad, Ignyta, Peregrine Pharma, GlaxoSmithKline, Astellas Pharma, Chugai Pharma

Qiuxiang Ou Employee (full time or part time)

Geneseeq Technology

Dwight Owen Other L&M Policy Research

Scott Owen Speakers or Advisory Board

AstraZeneca, Bristol-Meyers Squibb, Roche, Merck

Honoraria AstraZeneca

Other Roche Canada

Sherry Owens Employee (full time or part time)

Incyte

Taofeek Owonikoko Speakers or Advisory Board

AbbVie, Bristol-Meyers Squibb, G1 Therapeutics

Supported/Contracted Research/Grant

Bristol-Meyers Squibb, AbbVie, United Pharma, G1 Therapeutics

Geoffrey Oxnard Speakers or Advisory Board

Inivata, GRAIL, DropWorks, AstraZeneca, Takeda/Ariad

Other Loxo, Inivata, AstraZeneca

Royalty, Intellectual Property/Patent Holder

Co-author of patent held by DFCI describing a plasma genotyping approach

Page 109: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

109

Honoraria Guardant, Sysmex

Randall Oyer Honoraria Association of Community Cancer Centers

Masahiro Ozaki Employee (full time or part time)

Canon Medical Systems Corporation

Mustafa Özgüroğlu Speakers or Advisory Board

Astellas

Honoraria Janssen

Page 110: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

110

Jose Pacheco Speakers or Advisory Board AstraZeneca, Novartis

Honoraria Ariad Pharma

Supported/Contracted Research/Grant

Janssen, AstraZeneca and Pfizer

Sukhmani Padda Supported/Contracted Research/Grant

Forty-Seven, EpicentRx

Speakers or Advisory Board G1 therapeutics, Janssen, AstraZeneca, AbbVie

Other Physician Education Resource, MedScape

Damian Page Employee (full time or part time) Roche, Novartis

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Roche, Novartis

Other Roche

Salary Roche

Venkata Palle Employee (full time or part time) Lupin

Xiaoyun Pan Employee (full time or part time) Takeda

Zhiying Pan Employee (full time or part time) Amgen

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Amgen

Kaimin Pang Employee (full time or part time) Boehringer Ingelheim

Vassiliki Papadimitrakopoulou

Speakers or Advisory Board Nektar Therapeutics, AstraZeneca, Arrys, Merck, Loxo, Araxes Pharma, Roche, Janssen Research Foundation, Bristol-Meyers Squibb, Clovis Oncology, Eli Lilly, Novartis, Takeda Pharma, AbbVie, TRM Oncology, Pfizer

Page 111: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

111

Supported/Contracted Research/Grant

Eli Lilly, Novartis, Merck, AstraZeneca, Roche, Nektar Therapeutics, Janssen, Bristol-Meyers Squibb, Checkmate, Incyte, Oregon Health Science, ACEA Biosciences, American Association of Cancer Research, Hope Foundation, Cancer Prevention and Research Institute of Texas, Genentech, Guardant Health

Mauro Giulio Papotti Speakers Bureau Pfizer, Merck, Roche, AstraZeneca

Speakers or Advisory Board AbbVie

Drew Pardoll Other Aduro, Compugen, GlaxoSmithKline, MedImmune, AstraZeneca, Merck, Potenza Therapeutics, Sanofi, Tizona, DNatrix, Amgen, Rock Springs Capital, Janssen, Bayer

Speakers or Advisory Board Immunomic Therapeutics, WindMil Therapeutics

Joseph Park Employee (full time or part time) Amgen

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Amgen

Keunchil Park Other Astellas Pharma, AstraZeneca, Boehringer Ingelheim, Clovis Oncology, Eli Lilly, Hanmi, Kyowa Kakko Kirin, Novartis, Ono Pharma, Roche, Bristol-Meyers Squibb, GlaxoSmithKline, Merck, GlaxoSmithKline

Supported/Contracted Research/Grant

AstraZeneca

Speakers or Advisory Board AstraZeneca, Astellas, Boehringer Ingelheim, Bristol-Meyers Squibb, Clovis, Daiichi Sankyo, Eli Lilly,

Page 112: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

112

GlaxoSmithKline, Hanmi, KHK, Merck, Novartis, Roche

Rahul Parulkar Employee (full time or part time) Nantomics

Ugo Pastorino Royalty, Intellectual Property/Patent Holder

Gensignia Life Science

Greg Pate Employee (full time or part time) Roche

Bhavin Patel Employee (full time or part time) MagArray

Jyoti Patel Speakers or Advisory Board AbbVie, AstraZeneca, Bristol-Meyers Squibb, Takeda, Roche

Supported/Contracted Research/Grant

Bristol-Meyers Squibb

Other Genentech

Sabina Patel Other AstraZeneca

Sandip Patel Speakers or Advisory Board AstraZeneca

Supported/Contracted Research/Grant

Xcovery Holding Company

Other Merck, Incyte

Melissa Pavilack Employee (full time or part time) AstraZeneca

Nick Pavlakis Speakers or Advisory Board Bristol-Meyers Squibb, Merck, Astra Zeneca, Roche, Novartis, Boehringer Ingelheim, Merck, Pfizer, Ipsen, Amgen

Supported/Contracted Research/Grant

Bayer

Dean Pavlick Employee (full time or part time) Foundation Medicine

Luis Paz-Ares Other Novartis, Roche, Pfizer, Bristol-Meyers Squibb, Merck, Boehringer Ingelheim, AstraZeneca, Amgen, Clovis, Takeda

Page 113: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

113

Honoraria Eli Lilly, Roche, Novartis, Bristol-Meyers Squibb, Merck, Pfizer, Amgen, Takeda, Boehringer Ingelheim, AstraZeneca, Clovis Oncology, Astillas

Speakers or Advisory Board Bristol-Meyers Squibb, Merck, AstraZeneca, Roche, Lilly, Merck, Pfizer, Novartis, Takeda, Incyte, Boehringer Ingelheim, Celgene

Laura Peek Employee (full time or part time) Oncimmune

Tobias Peikert Speakers or Advisory Board Epizyme

Nir Peled Honoraria AstraZeneca, Boehringer Ingelheim, Bristol-Meyers Squibb, Eli Lilly, Merck, Novartis, Pfizer, Roche, NovellusDx, FMI, Gaurdant360

Other AstraZeneca, Boehringer Ingelheim, Bristol-Meyers Squibb, Eli Lilly, Merck, Novartis, Pfizer, Roche, NovellusDx, FMI, Gaurdant360

Gerson Peltz Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Pfizer

Employee (full time or part time) Pfizer

Frederique Penault-Llorca Speakers or Advisory Board Pfizer

John Penrod Employee (full time or part time) Bristol-Meyers Squibb

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Bristol-Meyers Squibb

Salary Bristol-Meyers Squibb

Maurice Pérol Honoraria AstraZeneca

Speakers or Advisory Board Pfizer

Page 114: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

114

Francesco Perrone Honoraria Amgen, AstraZeneca, Bayer, Bristol-Meyers Squibb, Boehringer Ingelheim, Eli Lilly, Ipsen, Novartis, Pfizer, Sandoz, Tesaro AstraZeneca, Baxter, Eli Lilly, Merck, Roche

Heiko Peschl Salary EIT health, National Institute for Health Research

Solange Peters Speakers or Advisory Board Amgen, AstraZeneca, Boehringer Ingelheim, Bristol-Meyers Squibb, Eli Lilly, Roche, Janssen, Merck, Pfizer, Regeneron, Takeda

Emanuel Petricoin Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Perthera

See Phan Employee (full time or part time) Genentech

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Roche

Andrew Phillips Employee (full time or part time) AbbVie

Lyndsey Pickup Employee (full time or part time) Optellum

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Optellum

Rathi Pillai Supported/Contracted Research/Grant

Bristol-Meyers Squibb

Speakers or Advisory Board AstraZeneca

Zosia Piotrowska Other AstraZeneca, Boehringer Ingelheim, Ariad, Novartis, Guardant Health, Takeda, AbbVie

Speakers or Advisory Board AstraZeneca, Ariad, Takeda, Novartis, Boehringer Ingelheim, AbbVie

Page 115: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

115

Supported/Contracted Research/Grant

Novartis

Honoraria Guardant Health

J Pipas Employee (full time or part time) Merrimack Pharmas

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Merrimack Pharmas

Bilal Piperdi Employee (full time or part time) Merck

Robert Pirker Speakers Bureau Boehringer Ingelheim

Speakers or Advisory Board Boehringer Ingelheim, AstraZeneca, Eli Lilly

Honoraria Merck, Genmab and Regeneron

Yazdi Pithavala Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Pfizer

Employee (full time or part time) Pfizer

Vincent Plagnol Employee (full time or part time) Inivata

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Inivata

Royalty, Intellectual Property/Patent Holder

Inivata

David Planchard Other AstraZeneca, Boehringer Ingelheim, Bristol-Meyers Squibb, Merck, Novartis, Roche, Pfizer, Celgene

Speakers or Advisory Board AstraZeneca, Boehringer, Bristol-Meyers Squibb, Merck, Celgene, Novartis, Pfizer, Roche Celtes

Speakers Bureau Boehringer Ingelheim, Merck, Pfizer, Novartis, Roche, Celgene

Page 116: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

116

Lukas Plank Supported/Contracted Research/Grant

AstraZeneca, Boehringer Ingelheim, Roche

Speakers Bureau AstraZeneca, Boehringer Ingelheim, Roche

Miklos Pless Speakers or Advisory Board AstraZeneca, Bristol-Meyers Squibb, Roche, Merck, Boehringer

Adam Pluzanski Speakers Bureau AstraZeneca, Boehringer Ingelheim, Bristol-Meyers Squibb, Merck, Roche

Speakers or Advisory Board AstraZeneca, Boehringer Ingelheim, Bristol-Meyers Squibb, Merck, Roche

Katerina Politi Supported/Contracted Research/Grant

AstraZeneca, Roche, Kolltan, Symphogen

Honoraria AstraZeneca, Merck, Novartis, Tocagen

Royalty, Intellectual Property/Patent Holder

Molecular MD

Anna Polli Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Pfizer

Employee (full time or part time) Pfizer

Rodney Pommier Speakers or Advisory Board Novartis Oncology, Ipsen

Honoraria Novartis Oncology, Ipsen

Greg Pond Employee (full time or part time) Roche Canada

Lynne Poole Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

AstraZeneca

Other AstraZeneca

Employee (full time or part time) AstraZeneca

Page 117: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

117

Sanjay Popat Other Boehringer Ingelheim, Epizyme, Bristol-Meyers Squibb, Clovis Oncology, Roche, Eli Lilly, Takeda, AstraZeneca, Novartis, Pfizer, Merck, Guardant Health, AbbVie

Honoraria Boehringer Ingelheim, AstraZeneca, Roche, Eli Lilly, Novartis, Takeda, Guardant Health, Bristol-Meyers Squibb, Pfizer, Chugai Pharma, Merck, Abbvie

Supported/Contracted Research/Grant

Boehringer Ingelheim, Epizyme, Bristol-Meyers Squibb, Clovis Oncology, Roche, Eli Lilly, Takeda

Speakers Bureau Pfizer, AstraZeneca, Boehringer Ingelheim, Roche, Merck, Chugai

Speakers or Advisory Board Boehringer Ingelheim, AstraZeneca, Roche, Novartis, Pfizer, Bristol-Meyers Squibb, Merck, Guardant Health, AbbVie, Takeda, Chugai

Bryce Portier Employee (full time or part time) Roche Diagnostics

Pieter E. Postmus Speakers or Advisory Board Celgene, AstraZeneca, Roche, Bristol-Meyers Squibb, Boehringer Ingelheim, Janssen, Merck, Clovis

Vaclav Potesil Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Optellum

John Powderly Supported/Contracted Research/Grant

Genentech, Bristol-Meyers Squibb, Curius, Corvus, Merck, Macrogenics

Speakers Bureau Genentech, Bristol-Meyers Squibb

Other Bristol-Meyers Squibb

Page 118: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

118

Royalty, Intellectual Property/Patent Holder

T cell immunotherapy development

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

BioCytics, LionBiotech, Juno, Blue Bird, Kite Pharma, ZioPharma

Courtney Powell Employee (full time or part time) Roche

Masha Poyurovsky Employee (full time or part time) Kadmon Corporation LLC

Chris Presley Employee (full time or part time) VisionGate

Michael Pritchett Honoraria Biodesix, Medtronic, AstraZeneca, Johnson & Johnson

Speakers or Advisory Board Biodesix, Medtronic, AstraZeneca

Speakers Bureau Medtronic, AstraZeneca

Claudia Proto Honoraria Bristol-Meyers Squibb, Merck

Mariano Provencio Speakers or Advisory Board AstraZeneca, Bristol-Meyers Squibb, Fabre, Merck, Pierre, Roche

Other Bristol-Meyers Squibb

Supported/Contracted Research/Grant

Bristol-Meyers Squibb

Xiangping Qian Employee (full time or part time) NeuPharma

Jingxin Qiu Speakers or Advisory Board Merck

Syed Quadri Employee (full time or part time) AbbVie

Susan Quinn Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Pfizer

Employee (full time or part time) Pfizer

Katie Quinn Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Guardant Health

Page 119: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

119

Employee (full time or part time) Guardant Health

Christina Raabe Employee (full time or part time) Boehringer Ingelheim

Shahrooz Rabizadeh Employee (full time or part time) Nanth Health

Frederick Racke Employee (full time or part time) Quest Diagnostics

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Quest Diagnostics

Janna Radtchenko Employee (full time or part time) Cardinal Health

Luis Raez Supported/Contracted Research/Grant

Bristol-Meyers Squibb, Pfizer, Roche, Genentech, Syndax, Novartis

Judith Raimbourg Other Bristol-Meyers Squibb, Amgen, Leo Pharma

Suresh Ramalingam Other AbbVie, Amgen, AstraZeneca, Bristol-Meyers Squibb, Celgene, Genentech, Roche, Nektar, Takeda, Loxo, Eli Lilly, Merck, Novartis

Speakers or Advisory Board AbbVie, Amgen, AstraZeneca, Bristol-Meyers Squibb, Celgene, Genentech, Roche, Nektar, Takeda, Loxo, Eli Lilly, Merck, Novartis

Robert Ramirez Speakers or Advisory Board AstraZeneca, Biotheranostics, Advanced Accelerator Applications, Novartis

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Advanced Accelerator Applications

Honoraria Merck, Genetech, AstraZeneca, Ipsen, Guardant

Speakers Bureau Guardant Health, Merck, AstraZeneca, Ipsen BioPharmas, Inc

Erik Rasmussen Employee (full time or part time) Eli Lilly, Amgen

Page 120: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

120

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Amgen

Marianne Ratcliffe Employee (full time or part time) AstraZeneca

Tobias Raum Employee (full time or part time) Amgen

Victoria Raymond Employee (full time or part time) Guardant Health

Dan Raz Supported/Contracted Research/Grant

Merck

Neal Ready Other Bristol-Meyers Squibb

Martin Reck Speakers Bureau Roche, Eli Lilly, AstraZeneca, Bristol-Meyers Squibb, Celgene, Merck, Boehringer-Ingelheim, Novartis, Pfizer, Abbot

Speakers or Advisory Board Roche, Eli Lilly, AstraZeneca, Bristol-Meyers Squibb, Celgene, Merck, Boehringer Ingelheim, Novartis, Pfizer, Abbot

Other AstraZeneca, Boehringer Ingelheim, Bristol-Meyers Squibb, Lilly, Merck, Practa, Roche

Honoraria AstraZeneca, Boehringer Ingelheim, Bristol-Meyers Squibb, Celgene, Eli Lilly, Merck, Pfizer, Proacta, Novartis, Roche, Abbott

Karen Reckamp Other Amgen, Ariad, Astellas Pharma, Euclises, Tesaro, Boehringer Ingelheim, Takeda

Supported/Contracted Research/Grant

Bristol-Meyers Squibb, Pfizer, Novartis, Ariad, Clovis Oncology, Xcovery, Gilead Sciences, Pfizer, Adaptimmune, Genentech, Roche, Boehringer Ingelheim, AbbVie

Sandeep Reddy Employee (full time or part time) NantHealth

Page 121: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

121

Jordi Remon Other Inivata

Dennis Revicki Other Takeda

Thereasa Rich Employee (full time or part time) Guardant Health

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Myriad Genetics

Eduardo Richardet Other Bristol-Meyers Squibb

Bill Richardson Employee (full time or part time) Roche

Otis Rickman Other Medtronic, Medtronic, BD, Olympus, AbbVie

Honoraria Veran Medical

Supported/Contracted Research/Grant

Olympus, BD

Todd Riehl Employee (full time or part time) Roche/Genentech

Gregory Riely Supported/Contracted Research/Grant

Novartis, Genentech Roche, Millennium, GlaxoSmithKline, Pfizer, Infinity Pharmas, Ariad

Speakers or Advisory Board Genetech

Other Ariad Pharmas, GlaxoSmithKline, Infinity Pharmas, Millennium Pharmas, Inc., Novartis Pharmas Corporation, Pfizer, Roche Laboratories, Genentech, Merck

Jonathan Riess Supported/Contracted Research/Grant

Merck, Boehringer Ingelheim, AstraZeneca

Speakers or Advisory Board Takeda, Celgene, Biodesix, AbbVie

Petra Rietschel Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Regeneron Pharma

Honoraria Regeneron Pharma

Page 122: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

122

Employee (full time or part time) Regeneron Pharma

James Rigas Speakers or Advisory Board AstraZeneca

Erika Rijavec Honoraria AstraZeneca

Ed Riley Employee (full time or part time) AbbVie

David Rimm Speakers or Advisory Board AstraZeneca, Agendia, Agilent, Bethyl Labs, Biocept, Bristol-Meyers Squibb, Cell signaling technology, Cepheid, Merck, Optrascan, Perkin Elmer, Ultivue

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

PixelGear

Supported/Contracted Research/Grant

Navigate, Novartis, Gilead Sciences, Perkin Elmer

Andreas Rimner Supported/Contracted Research/Grant

Varian Medical Systems, Boehringer Ingelheim, AstraZeneca, Pfizer

Honoraria Varian Medical Systms, Bristol-Meyers Squibb, AstraZeneca, Pfizer, Merck

Speakers or Advisory Board AstraZeneca, Merck

Naiyer Rizvi Honoraria Roche, AstraZeneca, Novartis, Merck, Pfizer, Lilly, Bristol-Meyers Squibb

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Gritsone Oncology, Armo Biosciences

Speakers or Advisory Board Merck, AstraZeneca, Roche, Bristol-Meyers Squibb, Novartis, Pfizer, Eli Lilly, AbbVie, Regeneron

Other Merck, AstraZeneca, Roche, Bristol-Meyers Squibb, Novartis, Pfizer, Eli Lilly, AbbVie, Regeneron

Page 123: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

123

Michael Roach Supported/Contracted Research/Grant

Varian

Kate Roberts Other Roche

Laurie Roberts Employee (full time or part time) Evidera

Jacqulyne Robichaux Royalty, Intellectual Property/Patent Holder

Spectrum Pharma

Cliff Robinson Speakers Bureau Varian Medical Systems

Speakers or Advisory Board Radiologica

Andrew Robinson Speakers or Advisory Board Merck, Kirkland

Other Merck, Kirkland,

Gaetano Rocco Speakers Bureau Baxter, Medtronic

Heinrich Roder Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Biodesix

Employee (full time or part time) Biodesix

Joanna Roder Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Biodesix

Employee (full time or part time) Biodesix

Brent Roeck Employee (full time or part time) Spectrum Pharma

Julia Roeper Honoraria Roche, Boehringer Ingelheim

Kimberly Rohan Speakers Bureau Merck, Genentech, AstraZeneca

Speakers or Advisory Board AstraZeneca

Simon Roitt Supported/Contracted Research/Grant

Inivata

Employee (full time or part time) Inivata

Lee Rosen Supported/Contracted Research/Grant

Regeneron Pharma

Nitzan Rosenfeld Employee (full time or part time) Inivata

Page 124: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

124

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Inivata

Mark Rosenzweig Employee (full time or part time) Foundation Medicine

Jeffrey Ross Employee (full time or part time) Foundation Medicine

Kenneth Roth Employee (full time or part time) Eli Lilly

S Rothenberg Employee (full time or part time) Loxo

Jeffrey Rothenstein Speakers or Advisory Board AstraZeneca, Bristol-Meyers Squibb, Merck, Pfizer, Roche

Sacha Rothschild Supported/Contracted Research/Grant

AstraZeneca, Bristol-Meyers Squibb, Merck

Speakers or Advisory Board AstraZeneca, Bristol-Meyers Squibb, Merck, Novartis, Pfizer, Roche

Julia Rotow Other Revolution Medicines

Etienne Rouleau Salary Lundbeck

Honoraria AstraZeneca, Roche, Bristol-Meyers Squibb

Speakers Bureau AstraZeneca

Supported/Contracted Research/Grant

AstraZeneca

Other AstraZeneca, Roche

John Ruckdeschel Employee (full time or part time) EMX International

Other ProLung

Charles Rudin Speakers or Advisory Board AbbVie, Amgen, AstraZeneca, Bristol-Meyers Squibb, Genentech, Harpoon, Genetics

Other Bristol-Meyers Squibb, AbbVie, Seattle Genetics, Harpoon Therapeutics, Genentech Roche, AstraZeneca

Mary Ruisi Employee (full time or part time) Merck

Page 125: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

125

Valerie Rusch Other Da Vinci Surgery, Bristol-Meyers Squibb

Supported/Contracted Research/Grant

Genelux

Page 126: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

126

Kris Sachsenmeier Other AstraZeneca

Matilde Saggese Employee (full time or part time) AstraZeneca

Nobuhiko Saijo Speakers Bureau Ono Pharma, Bristol-Myers Squibb, AstraZeneca, Merck

Pierre Saintigny Supported/Contracted Research/Grant

AstraZeneca, Roche, Novartis

Speakers or Advisory Board HTG

Tomohito Saito Supported/Contracted Research/Grant

Ono Pharma, Bristol-Myers Squibb

Other Ono Pharma

Gabriella Salvatore Employee (full time or part time) Millennium Pharma, Cambridge, MA, Takeda

Ayman Samkari Employee (full time or part time) Merck

Rachel Sanborn Speakers or Advisory Board Genetics, AstraZeneca, Celldex, AbbVie, Takeda

Honoraria AstraZeneca

Supported/Contracted Research/Grant

Merck, Bristol-Meyers Squibb, Medimmune

Alan Sandler Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Roche, Genentech

Salary Roche, Genentech

Employee (full time or part time) Roche, Genentech

Other Roche

Mansee Sangani Employee (full time or part time) Novartis

Randeep Sangha Honoraria Pfizer, Boehringer Ingelheim, AstraZeneca, Roche, Genentech, Lundbeck, Bristol-Meyers Squibb, Merck, AbbVie, Takeda

Page 127: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

127

Speakers or Advisory Board Boehringer Ingelheim, AstraZeneca, Roche, Genentech, Lundbeck, Eli Lilly, Bristol-Meyers Squibb, Merck, Novartis, AbbVie, Takeda

Other Bristol-Meyers Squibb

Serap Sankoh Employee (full time or part time) Syndax

Ademi Santiago-Walker

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Johnson & Johnson

Employee (full time or part time) Johnson & Johnson

Sergio Santillana Employee (full time or part time) Merrimack Pharma

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Merrimack Pharma

Antonio Santo Speakers or Advisory Board Merck

Catarina Santos Employee (full time or part time) Optellum

Edgardo Santos Speakers Bureau Genentech, Pfizer, Novartis, Amgen, Takeda, Boehringer Ingelheim, Celgene, Merck, AstraZeneca

Orestes Santos Morales Employee (full time or part time) Center of Molecular Immunology

Indrani Sarkar Employee (full time or part time) Genentech

Andreas Sashegyi Employee (full time or part time) Eli Lilly

Masafumi Sata Speakers or Advisory Board Ono Pharma, AstraZeneca

Miyako Satouchi Honoraria Chugai, Eli Lilly, AstraZeneca, Pfizer, Taiho, Boehringer Ingelheim, Ono Pharma, Bristol-Myers Squibb, Merck, Novartis

Supported/Contracted Research/Grant

Chugai, Eli Lilly Japan, Merck, AstraZeneca, Pfizer, Bristol-Myers Squibb, Ono, Novartis, Astellas

Page 128: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

128

Laura Saunders Employee (full time or part time) AbbVie

Mark Sausen Employee (full time or part time) Personal Genome Diagnostics

Eric Sbar Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Pfizer

Employee (full time or part time) Pfizer

Giorgio Scagliotti Honoraria AstraZeneca, Roche, Pfizer, Merck, Eli Lilly, AbbVie, Novartis, Clovis

Speakers or Advisory Board Eli Lilly, Merck

Speakers Bureau Eli Lilly, Merck

Other Bayer

David Schaer Employee (full time or part time) Eli Lilly

Jürgen Scheele Employee (full time or part time) Merck

Devin Schellenberg Speakers or Advisory Board AstraZeneca

Honoraria Pfizer

Supported/Contracted Research/Grant

Varian Medical Systems

Erin Schenk Other Elsevier

Michael Schenker Supported/Contracted Research/Grant

Amgen, Bristol-Meyers Squibb, Roche, Novartis, Merck, Bayer, Eli Lilly, Pfizer, AbbVie, CMed, Astellas, Nektar, AstraZeneca, Boehringer Ingelheim, Mylan, Bioven, Pharma Mar, Eisai, Daichii Sankyo

Arnaud Scherpereel Speakers or Advisory Board Bristol-Meyers Squibb, Merck, Boehringer Ingelheim, AstraZeneca, Roche

Other Bristol-Meyers Squibb, Merck, Boehringer Ingelheim, AstraZeneca, Eli Lilly, Epizyme, Bayer, Roche

Page 129: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

129

Joan Schiller Speakers or Advisory Board AstraZeneca, Roche, Merck

Supported/Contracted Research/Grant

Merck, Genetech, Bristol-Meyers Squibb, Xcovery

Other Lung Cancer Research Foundation

Peter Schmid Employee (full time or part time) Roche

Honoraria AstraZeneca, Bayer, Boehringer Ingelheim, Celgene, Eisai, Novartis, Pfizer, Puma, Roche, Genentech

Supported/Contracted Research/Grant

Astellas, AstraZeneca, Medivation, Novartis, Oncogenex, Roche, Genentech

Emmett Schmidt Employee (full time or part time) Merck

Salary Merck

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Merck

Roland Schott Speakers or Advisory Board Roche

Alexa Schrock Employee (full time or part time) Foundation Medicine

Jody Schulz Employee (full time or part time) Thermo Fisher Scientific

Katja Schulze Employee (full time or part time) Genentech

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Roche, Genentech

Ed Schuuring Speakers or Advisory Board AstraZeneca, Roche, Pfizer, Novartis, Bristol-Meyers Squibb, Amgen, BioCartis, Abbot, Bio-rad, Illumina

Supported/Contracted Research/Grant

Pfizer, Biocartis, Bristol-Meyers Squibb, Roche, Boehringer Ingelheim

Lee Schwartzberg Speakers or Advisory Board Bristol-Myers Squibb, Merck

Page 130: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

130

Honoraria Eisai, Helsinn, Tesaro

Supported/Contracted Research/Grant

Tesaro

Joerg Schwock Honoraria Merck, Olympus

Andrew Scott Supported/Contracted Research/Grant

AbbVie

Speakers or Advisory Board Life Science Pharma

Royalty, Intellectual Property/Patent Holder

mAb806

Jeffrey Scott Employee (full time or part time) IntegraConnect

Marietta Scott Employee (full time or part time) AstraZeneca

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

AstraZeneca

Vieri Scotti Speakers or Advisory Board Boehringer Ingelheim

Eva Segelov Honoraria Ipsen

Tanguy Seiwert Honoraria Merck, Bristol-Meyers Squibb, AstraZeneca, Innate Pharma

Nobuhiko Seki Speakers Bureau Eli Lilly, AstraZeneca, Chugai Pharma, Boehringer Ingelheim, Taiho Pharma, Daiichi Sankyo, Ono Pharma, Bristol-Myers Squibb, Merck

Speakers or Advisory Board Eli Lilly

Giovanni Selvaggi Employee (full time or part time) Bristol-Myers Squibb

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Bristol-Myers Squibb

Salary Bristol-Myers Squibb

Suresh Senan Speakers or Advisory Board AstraZeneca, Eli Lilly, Merck

Page 131: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

131

Employee (full time or part time) VU University Medical Center

Honoraria Eli Lilly

Supported/Contracted Research/Grant

Varian Medical Systems, ViewRay

Lecia Sequist Speakers or Advisory Board AstraZeneca, Genentech, Pfizer, Bristol-Meyers Squibb, Merrimack Pharma, Blueprint Medicines

Other Merrimack, Novartis, Boehringer Ingelheim

Supported/Contracted Research/Grant

AstraZeneca, Novartis, Genentech, Boehringer Ingelheim, Merck, Merrimack, Guardant Health

Takashi Seto Honoraria Astellas Pharma, AstraZeneca, Bristol-Myers Squibb, Chugai Pharma, Eli Lilly, Merck, Nippon Boehringer Ingelheim, Ono Pharma, Pfizer, Taiho Pharma, Takeda

Supported/Contracted Research/Grant

AstraZeneca, Bayer, Chugai Pharma, Daiichi Sankyo, Eli Lilly, Kissei Pharma, Merck, Nippon Boehringer Ingelheim, Novartis Pharma, Pfizer

David Shames Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Roche, Genentech

Salary Roche, Genentech

Employee (full time or part time) Roche, Genentech

Royalty, Intellectual Property/Patent Holder

UT Southwestern, Genentech

Other Roche

Page 132: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

132

Geetha Shankar Employee (full time or part time) Genentech, Roche

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Roche

Yang W. Shao Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Geneseeq Technology

Employee (full time or part time) Geneseeq Technology

Geoffrey Shapiro Speakers or Advisory Board Pfizer, Eli Lilly, Vertex Pharma, Roche, G1 Therapeutics

Supported/Contracted Research/Grant

Pfizer, Eli Lilly

Sharad Sharma Employee (full time or part time) Lupin

Alan Sharpe Employee (full time or part time) AstraZeneca

Alice Shaw Speakers or Advisory Board Pfizer, Novartis, Genentech, Roche, Ariad, Takeda, Ignyta, Blueprint Medicines, Loxo, Daiichi Sankyo, Merck, Taiho Pharma, KSQ Therapeutics, Natera

Honoraria Pfizer, Novartis, Roche, Genentech, Foundation Medicine, Takeda

Supported/Contracted Research/Grant

Pfizer, Novartis, Roche, Genentech

Jay Shaw Employee (full time or part time) Thermo Fisher Scientific

Pamela Shaw Employee (full time or part time) Mesana Therapeutics

Jenny Sheng Employee (full time or part time) Pfizer

Page 133: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

133

Frances Shepherd Honoraria Bristol-Myers Squibb, Eli Lilly, AstraZeneca, Roche, Genentech, Merck, Novartis, Pfizer

Other Bristol-Myers Squibb, Eli Lilly, Pfizer, AstraZeneca, MedImmune, Roche, Merrimack

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Eli Lilly, AstraZeneca

Speakers or Advisory Board Eli Lilly, AstraZeneca, Merck

Ashwini Shewade Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Roche

Salary Genentech

Employee (full time or part time) Genentech

Other Roche

Weiwei Shi Employee (full time or part time) OrigiMed

Ryota Shiga Employee (full time or part time) Daiichi Sankyo

Jin-Yuan Shih Honoraria AstraZeneca, Roche, Boehringer Ingelheim, Eli Lilly, Pfizer, Novartis, Merck, Ono Pharma, Bristol-Myers Squibb

Michelle Shiller Speakers Bureau AstraZeneca, Merck

Speakers or Advisory Board AbbVie, Agendia, AstraZeneca, Genomic Health, Merck

Honoraria AbbVie, Agendia, AstraZeneca, Genomic Health, Merck, Molecular Match

Shani Shilo Honoraria Novartis, Takeda

Speakers or Advisory Board Novartis, Takeda

Other Bristol-Myers Squibb

Page 134: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

134

Nicole Shipitofsky Employee (full time or part time) Daiichi Sankyo

Lu Shun Speakers Bureau AstraZeneca, Eli Lilly, Roche, Pfizer

Speakers or Advisory Board AstraZeneca, Hutchison MediPharma, Simcere,Bristol-

Myers Squibb, Roche, Pfizer

Supported/Contracted Research/Grant

AstraZeneca

Yu Shyr Speakers or Advisory Board Roche

Salvatore Siena Speakers or Advisory Board Roche, Amgen, Ignyta, Bayer, Novartis, Merck

Diego Signorelli Honoraria AstraZeneca, Boehringer Ingelheim, Bristol Myers Squibb

Alan Sihoe Supported/Contracted Research/Grant

Medela

John Simmons Employee (full time or part time) Personal Genome Diagnostics

George Simon Speakers or Advisory Board Takeda

Supported/Contracted Research/Grant

Merck

Hélène Simon Honoraria Roche

Brian Simpson Employee (full time or part time) Tracon Pharma

Jasmeet Singh Employee (full time or part time) Daiichi Sankyo

Neeraj Singh Employee (full time or part time) Cellworks Research

Simron Singh Honoraria Ipsen, Novartis, Pfizer

Other Ipsen, Novartis

Supported/Contracted Research/Grant

Novartis, Merck

Sumeet Singh Other Roche Canada

Veena Singh Other Biocept

Employee (full time or part time) Biocept

Page 135: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

135

Shankar Siva Speakers Bureau Varian, Astellas, Bristol-Meyers Squibb

Speakers or Advisory Board Janssen, Astellas

Supported/Contracted Research/Grant

Varian, Merck

Other Bristol-Meyers Squibb, AstraZeneca

Stan Skrzypczak Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Guardant Health

Employee (full time or part time) Guardant Health

Tania Small Employee (full time or part time) Novartis

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Novartis

Supported/Contracted Research/Grant

Novartis

Other Novartis

Marie-Anne Smit Employee (full time or part time) Amgen

Derek Smith Employee (full time or part time) Roche

Steve Smith Employee (full time or part time) Loxo

Michael Snee Supported/Contracted Research/Grant

IQVIA

Jeremy Snider Employee (full time or part time) Flatiron Health

Stephanie Snow Speakers or Advisory Board AstraZeneca, Bristol-Meyers Squibb, Eli Lilly, Merck, Novartis, Roche

Mark Socinski Supported/Contracted Research/Grant

Genentech, Pfizer, Spectrum, Bristol-Meyers Squibb

Speakers Bureau Genentech, Bristol-Meyers Squibb, AstraZeneca

Page 136: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

136

Benjamin Solomon Speakers or Advisory Board AstraZeneca, Bristol-Myers Squibb, Merck, Pfizer, Roche, Genentech, Novartis

Honoraria Bristol-Myers Squibb, AstraZeneca

Supported/Contracted Research/Grant

Pfizer

Royalty, Intellectual Property/Patent Holder

Veristrat

Other AstraZeneca, Roche, Merck, Bristol-Myers Squibb, Novartis

Qingtao Song Employee (full time or part time) Amoy Diagnostics

Andreas Sonyi Employee (full time or part time) Eli Lilly

Ross Soo Supported/Contracted Research/Grant

AstraZeneca

Honoraria AstraZeneca, Bristol-Meyers Squibb, Boehringer Ingelheim, Eli Lilly, Merck, Novartis, Pfizer, Celgene, Ignyta, Roche, Taiho

Will Sopwith Supported/Contracted Research/Grant

IQVIA

Jean-Charles Soria Employee (full time or part time) AstraZeneca

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

AstraZeneca

Honoraria AstraZeneca, Bristol-Meyers Squibb, Pfizer, Roche, Sanofi, Pierre Fabre

Speakers or Advisory Board AstraZeneca, Bristol-Meyers Squibb, Pfizer, Roche, Sanofi, Pierre Fabre

Arturo Soto-Matos Employee (full time or part time) PharmaMar

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

PharmaMar

Page 137: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

137

Pierre Jean Souquet Other Roche

Speakers or Advisory Board Roche, Eli Lilly, Pfizer, Boehringer Ingelheim, AstraZeneca, Novartis

Honoraria Bristol-Myers Squibb, Takeda

Supported/Contracted Research/Grant

AstraZeneca, Novartis, Boehringer Ingelheim

Lior Soussan Gutman

Employee (full time or part time) Oncotest Teva Pharmas

Jessica Spahn Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Genentech, Roche

Salary Genentech

Employee (full time or part time) Genentech

ErnstJan Speel Honoraria Pfizer

Jonathan Spicer Other Bristol-Myers Squibb

Speakers or Advisory Board Bristol-Myers Squibb, AstraZeneca

Honoraria AstraZeneca

James Spicer Supported/Contracted Research/Grant

Bristol-Meyers Squibb

Alexander Spiers Honoraria Medtronic

Page 138: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

138

David Spigel Other Genentech, Roche, Celgene, Bristol-Myers Squibb, Eli Lilly, AstraZeneca, Pfizer, Clovis Oncology, Novartis, Boehringer Ingelheim

Supported/Contracted Research/Grant

Genentech, Roche, Novartis, Celgene, Bristol- Myers Squibb, Eli Lilly, AstraZeneca, Pfizer, Clovis Oncology, Boehringer Ingelheim, Peregrine Pharma, Oncogenex, OncoMed, Amgen, Verastem, Daiichi Sankyo, University of Texas Southwestern Medical Center-Simmons Cancer Center, Merck

Alexander Spira Other AbbVie, AstraZeneca, Bristol Myers, Eli Lilly, Takeda, Ariad, Clovis Oncology, Roche

Supported/Contracted Research/Grant

Genentech, Merck, AstraZeneca

Virote Sriuranpong Supported/Contracted Research/Grant

Boehringer Ingelheim

Rolf Stahel Speakers Bureau AstraZeneca, Boehringer Ingelheim, Eli Lilly, Merck, Novartis, Roche

Speakers or Advisory Board AbbVie, AstraZeneca, Bristol-Meyers Squibb, Boehringer Ingelheim, Eli Lilly, Merck, Pfizer, Roche

Elizabeth Stankevich Employee (full time or part time) Regeneron Pharma

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Regeneron Pharma, Celgene, Bristol-Myers Squibb, Merck

Victoria Stefaniak Employee (full time or part time) Eli Lilly

Page 139: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

139

David Stewart Supported/Contracted Research/Grant

Celgene, Boehringer Ingelheim, AstraZeneca, Novartis, Bristol-Myers Squibb

Speakers or Advisory Board Roche

Other Boehringer Ingelheim

Brendon Stiles Employee (full time or part time) Pfizer, Pharmaceutical Product Development

Speakers or Advisory Board Merck, AstraZeneca, Lung Cancer Research Foundation

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Pfizer, Pharmaceutical Product Development

Other Lung Cancer Research Foundation

Thomas Stinchcombe Speakers or Advisory Board Genentech, AstraZeneca, Novartis, Takeda

Martin Stockler Supported/Contracted Research/Grant

AbbVie, Amgen, AstraZeneca, Bayer, Bristol-Meyers Squibb, Celgene, Merck, Pfizer, Roche

Shanna Stopatschinskaja Employee (full time or part time) TP Therapeutics

Jonathan Strosberg Speakers or Advisory Board Novartis, Advanced Accelerator Applications

Honoraria Ipsen, Lexicon

Deepa Subramaniam Speakers Bureau AstraZeneca

Speakers or Advisory Board Bristol-Meyers Squibb

Janakiraman Subramanian Other Alexion, Biocept, Paradigm, AstraZeneca, Pfizer

Speakers Bureau AstraZeneca, Boehringer Ingelheim, Eli Lilly

Supported/Contracted Research/Grant

Biocept, Paradigm

Speakers or Advisory Board AstraZeneca, Pfizer

Sucha Sudarsanam Salary NeoGenomics, Laboratories

Page 140: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

140

Shunichi Sugawara Honoraria AstraZeneca, Chugai Pharma, Nippon Boehringer Ingelheim, Taiho Pharma, Pfizer, Eli Lilly, Novartis, Kyowa Hakko Kirin, Bristol-Myers Squibb, Ono Pharma, Merck

Speakers Bureau Eli Lilly

Masahiro Sugihara Employee (full time or part time) Daiichi Sankyo

Shawn Sun Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Roche

Salary Roche

Employee (full time or part time) Roche

Page 141: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

141

Daniel Sussman Employee (full time or part time) VisionGate

Kazumi Suzukawa Employee (full time or part time) Eli Lilly

Aurélie Swalduz Supported/Contracted Research/Grant

Pfizer, Boehringer Ingelheim

Speakers or Advisory Board Roche

Zsuzsanna Szalai Speakers or Advisory Board Boehringer Ingelheim, Bristol-Myers Squibb, Roche, Pfizer, AstraZeneca, Chiesi, Merck

Aleksandra Szczesna Other Roche

Christopher Szeto Employee (full time or part time) Nantomics

Eric Sztejman Other Medtronic

Maria Taboada Employee (full time or part time) AstraZeneca

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

AstraZeneca

Motoko Tachihara Honoraria Eli Lilly

Hisashi Tachizaki Employee (full time or part time) Canon Medical Systems Corporation

Kosei Tajima Employee (full time or part time) Genentech

Kazuhisa Takahashi Speakers Bureau AstraZeneca, Eli Lilly

Supported/Contracted Research/Grant

AstraZeneca, Eli Lilly

Shunji Takahashi Supported/Contracted Research/Grant

Daiichi Sankyo

Honoraria Daiichi Sankyo

Toshiaki Takahashi Supported/Contracted Research/Grant

Eli Lilly, Merck, Ono Pharma, AstraZeneca, Chugai Pharma

Speakers Bureau Eli Lilly Japan, Ono Pharma, Roche Diagnostics, Novartis Pharma

Page 142: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

142

Speakers or Advisory Board Merck, AstraZeneca, Chugai Pharma, Eli Lilly

Honoraria AstraZeneca, Chugai Pharma, Eli Lilly, Boehringer Ingelheim, Ono Pharma, Pfizer Japan

Yuichiro Takeda Supported/Contracted Research/Grant

Ono Pharma

Mitsuhiro Takenoyama Honoraria AstraZeneca, Bristol-Myers Squibb, Chugai Pharma, Covidien Japan, Eli Lilly, Kyowa Hakko Kirin, Merck, Boehringer Ingelheim, Ono Pharma, Taiho Pharma

Supported/Contracted Research/Grant

AstraZeneca, Bristol-Myers Squibb, Chugai Pharma, Eli Lilly, Kyowa Hakko Kirin, Ono Pharma

Denis Talbot Honoraria Pierre Fabre, Eli Lilly, Pfizer, Novartis, AstraZeneca, Celgene, Boehringer Ingelheim, Bristol-Meyers Squibb, Roche

Other Novartis, Merck, Ipsen, Eli Lilly, Roche

Akihiro Tamiya Supported/Contracted Research/Grant

Ono Pharma, Bristol-Myers Squibb

Speakers Bureau Ono Pharma, Bristol-Myers Squibb, Chugai Pharma, AstraZeneca, Eli Lilly, Boehringer Ingelheim

Honoraria Chugai Pharma, AstraZeneca, Bristol-Myers Squibb, Eli Lilly Pharma, Ono Pharma

Bo Tan Employee (full time or part time) Eli Lilly

Daniel Tan Honoraria National Cancer Centre Singapore, Pfizer, Merck, AstraZeneca, Loxo, Boehringer Ingelheim, Bristol-Meyers Squibb

Page 143: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

143

Speakers or Advisory Board AstraZeneca, Pfizer, Novartis, Merck

Supported/Contracted Research/Grant

GSK, AstraZeneca, Novartis

Fenlai Tan Employee (full time or part time) Bettapharma Pharma

Seng Chuen Tan Employee (full time or part time) Merck

Hiroshi Tanaka Speakers or Advisory Board AstraZeneca, Chugai pharma, Merck

Speakers Bureau Eli Lilly, Ono Pharma, Pfizer, Novartis, T Hiho Pharma, Bristol-Myers Squibb

Supported/Contracted Research/Grant

Astellas, Merck

Fumihiro Tanaka Speakers Bureau Chugai Pharma

Supported/Contracted Research/Grant

Chugai Pharma

Yoshihiko Taniguchi Supported/Contracted Research/Grant

Ono Pharma, Bristol-Myers Squibb

Speakers Bureau Chugai Pharma, Merck

Aiyang Tao Employee (full time or part time) Novartis

Ahmad Tarhini Other Merck, Incyte

Speakers or Advisory Board Merck, Incyte

Janis Taube Speakers or Advisory Board Amgen, AstraZeneca, Merck

Mahesh Tawney Employee (full time or part time) Eli Lilly

Fiona Taylor Employee (full time or part time) Adelphi Values

Other Bristol Myers Squibb

Paul Taylor Other Bristol Myers Squibb, Pierre Fabre

Mustapha Tehfe Speakers or Advisory Board Celgene, Eli Lilly, Pfizer, Ipsen, Merck, Taiho Pharma, AstraZeneca, Bristol-Myers Squibb

Page 144: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

144

Speakers Bureau Celgene

Ricardo Terra Speakers or Advisory Board Johnson & Johnson, Medtronic, H.Strattner, Intuitive

Speakers Bureau AstraZeneca, Boehringer, Merck, Medtronic, H.Strattner

Supported/Contracted Research/Grant

Johnson & Johnson

Nick Thatcher Speakers or Advisory Board Eli Lilly, Boehringer Ingelheim, Otsuka, Roche

Supported/Contracted Research/Grant

Amgen

Alia Thawer Other Novartis

Honoraria Pfizer

Supported/Contracted Research/Grant

Ipsen, Pfizer

Charles Theuer Employee (full time or part time) Tracon Pharma

Michael Thomas Other Novartis, Eli Lilly, Pfizer, Bristol-Meyers Squibb, Roche, AstraZeneca, Boehringer Ingelheim, Merck

Speakers or Advisory Board Merck, Bristol-Meyers Squibb, Eli Lilly, Novartis, Roche, Celgene, AstraZeneca

Matthew Thompson Supported/Contracted Research/Grant

IQVIA

Erik Thunnissen Speakers or Advisory Board Pfizer, Bristol-Meyers Squibb, Merck

Other Diaceutics

Supported/Contracted Research/Grant

Pfizer

Honoraria Oncologia, Histogenix, AstraZeneca, Ventana

Holger Thurm Ownership Interest (stocks or stock options, or other

Pfizer

Page 145: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

145

ownership interest Excluding diversified mutual funds)

Employee (full time or part time) Pfizer

Markus Tiemann Speakers or Advisory Board Novartis, Boehringer Ingelheim, AstraZeneca, Roche

Robert Timmerman Supported/Contracted Research/Grant

Varian Medical Systems, Accuray, Elekta Oncology

Marcello Tiseo Other AstraZeneca, Bristol-Meyers Squibb, Boehringer Ingelheim, Eli Lilly, Novartis, Otsuka, Pierre Fabre, Merck, Pfizer, Roche

Alexander Todd Employee (full time or part time) AstraZeneca

Kanae Togo Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Pfizer

Employee (full time or part time) Pfizer

Dianne Tomita Employee (full time or part time) Amgen

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Amgen

Betty Tong Speakers or Advisory Board Medtronic

Xiaoling Tong Employee (full time or part time) Geneseeq Technology

Aracelis Torres Employee (full time or part time) Flatiron Health

Shinichi Toyooka Honoraria AstraZeneca, Chugai Pharma, Daiichi Sankyo, Astellas Pharma, Boehringer Ingelheim, Taiho Pharma, Ono Pharma, Bayer, Medtronic, Johnson & Johnson, Kyorin

Supported/Contracted Research/Grant

Taiho Pharma

Page 146: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

146

Ryo Toyozawa Speakers Bureau Kyowa Hakko Kirin, Ono Pharma, AstraZeneca, Eli Lilly, Merck, Chugai Pharma, Nippon Boehringer Ingelheim

Honoraria AstraZeneca, Chugai Pharma, Eli Lilly, Kyowa Hakko Kirin, Merck, Nippon Boehringer Ingelheim, Ono Pharma

Diana Tran Employee (full time or part time) Cornerstone Research Group

Spyros Triantos Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Janssen

Salary Janssen

Employee (full time or part time) Janssen

Anne Tsao Speakers or Advisory Board Bristol-Meyers Squibb, Eli Lilly, Genentech, Roche, Novartis, Ariad, Merck, Seattle Genetics, Astra-Zeneca, Boehringer Ingelheim, Sellas Life Science, Takeda, Polaris, Astellas Pharma, Imedex

Supported/Contracted Research/Grant

Eli Lilly, Millennium, Polaris, Genentech, Merck, Boehringer Ingelheim, Bristol-Meyers Squibb, Ariad, Epizyme, Genetics

Other Bristol-Meyers Squibb, Eli Lilly, Genentech, Roche, Novartis, Ariad, Merck, Seattle Genetics, AstraZeneca, Boehringer Ingelheim, Sellas Life Sciences, MedImmune

Honoraria Bristol-Meyers Squibb, Astra-Zeneca, Novartis, Boehringer Ingelheim, Genentech, Roche, Takeda, Ariad, Eli Lilly

Royalty, Intellectual Property/Patent Holder

John Wiley

Page 147: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

147

Ming Tsao Honoraria Merck, AstraZeneca, Bristol Myers Squibb, Pfizer, Roche, Ventana

Supported/Contracted Research/Grant

Merck, Pfizer, Roche, Ventana, AstraZeneca

Speakers or Advisory Board AstraZeneca, Pfizer, Merck, Roche, Ventana, Bristol Myers Squibb, AbbVie, Celgene

Masahiro Tsuboi Speakers or Advisory Board Merck, AstraZeneca

Honoraria AstraZeneca KK, Eli Lilly, Boehringer Ingelheim, Daikichi-Sankyo, Chudai Pharma, Taiho Pharma, Teijin Pharma, Johnson & Johnson

Koji Tsuta Supported/Contracted Research/Grant

Ono Pharma

Michael Tu Other Roche, AstraZeneca

Brian Tuch Employee (full time or part time) Loxo

Ken Tuell Employee (full time or part time) Bristol-Myers Squibb

Tal Twito Employee (full time or part time) Oncotest Teva Pharmas

Dusty Tyree Employee (full time or part time) Roche

Luis Ubillos Speakers Bureau Roche, Tecnofarma

Speakers or Advisory Board Roche, Tecnofarma, Servier, Bayer

Hibiki Udagawa Honoraria Chugai

Yoshiko Urata Supported/Contracted Research/Grant

Chugai

Honoraria Taiho, Novartis

Tiziana Usari Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Pfizer

Employee (full time or part time) Pfizer

Joshua Usher Employee (full time or part time) Liquid Genomics

Page 148: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

148

 

 

 

 

 

 

 

 

 

Anil Vachani Honoraria MagArray

Shireen Vali Employee (full time or part time) Cellworks Group

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Cellworks Group

Other Cellworks Group

Eric Vallieres Speakers or Advisory Board AbbVie, AstraZeneca, Spiration

Speakers Bureau Synthes

Other Spiration, Olympus

Eliezer Van Allen Speakers or Advisory Board Tango Therapeutics, Invitae, Genome Medical

Other Bristol-Myers Squibb, Novartis

Marc van der Schee Employee (full time or part time) Owlstone Medical

Royalty, Intellectual Property/Patent Holder

Owlstone Medical

Bram van Ginneken Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Thirona

Supported/Contracted Research/Grant

MeVis Medical Systems

Page 149: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

149

Peter Van Vlasselaer Employee (full time or part time) Armo BioSciences

Feng Vang Employee (full time or part time) Guardant Health

Johan Vansteenkiste Supported/Contracted Research/Grant

University Hospitals KU Leuven, Merck

Speakers or Advisory Board Apotex, AstraZeneca, Apotex, Boehringer Ingelheim, Merck, Novartis, Roche

Other AstraZeneca, Merck, Bristol-Meyers Squibb, Roche

Honoraria AstraZeneca, Bristol-Meyers Squibb, Merck, Roche

Nebibe Varol Employee (full time or part time) Bristol-Myers Squibb

Sumath Vasista Employee (full time or part time) Cellworks Research, Bangalore

Anne Marie Velasco Roth Employee (full time or part time) Thermo Fisher Scientific

Vamsidhar Velcheti Speakers or Advisory Board Genentech, Bristol-Myers Squibb, Celgene, AstraZeneca, Takeda Oncology Foundation Medicine, Merck, Fulgent Genetics

Other Clovis Oncology, Genertech, Bristol-Myers Squibb, Merck, Celgene, Foundation Medicine, AstraZeneca, MedImmune, Genoptix, Trovagene, Eisai, OncoPlex Diagnostics

Supported/Contracted Research/Grant

Genentech, Bristol-Myers Squibb, Merck, Celgene, Foundation Medicine, AstraZeneca, MedImmune, Genoptix, Atreca, Heat Biologics, Leap Therapeutics, Eisai, OncoPlex Diagnostics, NantOmics, Alkermes, Trovagene

Victor Velculescu Speakers or Advisory Board Personal Genome Diagnostics, Ignyta

Galina Velikova Supported/Contracted Research/Grant

European Organisation for Research and Treatment of Cancer, YCR Cancer Research,

Page 150: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

150

National Institute for Health Research, Breast Cancer Now

Honoraria Novartis, Roche

Alain Vergnenegre Speakers or Advisory Board Merck, Roche, Bristol-Meyers Squibb, Pierre Fabre Oncology, Janssen, Teva, AstraZeneca, Boehringer Ingelheim

Karim Vermaelen Supported/Contracted Research/Grant

Bristol-Myers Squibb

Other Bristol-Myers Squibb, Merck, Roche

Giulia Veronesi Speakers or Advisory Board Medtronic

Honoraria Verbsurgical, Abmedica

Cecile Rose Vibat Employee (full time or part time) Biocept.

Donna Vickery Employee (full time or part time) Bristol-Myers Squibb

Michele Vigliotti Employee (full time or part time) Daiichi Sankyo

Victoria Villaflor Speakers or Advisory Board Takeda, Genentech

Liza Villaruz Speakers or Advisory Board Pfizer

Augusto Villegas Speakers Bureau Celgene, Alexion, Bristol-Meyers Squibb

Speakers or Advisory Board AstraZeneca

Sylvie Vincent Employee (full time or part time) Millennium Pharma, Takeda Pharma

Carla Visseren-Grul Employee (full time or part time) Eli Lilly

Nicholas Vogelzang Honoraria Boehringer Ingelheim

Everett Vokes Other Genentech

Jan Von Der Thüsen

Speakers or Advisory Board AbbVie, Bristol-Meyers Squibb, Merck, Roche

Page 151: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

151

Ute Von Wangenheim

Employee (full time or part time) Boehringer Ingelheim

Anagh Vora Employee (full time or part time) Thermo Fisher Scientific

Pieter Vuylsteke Employee (full time or part time) Agfa HealthCare

Catherine Wadsworth Employee (full time or part time) AstraZeneca

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

AstraZeneca

Momen Wahidi Other Medtronic, Olympus, Boston Scientific

Honoraria CSA, PneumoX, Veran, Intuitive, Medtronic, Uptake

Employee (full time or part time) Vida

Satoshi Wakai Employee (full time or part time) Canon Medical Systems Corporation

Heather Wakelee Honoraria ACEA, Genentech, Novartis, AstraZeneca

Supported/Contracted Research/Grant

Clovis, Exelixis, AstraZeneca, MedImmune, Genentech, Roche, Bristol-Meyers Squibb, Gilead, Novartis, Xcovery, Pfizer, Celgene, Pharmacyclics, Eli Lilly, Acea, Merck

Speakers or Advisory Board ACEA Biosyciences, Pfizer, Novartis, Genentech, Roche, AstraZeneca, Merck

Kazushige Wakuda Honoraria AstraZeneca, Chugai Pharma, Boehringer Ingelheim

Supported/Contracted Research/Grant

AstraZeneca

Andrew Walding Employee (full time or part time) AstraZeneca

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

AstraZeneca

Page 152: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

152

Jill Walker Employee (full time or part time) AstraZeneca

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

AstraZeneca

Ryan Walton Employee (full time or part time) AstraZeneca

Aodi Wang Employee (full time or part time) OrigiMed

Ben Wang Employee (full time or part time) Merrimack Pharma

Buhai Wang Speakers or Advisory Board AstraZeneca, Boehringer Ingelheim, Roche

Speakers Bureau Eli Lilly

Fufeng Wang Employee (full time or part time) Nanjing Geneseeq Technology

Kai Wang Employee (full time or part time) OrigiMed

Kongming Wang Employee (full time or part time) Daiichi Sankyo

Lisa Wang Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Roche

Salary Genentech

Employee (full time or part time) Genentech

Other Roche

Sherry Wang Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Pfizer

Employee (full time or part time) Pfizer

Tao Wang Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Pfizer

Employee (full time or part time) Pfizer

Weifeng Wang Employee (full time or part time) OrigiMed

Xiaonan Wang Employee (full time or part time) Nanjing Geneseeq Technology

Page 153: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

153

Yu Wang Employee (full time or part time) Boehringer Ingelheim

Zuobai Wang Employee (full time or part time) BeiGene

Saiama Waqar Supported/Contracted Research/Grant

Spectrum Pharma, Eli Lilly, Pfizer, Genentech/Roche, Daiichi Sankyo, Newlink Genetics, Puma Biotechnology, Novartis, Xcovery, Synermore biologics, Celgene, Vertex, Bristol-Myers Squibb, Stem CentRx, Hengrui Therapeutics, Checkpoint Therapeutics, Ignyta, AstraZeneca, Merck

Jeffery Wasser Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Merck, Pfizer, Bristol Meyers Squibb, Johnson & Johnson

Chenlu Wei Employee (full time or part time) BeiGene

Uri Weinberg Employee (full time or part time) Novocure

Glen Weiss Speakers Bureau Merck, Novartis, Medscape, Pharmatech, Amgen, Pfizer

Speakers or Advisory Board Blend Therapeutics, IDEA Pharma, Igynta, Angiex, Circulogene, Paradigm, Viomics, GLG Counsel

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Circulogene

Employee (full time or part time) Cancer Treatment Centers of America

Other NantWorks, Cambridge HealthTech Institute, Tesaro

Jared Weiss Supported/Contracted Research/Grant

AstraZeneca, Astellas, Celgene, Merck, Pfizer, Novartis

Speakers or Advisory Board Biodesix, AstraZeneca, Eli Lilly, Merck, Genentech, Clovis Oncology, Inivata, BioMarck Pharma

Page 154: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

154

Ashley Wells Employee (full time or part time) Guardant Health

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Guardant Health

Xiaohui Wen Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Roche

Salary Roche

Employee (full time or part time) Roche

Royalty, Intellectual Property/Patent Holder

Roche

Howard (Jack) West Other Ariad, Genentech, Roche, Takeda

Speakers Bureau Ariad, Bristol-Myers Squibb, Eli Lilly

Speakers or Advisory Board AbbVie, Ariad, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Merck, Roche, Genentech, Takeda, Spectrum

Paul Wheatley-Price Speakers or Advisory Board AstraZeneca, Novartis, Eli Lilly Oncology, Bristol-Meyers Squibb, Merck, Takeda

James White Employee (full time or part time) Personal Genome Diagnostics

Loretta Williams Supported/Contracted Research/Grant

Merck

Salary Merck

Keith Wilner Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Pfizer

Employee (full time or part time) Pfizer

Page 155: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

155

Robin Wiltshire Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Pfizer

Employee (full time or part time) Pfizer

Katherine Winfree Employee (full time or part time) Eli Lilly

Marie Wislez Speakers or Advisory Board AstraZeneca, Boehringer Ingelheim, Roche

Other Pfizer, Novartis, Roche, Chugai

Ignacio Wistuba Other Genentech, Roche, Eli Lilly, Bristol-Myers Squibb, Ariad, HTG Molecular Diagnostics, Asuragen, Pfizer, AstraZeneza, MedImmune

Speakers Bureau Pfizer, Boehringer Ingelheim, Merck, Bristol-Myers Squibb, Genentech, Roche

Supported/Contracted Research/Grant

Genentech, Merck, OncoPlex Diagnostics, Myriad Genetics, HTG Molecular Diagnostics, Silicon Biosystems, Adaptimmune, Pfizer, MedImmune, DepArray, Bristol-Myers Squibb, Adaptive, Takeda, Amgen

Speakers or Advisory Board Genentech, Roche, Bristol-Myers Squibb, AstraZeneca/Medimmune, Pfizer, HTG Molecular, Asuragen, Merck, GlaxoSmithKline, Bayer

B Wolf Employee (full time or part time) Blueprint Medicines Corp

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Blueprint Medicines Corp

Page 156: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

156

Jürgen Wolf Speakers or Advisory Board AbbVie, AstraZeneca, Bristol-Meyers Squibb, Boehringer Ingelheim, Chugai, Ignyta, Eli Lilly, Merck, Novartis, Pfizer, Roche

Supported/Contracted Research/Grant

Bristol-Meyers Squibb, Merck, Novartis, Pfizer

Honoraria AbbVie, AstraZeneca, Bristol-Meyers Squibb, Boehringer Ingelheim, Chugai, Ignyta, Eli Lilly, Merck, Novartis, Pfizer, Roche

Marianne Wolfsteiner Employee (full time or part time) PRA Health Sciences

Other Celgene

Eugene Woltering Speakers or Advisory Board Interscience Institute

Philip Wong Speakers or Advisory Board AstraZeneca, Bristol-Meyers Squibb

Supported/Contracted Research/Grant

Nexplasmagen, Instadesign

Antoinette Wozniak Speakers or Advisory Board AstraZeneca, Takeda, Boehringer Ingelheim, HUYA, BeyondSpring

Supported/Contracted Research/Grant

Boehringer Ingelheim

Jennifer Wu Supported/Contracted Research/Grant

AstraZeneca

Xue Wu Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Geneseeq Technology

Employee (full time or part time) Geneseeq Technology

Yi-Long Wu Speakers or Advisory Board AstraZeneca, Roche, Pfizer, Eli Lilly, Boehringer Ingelheim, Sanofi

Speakers Bureau AstraZeneca, Roche, Boehringer Ingelheim, Eli Lilly, Pfizer, Sanofi

Page 157: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

157

Honoraria AstraZeneca, Eli Lilly, Pfizer, Roche

Other AstraZeneca, Boehringer Ingelheim, Merck, Roche

Supported/Contracted Research/Grant

Boehringer Ingelheim, Roche

Alan Wu Employee (full time or part time) MagArray

Fan Xia Employee (full time or part time) BeiGene

Shuang Xie Employee (full time or part time) Merck

Bin Xu Honoraria Merck, AstraZeneca

Lu Xu Employee (full time or part time) Merck

Xia Xu Employee (full time or part time) Merck

Roi Yair Employee (full time or part time) Oncotest Teva Pharmas

Tadaaki Yamada Supported/Contracted Research/Grant

Ono Pharma, Boehringer Ingelheim, Takeda

Masafumi Yamaguchi Honoraria AstraZeneca, Chugai Pharma, Covidien Japan, Daiichi Sankyo, Eli Lilly, Kyowa Hakko Kirin, Ono Pharma, Taiho Pharma

Noboru Yamamoto Speakers Bureau Bristol-Meyers Squibb, Pfizer, AstraZeneca, Eli Lilly, Ono Pharma, Chugai

Speakers or Advisory Board Eisai, Takeda, OncoTherapy Science, Otsuka, Boehringer Ingelheim

Supported/Contracted Research/Grant

Quintiles, Astellas, Chugai, Esai, Taiho, Bristol-Meyers Squibb, Pfizer, Novartis, Daiichi-Sankyo, Bayer, Boehringer Ingelheim, Kyowa-Hakko Kirin, Takeda, Ono Pharma

Nobuyuki Yamamoto Speakers or Advisory Board Eli Lilly, Quintiles, Astellas, Chugai, Esai, Taiho, Bristol-Meyers Squibb, Pfizer, Novartis, Daiichi-Sankyo, Bayer, Boehringer Ingelheim, Kyowa-

Page 158: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

158

Hakko Kirin, Takeda, Ono, Takeda, OncoTherapy Science

Supported/Contracted Research/Grant

Eli Lilly

Honoraria AstraZeneca, Pfizer, Chugai Pharma, Bristol-Myers Squibb Japan, Ono Pharma, Eli Lilly Japan

Takeharu Yamanaka Supported/Contracted Research/Grant

Taiho, Takeda

Honoraria Taiho, Takeda, Chugai, Boehringer Ingelheim

Hiroaki Yanagimoto Supported/Contracted Research/Grant

Ono Pharma

James Chih-Hsin

Yang Other Boehringer Ingelheim, Eli Lilly, Bayer, Roche, Genentech, Chugai, Astellas, Merck, Novartis, Celgene, Merrimack, Yuhan Pharma, Bristol-Meyers Squibb, Ono Pharma, Daiichi Sankyo, Takeda, AstraZeneca, Hansoh Pharma

Speakers or Advisory Board Boehringer Ingelheim, Eli Lilly, Roche, Genentech, Chugai, Astellas, Merck, Pfizer, Novartis, Takeda, Celgene, Merrimack, Yuhan Pharma, Bristol-Meyers Squibb, Ono Pharma, Daiichi Sankyo, AstraZeneca, Hansoh Pharma

Honoraria Novartis, Roche, Genentech, Eli Lilly and Company, Merck, Celgene, Pfizer, Ono Pharma, Bristol-Myers Squibb, Hansoh, Takeda, Boehringer Ingelheim, Astellas, Merimack, Yuhan Pharma

Lulu Yang Employee (full time or part time) Eli Lilly

Rong Yang Ownership Interest (stocks or stock options, or other

Bristol-Myers Squibb

Page 159: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

159

ownership interest Excluding diversified mutual funds)

Employee (full time or part time) Bristol-Myers Squibb

Ming Yao Employee (full time or part time) OrigiMed

Zane Yang Employee (full time or part time) Spectrum Pharma

Luan Di Yao Employee (full time or part time) Eli Lilly

Kazuhiro Yasufuku Speakers or Advisory Board Concordia, Olympus America

Supported/Contracted Research/Grant

Olympus Corporation, Siemens, Veran Medical Technologies, Novadaq

Other Intuitive Surgical, Medtronic, Johnson & Johnson, Auris Surgical Robotics

Yasushi Yatabe Other Merck, Chugai-Pharma, AstraZeneca, Bristol-Meyers Squibb, Pfizer, Roche, ThermoFisher, Dako

Honoraria AstraZeneca, Merck, Bristol Myers, Chugai-pharma, Pfizer, Roche

Kiyotaka Yoh Speakers or Advisory Board Chugai Pharma, AstraZeneca, Eli Lilly

Honoraria Boehringer Ingelheim, Taiho Pharma, Novartis

Supported/Contracted Research/Grant

Bayer, Eli Lilly, AstraZeneca, Pfizer, Taiho Pharma

Takashi Yokoi Honoraria Chugai Pharma, Bristol-Myers Squibb, Ono Pharma, AstraZeneca, Eli Lilly, Boehringer Ingelheim, Taiho Pharma

Toshihide Yokoyama Speakers Bureau Eli Lilly

Sue Yom Supported/Contracted Research/Grant

Bristol-Myers Squibb, Merck, Genentech

Page 160: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

160

Royalty, Intellectual Property/Patent Holder

Springer, UpToDate

Ichiro Yoshino Honoraria Pfizer, Shionogi, Astellas Pharma, Nippon Boehringer Ingelheim, Daiichi Sankyo Company, Chugai Pharma, Teijin Pharma

Hiroshige Yoshioka Speakers or Advisory Board Chugai, Eli Lilly

Ming You Employee (full time or part time) Nanjing Geneseeq Technology

Jenean Young Employee (full time or part time) Genentech

Channing Yu Employee (full time or part time) Daiichi Sankyo

Helena Yu Other AstraZeneca, Boehringer Ingelheim, Eli Lilly

Supported/Contracted Research/Grant

AstraZeneca, Astellas Pharma, Eli Lilly, Clovis Oncology, Incyte, Daiichi, Novartis

Heng Yu Employee (full time or part time) MagArray

Wei Yu Employee (full time or part time) Genentech, Roche

Yong Yuan Employee (full time or part time) Bristol-Meyers Squibb

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Bristol-Myers Squibb

Salary Bristol-Myers Squibb

Kenneth Yuen Employee (full time or part time) Guardant Health

Gerard Zalcman Speakers or Advisory Board Roche, Boehringer Ingelheim, Pfizer, Bristol-Meyers Squibb, Merck, Oncology

Honoraria Roche, Eli Lilly, Pfizer, Bristol-Meyers Squibb, AstraZeneca, Boehringer Ingelheim

Alona Zer Honoraria Bristol-Meyers Squibb, Eli Lilly, Roche

Page 161: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

161

Bin Zhang Employee (full time or part time) Ipsen BioPharmas

Dan Zhang Employee (full time or part time) Zai Laboratory

Hui Zhang Employee (full time or part time) Daiichi Sankyo

Li Zhang Speakers or Advisory Board Merck, Boehringer Ingelheim

Steven Zhang Other Takeda

Sylvia Zhao Employee (full time or part time) Novartis

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Novartis

Cheng Zheng Employee (full time or part time) Novartis

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

Novartis

Anna Zhou Other Cornerstone Research Group

Caicun Zhou Honoraria Roche, Eli Lilly, Boehringer Ingelheim, Merck, Hengrui, Qiru, Sanofi, Pfizer

HaoJin Zhou Employee (full time or part time) Merck

Edward Zhu Employee (full time or part time) Loxo

Guanshan Zhu Employee (full time or part time) Amoy Diagnostics

Huiping Zhu Employee (full time or part time) Asuragen

Jian Zhu Other Ariad

Viola Zhu Speakers or Advisory Board AstraZeneca, Biocept, Roche, Genentech, Takeda

Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds)

TP Therapeutics

Christoph Zielinski Speakers or Advisory Board Roche, Novartis, Bristol-Meyers Squibb, Merck, Ariad,

Page 162: WCLC 2018 - Disclosure Summary - MASTER - 2018.08.20 LC · 2018. 8. 23. · Ono Pharmaceuticals Thomas Asfeldt Honoraria Association of Community Cancer Centers Vasileios Askoxylakis

  

162

 

 

 

Boehringer Ingelheim, Imugene, Fibrogen, AstraZeneca

Robert Zielinski Honoraria Bristol Myers Squibb